syndrome	score	normalized_score
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	2.09345325	100.0
FIBULAR HEMIMELIA	1.78345962	85.19223536517951
MEIER-GORLIN SYNDROME 1; MGORS1	1.7056264800000003	81.47430471638191
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	1.61657548	77.2205197321698
FOCAL DERMAL HYPOPLASIA; FDH	1.5131501299999999	72.28010131107536
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	1.361696748	65.04548157452285
118610 CHONDROCALCINOSIS DUE TO APATITE CRYSTAL DEPOSITION;;FAMILIAL APATITE DISEASE	1.333333	63.690603074131225
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	1.2413619	59.297330857519746
NAIL-PATELLA SYNDROME	1.2110555600000001	57.84965869192447
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	1.198474628	57.2486931819471
CLEIDOCRANIAL DYSPLASIA; CCD	1.1979220899999998	57.222299566517655
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	1.1937483899999999	57.0229304141375
PSEUDOACHONDROPLASIA	1.1615563199999999	55.485180765321594
CRANIO-CERVICAL DYSTONIA WITH LARYNGEAL AND UPPER-LIMB INVOLVEMENT	1.1455937999999999	54.72268368066017
SPINOCEREBELLAR ATAXIA TYPE 20	1.12474693	53.726871139826024
DIAPHANOSPONDYLODYSOSTOSIS	1.086151738	51.88325738824118
DYGGVE-MELCHIOR-CLAUSEN DISEASE	1.0484324699999998	50.08148474297192
MARSHALL-SMITH SYNDROME; MRSHSS	1.0472726980000002	50.026084795540584
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF	1.0434783	49.84483412753546
GRANT SYNDROME	1.0428422899999998	49.81445322459433
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	1.04253906	49.79996854479554
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	1.027969288	49.10400019680401
HALLERMANN-STREIFF SYNDROME; HSS	1.02644054	49.03097501699644
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	1.0138953979999998	48.4317191224595
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	1.013619738	48.41855140543502
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS	1.0135135	48.413476632449274
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	1.010101	48.25046845445438
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	1.0085354499999999	48.17568531802656
C SYNDROME	1.003735918	47.94642144504541
COCAINE EMBRYOFETOPATHY	1.00200803	47.863883752837566
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	1.000961538	47.81389496039618
259660 OSTEOMALACIA, SCLEROSING, WITH CEREBRAL CALCIFICATION	1.0	47.767964247589475
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	1.0	47.767964247589475
ULNA METAPHYSEAL DYSPLASIA SYNDROME	1.0	47.767964247589475
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	1.0	47.767964247589475
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	1.0	47.767964247589475
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	1.0	47.767964247589475
EHLERS-DANLOS SYNDROME, TYPE I	1.0	47.767964247589475
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	1.0	47.767964247589475
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	1.0	47.767964247589475
DISTAL 16P11.2 MICRODELETION SYNDROME	1.0	47.767964247589475
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	1.0	47.767964247589475
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	47.767964247589475
PELVIS-SHOULDER DYSPLASIA	0.9619051000000001	45.948248426373986
YUNIS-VARON SYNDROME	0.8785718	41.967586331340335
OSGOOD-SCHLATTER DISEASE	0.8666670000000001	41.39891827056563
THANATOPHORIC DYSPLASIA, TYPE II	0.85095209	40.64824901153155
THANATOPHORIC DYSPLASIA, TYPE I	0.85095209	40.64824901153155
HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE	0.833333	39.80662095033648
RESTRICTIVE DERMOPATHY	0.7875002999999999	37.61728617536598
POLAND SYNDROME	0.7580325800000001	36.20967317994801
DYSOSTEOSCLEROSIS	0.68442094	32.69339499222158
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.626011938	29.9033158729482
DUPLICATION/INVERSION 15Q11	0.614846918	29.36998559676458
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.6146075	29.35854908630035
RESTRICTIVE DERMOPATHY, LETHAL	0.611111	29.191528399308652
THORACOLARYNGOPELVIC DYSPLASIA	0.6071429	29.0019803403778
FIBROCHONDROGENESIS 1; FBCG1	0.5996137	28.642325783964846
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.599019798	28.613956294462273
NAIL-PATELLA SYNDROME	0.5989247999999999	28.609418433394673
EXOSTOSES, MULTIPLE, TYPE II	0.5890148199999999	28.136038863060346
EXOSTOSES, MULTIPLE, TYPE I	0.5890148199999999	28.136038863060346
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.58807062	28.090936351217778
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.584294538	27.91056060124581
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.5661451	27.043598895747966
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.562072538	26.84906089973588
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.562072538	26.84906089973588
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.562072538	26.84906089973588
KAGAMI-OGATA SYNDROME	0.5548872	26.50583193104503
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.54724334	26.14070029985145
MOSAIC TRISOMY 1	0.53924787	25.75877297474878
FRONTOMETAPHYSEAL DYSPLASIA	0.53622314	25.614287780250166
COG1-CDG	0.533740588	25.495701325071384
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.5333333	25.476246006448918
TREMOR, HEREDITARY ESSENTIAL, 5; ETM5	0.5324612	25.434587564828586
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.5285714	25.248779737498317
CEREBROCOSTOMANDIBULAR SYNDROME	0.5285714	25.248779737498317
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.5226468900000001	24.965777955633836
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.521399408	24.906188280058316
SPINOCEREBELLAR ATAXIA TYPE 42	0.51971523	24.825738525567743
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.51935099	24.8083395222702
KAPOSIFORM LYMPHANGIOMATOSIS	0.5107527	24.397616712959792
KYPHOMELIC DYSPLASIA	0.50990969	24.357347841419433
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.506643358	24.20132181122268
GREENBERG DYSPLASIA	0.50571429	24.156942124215096
PARANA HARD SKIN SYNDROME	0.50546448	24.145009209066405
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.5054444600000001	24.144052894422174
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.500961538	23.929912836601435
JUVENILE POLYPOSIS OF INFANCY	0.500961538	23.929912836601435
%152800 LYMPHANGIECTASIA, INTESTINAL	0.5	23.883982123794738
TALO-PATELLO-SCAPHOID OSTEOLYSIS, SYNOVITIS, AND SHORT FOURTH METACARPALS	0.5	23.883982123794738
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.5	23.883982123794738
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.5	23.883982123794738
INTESTINAL LYMPHANGIECTASIA	0.5	23.883982123794738
TALO-PATELLO-SCAPHOID OSTEOLYSIS	0.5	23.883982123794738
SPONDYLOMETAPHYSEAL DYSPLASIA, A4 TYPE	0.5	23.883982123794738
DISTAL MYOPATHY WITH POSTERIOR LEG AND ANTERIOR HAND INVOLVEMENT	0.5	23.883982123794738
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.5	23.883982123794738
PARANA HARD-SKIN SYNDROME	0.5	23.883982123794738
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.49225303800000003	23.513925519951307
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.4882206	23.321304165736684
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.48547307	23.190060250927505
SCLEROSTEOSIS 1; SOST1	0.4829055	23.06741265896432
KYPHOMELIC DYSPLASIA	0.4820264	23.025419841594267
YUNIS-VARON SYNDROME	0.45512853799999997	21.740563731241668
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.450961538	21.541514624221964
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.43854670799999995	20.94848346864206
MORQUIO SYNDROME A	0.43345749	20.705381885169874
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.42798471	20.44395832579495
SPONDYLOCOSTAL DYSOSTOSIS 5	0.42173207999999995	20.145282919501543
ULNAR HEMIMELIA	0.39141399999999993	18.697049958005984
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.3818178	18.23865901949327
SPINOCEREBELLAR ATAXIA TYPE 12	0.37657416	17.988181011446038
CAMPOMELIC DYSPLASIA	0.37608429	17.964780918800074
CARTILAGE-HAIR HYPOPLASIA	0.3639389	17.384620363507043
POSTENCEPHALITIC PARKINSONISM	0.3619044	17.287436440245322
COFFIN-LOWRY SYNDROME; CLS	0.3476544979999999	16.606747630977665
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.34696893	16.573999443264377
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.34036658	16.258618624514305
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.33616586	16.05795878174017
SAY-BARBER-MILLER SYNDROME	0.33539061	16.020926667457225
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.33523776	16.01362533412198
ACITRETIN/ETRETINATE EMBRYOPATHY	0.33486204999999997	15.995678432274518
LATHOSTEROLOSIS	0.33486204999999997	15.995678432274518
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.334294538	15.96856953934844
CARTILAGE-HAIR HYPOPLASIA; CHH	0.333333	15.922638826541743
CHONDRODYSPLASIA, LETHAL, WITH LONG BONE ANGULATION AND MIXED BONE DENSITY	0.333333	15.922638826541743
CRANIORACHISCHISIS	0.333333	15.922638826541743
PLACENTAL INSUFFICIENCY	0.333333	15.922638826541743
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.333333	15.922638826541743
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.333333	15.922638826541743
KEUTEL SYNDROME; KTLS	0.333333	15.922638826541743
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.333333	15.922638826541743
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.33330791	15.92144032831877
MEIER-GORLIN SYNDROME 3; MGORS3	0.31788585	15.184759917614594
CAMPOMELIC DYSPLASIA	0.315450638	15.068434797863292
WOLF-HIRSCHHORN SYNDROME	0.31475343	15.035130591046158
OPSISMODYSPLASIA; OPSMD	0.312170328	14.911741067062282
BASAL CELL NEVUS SYNDROME	0.3003104	14.345216450379294
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.2994318	14.303247516991362
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.287676018	13.741697742712905
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.28169532	13.456011974473277
LOEYS-DIETZ SYNDROME 3; LDS3	0.27930685	13.341919624906836
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.27854716	13.305630780147586
SPRENGEL DEFORMITY	0.277027	13.23301583161697
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.27652905	13.209229773819883
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.27652905	13.209229773819883
BRACHYDACTYLY, TYPE E	0.275	13.136190168087108
ATELOSTEOGENESIS TYPE III	0.27438854999999995	13.106982446347914
ACHONDROGENESIS TYPE 1A	0.27389609000000004	13.083458634674553
MYOPATHIC EHLERS-DANLOS SYNDROME	0.26549106	12.681967462134633
EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2	0.2635135	12.58750344675717
HALLERMANN-STREIFF SYNDROME	0.26315013	12.570146001588522
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.2628205	12.55440024753359
OTOONYCHOPERONEAL SYNDROME	0.2626582	12.546647506936207
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.260101	12.424495268762273
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.260101	12.424495268762273
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.25982638999999996	12.411377708100238
TURNPENNY-FRY SYNDROME; TPFS	0.25901898	12.372809376087094
POTOCKI-LUPSKI SYNDROME	0.258046188	12.326341082610753
AICARDI SYNDROME; AIC	0.25800313799999997	12.324284671749892
AICARDI SYNDROME	0.2570416	12.278353958943194
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.2555556	12.207370764071278
CHILDHOOD APRAXIA OF SPEECH	0.2555556	12.207370764071278
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.25364345	12.116031251235249
DISTAL 17P13.1 MICRODELETION SYNDROME	0.25152905	12.015030667630146
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.250961538	11.987921774704068
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.250961538	11.987921774704068
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.25079857	11.980137125106568
NOONAN SYNDROME 4; NS4	0.25	11.941991061897369
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.25	11.941991061897369
ATYPICAL WERNER SYNDROME	0.25	11.941991061897369
OMODYSPLASIA 1; OMOD1	0.25	11.941991061897369
AUTOSOMAL DOMINANT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1A	0.25	11.941991061897369
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.25	11.941991061897369
SINDING-LARSEN-JOHANSSON DISEASE	0.25	11.941991061897369
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.25	11.941991061897369
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.24822053	11.856989402557712
SPINOCEREBELLAR ATAXIA TYPE 18	0.24545450000000002	11.724861780409952
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.24545450000000002	11.724861780409952
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.24388158999999998	11.649727071765275
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.24085129	11.504975809705805
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.23809560000000002	11.373342108308366
DRAVET SYNDROME	0.23409311000000002	11.182151309087033
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.23372812	11.164716479816304
TETRASOMY 9P	0.23166834800000002	11.066325364562118
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.23057943	11.014309968469561
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.23046448000000003	11.008819040979303
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.22974029	10.97422595895084
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.22903932	10.940742049052206
COFFIN-SIRIS SYNDROME 1; CSS1	0.22756395000000001	10.870266627640241
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.22222199999999998	10.615092551027828
CRANIOFRONTONASAL SYNDROME; CFNS	0.22072019799999998	10.543354526784869
CONGENITAL PATELLA DISLOCATION	0.21726512	10.378312484408237
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.21719682800000004	10.375050314593844
CHROMOSOME 1P36 DELETION SYNDROME	0.21678467799999998	10.355362748129195
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.2165438	10.343856496437166
1P36 DELETION SYNDROME	0.21588583	10.312426609001179
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.2116279	10.109033960992441
WIEDEMANN-STEINER SYNDROME	0.21119278000000002	10.088249164389032
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.20941189	10.00317967454014
OSTEOGENESIS IMPERFECTA, TYPE IX	0.20829734	9.94993988998799
CEREBROFACIOTHORACIC DYSPLASIA	0.20809361999999998	9.94020860031147
ANGELMAN SYNDROME	0.20771139800000002	9.92195063348083
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.20365924000000005	9.728387295011247
6Q TERMINAL DELETION SYNDROME	0.20315009	9.704066236014587
CREE MENTAL RETARDATION SYNDROME	0.20283286	9.688912804716322
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.20200803	9.649512354765983
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.20096153800000002	9.599523562324595
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.20096153800000002	9.599523562324595
SPINOCEREBELLAR ATAXIA TYPE 13	0.20096153800000002	9.599523562324595
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.20027911799999998	9.566925748162754
COSTOCORACOID LIGAMENT, CONGENITALLY SHORT	0.20000030000000002	9.553607179907171
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.2	9.553592849517896
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.2	9.553592849517896
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.2	9.553592849517896
CLEFT VELUM	0.2	9.553592849517896
PATELLA, CHONDROMALACIA OF	0.2	9.553592849517896
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.2	9.553592849517896
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.2	9.553592849517896
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.19969099999999998	9.53883254856539
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.19958105	9.533580460896369
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.19946985000000003	9.528268663272039
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.196501968	9.386498982004971
ATELOSTEOGENESIS TYPE II	0.19472931	9.301822718037768
FLOATING-HARBOR SYNDROME	0.19291193	9.215010175173484
ANAUXETIC DYSPLASIA 2; ANXD2	0.192857	9.212386280897364
MICROPHTHALMIA, LENZ TYPE	0.192803	9.209806810827995
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.192105898	9.176507667415072
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.19156767	9.150797611554019
WEAVER SYNDROME	0.191455358	9.145432695953444
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.19101827999999998	9.124554369676035
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.18861589	9.00979709004727
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.1875003	8.956507626812302
SCHWARTZ-JAMPEL SYNDROME	0.18380765	8.780117253633438
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.18344382800000003	8.762738217344955
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.18228692999999999	8.707475555042846
3M SYNDROME	0.1810023	8.646111395131467
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.18085613	8.639129151797395
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.18085613	8.639129151797395
X-LINKED HYPOPHOSPHATEMIA	0.18018050000000002	8.606855682112798
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.179838468	8.590517509765265
HYPOPHOSPHATASIA, INFANTILE	0.17953333800000001	8.5759420708344
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.17690983000000002	8.450622434487133
HEART-HAND SYNDROME TYPE 2	0.17613630000000002	8.413672481102697
CRANIOFRONTONASAL DYSPLASIA	0.17583321	8.399194488818893
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.17502954	8.360804808992032
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.1749383	8.356446459934082
CONGENITAL PSEUDOARTHROSIS OF THE CLAVICLE	0.173611	8.293044040988256
CYSTINOSIS, NEPHROPATHIC; CTNS	0.17234882	8.232752271874237
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.17234882	8.232752271874237
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.17216409000000002	8.223928095838778
SCHNECKENBECKEN DYSPLASIA	0.17029969	8.134869503295572
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.17020057000000002	8.13013474267935
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.17020057000000002	8.13013474267935
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.16917279999999998	8.081040262064604
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.16819605	8.034382902985774
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.16788447799999998	8.019499742829222
TRIGEMINAL NEURALGIA	0.166667	7.961343297252996
PARAGANGLIOMAS 3	0.166667	7.961343297252996
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.166667	7.961343297252996
PARAGANGLIOMAS 4	0.166667	7.961343297252996
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.166667	7.961343297252996
DIAPHRAGMATIC DEFECT-LIMB DEFICIENCY-SKULL DEFECT SYNDROME	0.166667	7.961343297252996
HYPOPHOSPHATASIA, CHILDHOOD	0.166667	7.961343297252996
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.166667	7.961343297252996
WIDOW'S PEAK SYNDROME	0.166667	7.961343297252996
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.166667	7.961343297252996
%169000 PATELLA, FAMILIAL RECURRENT DISLOCATION OF	0.166667	7.961343297252996
PARAGANGLIOMAS 1	0.166667	7.961343297252996
8Q24.3 MICRODELETION SYNDROME	0.16327858800000003	7.7994857539808935
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.16319223800000002	7.795360990268114
NON-DISTAL MONOSOMY 20Q	0.16275520799999998	7.774484956852988
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.1625	7.76229419023329
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.1625	7.76229419023329
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.16056214	7.669726563036456
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.1596458	7.625954866677819
PYKNOACHONDROGENESIS	0.1592533	7.6072059407106405
SPINOCEREBELLAR ATAXIA TYPE 15/16	0.15857353	7.574734711654058
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.15753687	7.525215573837151
MOMO SYNDROME	0.15736368	7.516942640109112
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.15701762800000002	7.500412440545305
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.15690560000000003	7.495061091046577
SPINOCEREBELLAR ATAXIA TYPE 28	0.1565655	7.47881520640597
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.152856638	7.301650418990727
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.15113632000000002	7.219474330272243
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.14727716	7.035130113366515
BRANCHIOSKELETOGENITAL SYNDROME	0.14693518999999997	7.018794902632765
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.14677748799999998	7.011261799134994
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.14285699999999998	6.823988068517889
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.14285699999999998	6.823988068517889
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.14285699999999998	6.823988068517889
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.14285699999999998	6.823988068517889
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.1423853	6.801455919782303
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.142361	6.800295158251085
MEDIAL CONDENSING OSTEITIS OF THE CLAVICLE	0.14141399999999998	6.7550588961086175
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.14043258	6.7081784606367485
GABRIELE-DE VRIES SYNDROME	0.13963342	6.670004214328645
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.13918725	6.648691581720299
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.13858599000000002	6.6199706155367934
9Q33.3Q34.11 MICRODELETION SYNDROME	0.13681172	6.535217349611222
RUIJS-AALFS SYNDROME; RJALS	0.13616616	6.504380262611549
DYSTONIA 16; DYT16	0.13585708999999999	6.489616617901546
AMISH NEMALINE MYOPATHY	0.13390091	6.3961738815996965
KBG SYNDROME	0.13375	6.388965218115093
SPINOCEREBELLAR ATAXIA TYPE 2	0.132905838	6.348641317879919
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.13230801	6.320084291349712
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.13046448	6.232022616220352
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.13043833	6.230773483955278
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.12988729999999998	6.204451902615928
PONTINE TEGMENTAL CAP DYSPLASIA	0.129870498	6.203649305280641
ACHONDROPLASIA	0.12932879	6.177773016904007
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.12873009	6.149174336708976
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.12777438	6.103522015597912
3P25.3 MICRODELETION SYNDROME	0.12726569999999998	6.079223407544447
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.12641875	6.038766330224952
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.125	5.970995530948684
SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS	0.125	5.970995530948684
RAMON SYNDROME	0.125	5.970995530948684
ENTHESITIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.125	5.970995530948684
RHEUMATOID FACTOR-POSITIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.125	5.970995530948684
OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS	0.125	5.970995530948684
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.125	5.970995530948684
RHEUMATOID FACTOR-NEGATIVE JUVENILE IDIOPATHIC ARTHRITIS	0.125	5.970995530948684
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.12452	5.948066908109842
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.12393149999999999	5.919955461150135
GNE MYOPATHY	0.12393149999999999	5.919955461150135
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.12377077	5.912277716256621
FAMILIAL ARTICULAR HYPERMOBILITY SYNDROME	0.1231672	5.883446406075703
PERIVENTRICULAR NODULAR HETEROTOPIA	0.1231672	5.883446406075703
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.12313707	5.882007157312923
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.12225729999999999	5.8399823354068205
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.11904760000000002	5.686661500561334
FRANK-TER HAAR SYNDROME; FTHS	0.11900648	5.684697281871473
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.118283348	5.650154738349184
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.11738188	5.607093447154838
KAGAMI-OGATA SYNDROME	0.11703293799999999	5.590425198174356
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.11682528999999998	5.580506275934272
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.11681436799999999	5.579984554228759
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.11681436799999999	5.579984554228759
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.11639075999999998	5.559749662429766
METATROPIC DYSPLASIA	0.11581529	5.532260632044207
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.11556903799999999	5.52049767531231
OCCIPITAL HORN SYNDROME	0.11552675	5.5184776636402075
ACRO-RENAL-MANDIBULAR SYNDROME	0.11545982999999999	5.5152810314727585
MICROPHTHALMIA, SYNDROMIC 3	0.115146138	5.500296603232004
FIBROCHONDROGENESIS	0.11495498999999999	5.4911658524020055
SPINOCEREBELLAR ATAXIA 12	0.11488864	5.4879964479741785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.11460749999999999	5.474566962505611
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.11460749999999999	5.474566962505611
GAPO SYNDROME	0.11363630000000001	5.428174715628352
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.11301575999999999	5.398532783094153
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.11264004999999999	5.380585881246692
EAR-PATELLA-SHORT STATURE SYNDROME	0.112601	5.378720542242823
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.11249806000000001	5.373803308003176
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.11229535	5.364120263970547
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.11207253799999999	5.353476988320613
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.11207253799999999	5.353476988320613
TREMOR, NYSTAGMUS, AND DUODENAL ULCER	0.11111099999999999	5.307546275513914
PRIMARY DYSTONIA, DYT4 TYPE	0.11111099999999999	5.307546275513914
BRUNNER SYNDROME; BRNRS	0.11111099999999999	5.307546275513914
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.11111099999999999	5.307546275513914
PRIMARY DYSTONIA, DYT27 TYPE	0.11111099999999999	5.307546275513914
GRAFT VERSUS HOST DISEASE	0.11111099999999999	5.307546275513914
COMPLEX REGIONAL PAIN SYNDROME	0.11111099999999999	5.307546275513914
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.11111099999999999	5.307546275513914
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.11111099999999999	5.307546275513914
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.11111099999999999	5.307546275513914
DIAPHANOSPONDYLODYSOSTOSIS	0.1109848	5.301517958425869
CLEIDOCRANIAL DYSPLASIA	0.11013341	5.260848791345114
PIGMENTED VILLONODULAR SYNOVITIS	0.110119	5.260160454980305
PSORIASIS-RELATED JUVENILE IDIOPATHIC ARTHRITIS	0.110119	5.260160454980305
TRISOMY 18	0.110101	5.259300631623849
CORNELIA DE LANGE SYNDROME 1	0.10956097000000001	5.233504497891224
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.1083333	5.174861201223385
MONOSOMY X	0.10816442000000001	5.166794147421252
MOSAIC MONOSOMY X	0.10816442000000001	5.166794147421252
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.10816442000000001	5.166794147421252
TURNER SYNDROME	0.10816442000000001	5.166794147421252
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.10568182000000001	5.048205399380187
CLASSICAL EHLERS-DANLOS SYNDROME	0.10546448	5.0378235100306155
SAGLIKER SYNDROME	0.10492611	5.012106671118641
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.10416660000000001	4.975826424592954
KBG SYNDROME	0.10374533	4.955703214294372
HOLT-ORAM SYNDROME	0.10359716	4.948625435031807
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.103498538	4.94391446286178
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.10323890000000001	4.931512084160466
2P15P16.1 MICRODELETION SYNDROME	0.103231638	4.931165193204099
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.102537	4.897983750055083
NAGER SYNDROME	0.10190476000000001	4.867782932339186
COFFIN-SIRIS SYNDROME	0.1017486	4.860323487042282
TRISOMY 8Q	0.10152905000000001	4.8498360304917245
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.10152905000000001	4.8498360304917245
DISTAL TRISOMY 6P	0.10124533000000001	4.836283303675399
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.1007706	4.81360641800814
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.1	4.776796424758948
GLOMUVENOUS MALFORMATION	0.1	4.776796424758948
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.1	4.776796424758948
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.1	4.776796424758948
METAPHYSEAL ANADYSPLASIA	0.1	4.776796424758948
KAPOSI SARCOMA	0.1	4.776796424758948
DESMINOPATHY	0.1	4.776796424758948
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.09967966000000002	4.761494435091876
ISOLATED KLIPPEL-FEIL SYNDROME	0.099628	4.759026742058844
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.09848077000000002	4.704225900435084
OCULOSKELETODENTAL SYNDROME; OCSKD	0.09762717000000001	4.663451166153341
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.09754238999999999	4.659401398144429
PELIZAEUS-MERZBACHER DISEASE	0.09721182800000001	4.643611124346818
KUSKOKWIM SYNDROME	0.09696969999999999	4.632045162699477
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.09641363	4.60548283082032
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.09580791	4.576548819516271
ELLIS-VAN CREVELD SYNDROME	0.09543208999999998	4.55859666319274
PSEUDOAMINOPTERIN SYNDROME	0.09527101000000002	4.55090219951174
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.095123998	4.543879735551773
LETHAL KNIEST-LIKE DYSPLASIA	0.09454219	4.516087951808812
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.09429109999999999	4.504093893665884
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.09416246	4.4979490227450745
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.09405919000000001	4.493016025077226
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.09375	4.478246648211513
SPINOCEREBELLAR ATAXIA TYPE 36	0.09357323000000001	4.4698027051714675
SCHNECKENBECKEN DYSPLASIA	0.09337659	4.460409612681821
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.0929825	4.441584735651488
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.09291713	4.438462143828624
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.092803	4.4330103860690455
CRANE-HEISE SYNDROME	0.092803	4.4330103860690455
PATELLA APLASIA-HYPOPLASIA	0.09263160000000001	4.42482295699701
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.092484668	4.417804314474183
BECKER NEVUS SYNDROME	0.09217894	4.403200310300695
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.09210523000000001	4.399679333656007
DESBUQUOIS SYNDROME	0.0920795	4.398450263935915
JEUNE SYNDROME	0.09207789	4.398373357513476
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.0909965	4.346717558655776
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.0909091	4.342542638580537
CONGENITAL DIAPHRAGMATIC HERNIA	0.0909091	4.342542638580537
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.089527	4.276522535193943
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	0.0894318	4.271975024997573
GENITOPATELLAR SYNDROME; GTPTS	0.089411408	4.2710009406706355
WILLIAMS SYNDROME	0.08925555	4.263555921298935
FRYNS SYNDROME; FRNS	0.08914417	4.258235525441038
NOONAN SYNDROME 6; NS6	0.08903245800000001	4.252899270619012
ACRORENAL-MANDIBULAR SYNDROME	0.08868264	4.236189176901848
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.0886477	4.2345201642310375
RARE CIRCULATORY SYSTEM DISEASE	0.087619	4.185381259409542
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.08696429	4.154107095537003
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.086656568	4.139407842042806
WOLCOTT-RALLISON SYNDROME	0.08636362	4.125414312452404
OROFACIODIGITAL SYNDROME TYPE 3	0.08631116	4.122908405047975
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.08532819	4.075953929231522
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.08486235000000002	4.0537017007664256
KENNERKNECHT SYNDROME	0.08486235000000002	4.0537017007664256
PROTEUS SYNDROME	0.08457863000000002	4.0401489739500995
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.08374455	4.0003066703304695
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.08351465999999999	3.989325293029591
METACHONDROMATOSIS	0.08333330000000001	3.980662095033649
BOWEN-CONRADI SYNDROME	0.08333330000000001	3.980662095033649
ISOLATED HEMIHYPERPLASIA	0.08333330000000001	3.980662095033649
LARON SYNDROME	0.08333330000000001	3.980662095033649
CORACOCLAVICULAR JOINT, ANOMALOUS	0.08333330000000001	3.980662095033649
OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	0.08333330000000001	3.980662095033649
APHALANGY-HEMIVERTEBRAE-UROGENITAL-INTESTINAL DYSGENESIS SYNDROME	0.08333330000000001	3.980662095033649
POSTPOLIOMYELITIS SYNDROME	0.08333330000000001	3.980662095033649
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.08333330000000001	3.980662095033649
CALCIFICATION OF JOINTS AND ARTERIES; CALJA	0.08333330000000001	3.980662095033649
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.08333330000000001	3.980662095033649
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.08314971	3.9718923744774335
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.08260492000000001	3.9458688652349894
TUBEROUS SCLEROSIS COMPLEX	0.08184921	3.9097701369734437
CRANIOFACIOFRONTODIGITAL SYNDROME	0.08184886	3.9097534181859563
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.08160486000000002	3.898098034909545
SCARF SYNDROME	0.08143811	3.8901327268712587
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.08141914000000001	3.889226568589483
DDOST-CDG	0.08132106800000001	3.8845418687997935
%300712 CRANIOFACIOSKELETAL SYNDROME	0.08125	3.881147095116645
THREE M SYNDROME 2; 3M2	0.08114245	3.876009650561817
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.08108062799999999	3.8730565394761016
KNIEST DYSPLASIA	0.0806818	3.8540053378311643
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.0806818	3.8540053378311643
BECKWITH-WIEDEMANN SYNDROME	0.08045667000000001	3.843251336040105
OTOFACIOCERVICAL SYNDROME	0.07999388	3.821144799865963
CERVICAL RIB	0.0797414	3.809084344252732
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.0797348	3.808769075688697
WAARDENBURG SYNDROME, TYPE 1; WS1	0.0796586	3.805129156813031
TRISOMY 8P	0.07912996800000001	3.7798774823368997
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.0781441	3.7327845749600566
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.07792199999999999	3.722175310100667
GENOCHONDROMATOSIS TYPE 1	0.07792199999999999	3.722175310100667
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.077884638	3.720390603420449
ETHYLMALONIC ENCEPHALOPATHY	0.077884638	3.720390603420449
NOONAN SYNDROME 2; NS2	0.07777780000000001	3.715287169656165
ULBRIGHT-HODES SYNDROME	0.07774545	3.713741876012755
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.07774545	3.713741876012755
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.0771825	3.6868509005395746
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	3.674459890613751
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.07692310000000001	3.674459890613751
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	3.674459890613751
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	3.674459890613751
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	3.674459890613751
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.07661163	3.6595816027895536
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.07603393	3.631986049843721
MONOSOMY 18P	0.07600955	3.6308214668753647
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0753205	3.5979069511105632
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.07456218	3.5616835484623315
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.07400129	3.5348909749955006
SCHINZEL-GIEDION SYNDROME	0.07382712	3.526571228662498
NOONAN SYNDROME	0.07357172000000001	3.514371290593664
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.072390138	3.457929523862069
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.07232639	3.4548844116772135
48,XXYY SYNDROME	0.07210787	3.44444615612983
OSTEOGENESIS IMPERFECTA, TYPE X	0.071652448	3.422691574316264
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.07142860000000001	3.41199881105537
CAMPTODACTYLY 1; CAMPD1	0.07142860000000001	3.41199881105537
MELNICK-NEEDLES SYNDROME	0.0707773	3.380887535940915
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.07018179999999999	3.352441713231475
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.069827968	3.335539878905822
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.06945962	3.317944644811151
MEIER-GORLIN SYNDROME 7	0.06944108	3.317059026754001
HUNTINGTON DISEASE-LIKE 2	0.06943413999999999	3.316727517082122
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.069175338	3.304365072398918
MYCETOMA	0.0688956	3.291002557616226
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.068390308	3.2668657874256324
RAPADILINO SYNDROME	0.06819575	3.25757214783755
BALLER-GEROLD SYNDROME	0.06819575	3.25757214783755
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.06818182	3.2569067400955816
NEONATAL MARFAN SYNDROME	0.06796448	3.2465248507460096
MICROPHTHALMIA, SYNDROMIC 1	0.067841988	3.2406736572693946
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.06771258999999999	3.234492578231684
SPINOCEREBELLAR ATAXIA 27; SCA27	0.06753313000000001	3.2259201393678127
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.06753313000000001	3.2259201393678127
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0672078	3.210379787559144
FIBROCHONDROGENESIS 2; FBCG2	0.06679199999999999	3.190517868024996
COXOPODOPATELLAR SYNDROME	0.0666667	3.1845325421047734
ANIRIDIA-ABSENT PATELLA SYNDROME	0.0666667	3.1845325421047734
ANIRIDIA AND ABSENT PATELLA	0.0666667	3.1845325421047734
MEIER-GORLIN SYNDROME 2; MGORS2	0.0666667	3.1845325421047734
17Q23.1Q23.2 MICRODELETION SYNDROME	0.06656165	3.179514517460564
MUCOPOLYSACCHARIDOSIS TYPE 7	0.06603357	3.1542892109006972
MUCOPOLYSACCHARIDOSIS TYPE 1	0.06603357	3.1542892109006972
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.06595871	3.150713301097123
HUNTINGTON DISEASE-LIKE 1	0.065366298	3.1224149858612797
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.06533286	3.120817720672769
8P23.1 MICRODELETION SYNDROME	0.06527438	3.11802425012357
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.06515492	3.112317889114553
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.0646598	3.0886670146562865
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.06458868999999999	3.0852702347186396
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.06440476	3.0764842730545814
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.06440476	3.0764842730545814
SHORT RIB-POLYDACTYLY SYNDROME	0.06430008999999999	3.0714844002367854
HARROD SYNDROME	0.06402905	3.058537371207119
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.06396791	3.0556168378730217
IVIC SYNDROME	0.06374533	3.044984644390793
CHIME SYNDROME	0.06374533	3.044984644390793
HOLT-ORAM SYNDROME	0.06354716	3.035518466915849
XYLT1-CDG	0.0634615	3.0314266630984
X-LINKED DYSTONIA-PARKINSONISM	0.0630542	3.0119707712603567
ULNAR-MAMMARY SYNDROME	0.06279447999999999	2.999564475585972
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.0625	2.985497765474342
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.0625	2.985497765474342
SPRENGEL DEFORMITY	0.0625	2.985497765474342
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0625	2.985497765474342
DILATED CARDIOMYOPATHY WITH ATAXIA	0.0625	2.985497765474342
UROCANIC ACIDURIA	0.0625	2.985497765474342
CARIBBEAN PARKINSONISM	0.0625	2.985497765474342
WILD TYPE ABETA2M AMYLOIDOSIS	0.0625	2.985497765474342
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.0625	2.985497765474342
DISTAL MONOSOMY 9P	0.0625	2.985497765474342
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.0625	2.985497765474342
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0625	2.985497765474342
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.0625	2.985497765474342
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.0625	2.985497765474342
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.0625	2.985497765474342
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.0625	2.985497765474342
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.0625	2.985497765474342
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.062124378	2.9675550672077344
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.061968550000000004	2.960111480874961
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.061727040000000004	2.948575039829526
NOONAN SYNDROME 7; NS7	0.060504208000000004	2.8901628445727177
17P11.2 MICRODUPLICATION SYNDROME	0.06048171	2.889088160913075
MUCOLIPIDOSIS III GAMMA	0.060134370000000006	2.8724964362113177
SIALURIA	0.060050708	2.8685000727864356
22Q11.2 DELETION SYNDROME	0.05970614	2.852040760881572
FEMORAL-FACIAL SYNDROME	0.05952233	2.843260531373222
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.059195319999999996	2.827639929384618
LÉRI-WEILL DYSCHONDROSTEOSIS	0.059195319999999996	2.827639929384618
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.059185869999999995	2.8271885221224786
MELNICK-NEEDLES SYNDROME	0.05899709	2.818170885831819
MOSAIC TRISOMY 8	0.058589669999999996	2.7987092618380656
MYHRE SYNDROME	0.05857976000000001	2.798235881312373
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.058333300000000005	2.7864629888439114
EMANUEL SYNDROME	0.058272278000000004	2.783548092129595
GENITOPATELLAR SYNDROME	0.05809653	2.7751529679490097
RENPENNING SYNDROME 1; RENS1	0.05799588	2.7703451223474893
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.05789261	2.765412124679641
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.0578703	2.7643464213972773
ACROCEPHALOPOLYDACTYLY	0.0575658	2.7498010762838865
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.057082400000000005	2.726710042366602
FLOATING-HARBOR SYNDROME	0.056800930000000006	2.7132647934698326
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.056560578	2.7017836677269957
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.056517138	2.699708627360081
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.0561547	2.6823957019341127
TRICHOTHIODYSTROPHY	0.056123008	2.680881839611178
KNIEST-LIKE DYSPLASIA, LETHAL	0.05608059	2.6788556181037237
ODONTOCHONDRODYSPLASIA; ODCD	0.05594227	2.672248353288998
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.055555600000000004	2.653777914553382
FAMILIAL DEVELOPMENTAL DYSPHASIA	0.055555600000000004	2.653777914553382
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.055555600000000004	2.653777914553382
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.055555600000000004	2.653777914553382
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.05546446	2.649424342291857
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.05546446	2.649424342291857
DESBUQUOIS DYSPLASIA 2; DBQD2	0.055391428	2.6459357523269267
TREMOR, HEREDITARY ESSENTIAL, 1	0.0553161	2.6423374871160843
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.0553161	2.6423374871160843
PELVIS-SHOULDER DYSPLASIA	0.055303	2.6417117267844406
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.055303	2.6417117267844406
ULNAR-MAMMARY SYNDROME; UMS	0.055303	2.6417117267844406
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.05478003	2.616730514521879
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.05433080999999999	2.5952721896225763
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.05433080999999999	2.5952721896225763
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.05433080999999999	2.5952721896225763
OCULOCEREBRORENAL SYNDROME OF LOWE	0.054212359999999994	2.5896140742574496
ROBERTS SYNDROME	0.05418725	2.588414620675193
MOSAIC TRISOMY 9	0.05416065	2.587143992826207
8P11.2 DELETION SYNDROME	0.05416065	2.587143992826207
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.0539897	2.5789780593380818
MUCOLIPIDOSIS III ALPHA/BETA	0.05389987	2.574687063109721
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.05387693	2.573591266009881
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.05387693	2.573591266009881
INCONTINENTIA PIGMENTI; IP	0.05387693	2.573591266009881
ROTHMUND-THOMSON SYNDROME	0.05387693	2.573591266009881
INCONTINENTIA PIGMENTI	0.05387693	2.573591266009881
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.05377193	2.568575629763884
SCARF SYNDROME	0.05372168000000001	2.566175289560443
SCHOLTE SYNDROME; SHLTS	0.053593138	2.5600350999001287
FGFR2-RELATED BENT BONE DYSPLASIA	0.053571400000000005	2.5589967198933152
BENT BONE DYSPLASIA SYNDROME; BBDS	0.053571400000000005	2.5589967198933152
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.0535347	2.5572436356054284
AYMÉ-GRIPP SYNDROME	0.0526316	2.5141043870934308
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.0526316	2.5141043870934308
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.0526316	2.5141043870934308
PRIMARY PULMONARY HYPOPLASIA	0.0526316	2.5141043870934308
ACROMELIC FRONTONASAL DYSPLASIA	0.0526316	2.5141043870934308
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.0526316	2.5141043870934308
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.052166550000000006	2.491889895320089
THORACOMELIC DYSPLASIA	0.051872310000000005	2.4778346495198784
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.051478658000000004	2.4590306948578866
SHPRINTZEN-GOLDBERG SYNDROME	0.05124178	2.4477155150228453
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.051195399999999995	2.4455000368410422
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.051168790000000006	2.4442289313124146
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.05091898	2.432296016163724
LATERAL MENINGOCELE SYNDROME	0.050777948	2.4255592046299577
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.050439899999999996	2.4094113398519883
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.05013626	2.3949070751878505
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.050101	2.3932227767684804
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.05	2.388398212379474
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.05	2.388398212379474
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.05	2.388398212379474
SPONDYLOOCULAR SYNDROME; SOS	0.05	2.388398212379474
CHROMOSOME 10Q26 DELETION SYNDROME	0.049566128	2.367673030195444
MULTIPLE SYSTEM ATROPHY	0.049404699999999996	2.359961943262884
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.04937268	2.358432413047676
RHIZOMELIC SYNDROME, URBACH TYPE	0.04914805	2.3477022952387396
TARP SYNDROME; TARPS	0.048801748	2.3311601536838715
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.04867815	2.325256128838798
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.04867431	2.325072699856087
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.048611100000000004	2.322053286835997
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.048372500000000006	2.3106558505665222
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.048144839999999994	2.2997809958259157
RIGID SPINE MUSCULAR DYSTROPHY 1	0.047945088000000004	2.2902392494315316
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.047709360000000006	2.278979002755376
MUCOPOLYSACCHARIDOSIS TYPE 6	0.04767689	2.2774279769562566
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, KOHN TYPE	0.047619	2.274662689505963
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.047619	2.274662689505963
HEMIMELIA	0.047619	2.274662689505963
CRANIO-OSTEOARTHROPATHY	0.047619	2.274662689505963
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 2	0.047619	2.274662689505963
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.047619	2.274662689505963
OSTEOCHONDRITIS DISSECANS	0.047619	2.274662689505963
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 61	0.047619	2.274662689505963
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.047619	2.274662689505963
BLOUNT DISEASE	0.047619	2.274662689505963
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.047619	2.274662689505963
POPLITEAL CYST	0.047619	2.274662689505963
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.04746253	2.267188436140143
TARP SYNDROME	0.047272698	2.2581205479510946
BARATELA-SCOTT SYNDROME	0.04719854	2.2545781712584216
NEMALINE MYOPATHY 2; NEM2	0.04698355	2.2443085366248323
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.04655352	2.2237668789594416
OROFACIODIGITAL SYNDROME III	0.046311160000000004	2.2121898351443963
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.046252680000000004	2.209396364595197
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.04619049	2.2064256748986395
211120 BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	0.04619049	2.2064256748986395
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.04619049	2.2064256748986395
OTOFACIOCERVICAL SYNDROME	0.04615380000000001	2.2046730682903957
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.04611828999999999	2.2029768278799633
MUCOPOLYSACCHARIDOSIS TYPE 3	0.04608581999999999	2.2014258020808435
ACROCAPITOFEMORAL DYSPLASIA	0.04570692999999999	2.1833269981070744
DIAMOND-BLACKFAN ANEMIA 1	0.045525670000000004	2.1746685769075573
PENOSCROTAL TRANSPOSITION	0.04546448	2.171745655175247
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.0454545	2.171268930892056
REIFENSTEIN SYNDROME	0.0454545	2.171268930892056
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.0454545	2.171268930892056
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.0454545	2.171268930892056
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.0454545	2.171268930892056
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0454545	2.171268930892056
X-LINKED CENTRONUCLEAR MYOPATHY	0.0454545	2.171268930892056
DYSTONIA 23; DYT23	0.0454545	2.171268930892056
WILLIAMS-BEUREN SYNDROME; WBS	0.045307168	2.16423118118353
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.045244889999999996	2.161256287906119
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.045040659999999996	2.1515006365678335
48,XXXY SYNDROME	0.04484593	2.1421987808899003
CRANIOFACIOFRONTODIGITAL SYNDROME	0.04482793	2.141338957533444
ANOCTAMIN-5-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R12	0.0440705	2.105158068373392
HURLER SYNDROME	0.043937569999999995	2.09880827288596
CHARGE SYNDROME	0.0434343	2.074768089519076
DOORS SYNDROME	0.04334495	2.0705000219135536
THORACIC DYSOSTOSIS, ISOLATED	0.04330906	2.0687856296767078
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.043254730000000005	2.0661903961791364
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.043254730000000005	2.0661903961791364
MEIER-GORLIN SYNDROME 6; MGORS6	0.04315009	2.0611919564002683
COSTELLO SYNDROME; CSTLO	0.04302243	2.055093898084421
MUCOPOLYSACCHARIDOSIS TYPE 4	0.042962669999999994	2.0522392845409847
RECOMBINANT 8 SYNDROME	0.04283286	2.0460385251020057
ATELOSTEOGENESIS, TYPE I; AO1	0.04275129	2.0421420922583295
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.04268036	2.0387539105542483
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.04268036	2.0387539105542483
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.04268036	2.0387539105542483
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.04268036	2.0387539105542483
SMITH-MCCORT DYSPLASIA 2; SMC2	0.0423963	2.025184942630078
COHEN SYNDROME	0.042357658	2.0233390929556223
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.04220733	2.016158230426211
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.0420849	2.0103099985633786
METACHROMATIC LEUKODYSTROPHY	0.042029960000000005	2.007685626607616
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.04190476	2.001705077483818
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.041796299999999995	1.9965241640815239
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.04179528	1.9964754407579917
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.04164933	1.9895037063760557
MUCOLIPIDOSIS TYPE IV	0.04153343	1.9839673993197602
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.04152905	1.9837581756363558
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.04149433799999999	1.9821000540613931
ACROOSTEOLYSIS DOMINANT TYPE	0.04125615	1.9707222981931887
RENPENNING SYNDROME	0.04120619	1.9683358106993791
MARFAN SYNDROME; MFS	0.04107639	1.9621355289400417
CAP MYOPATHY	0.041037748	1.9602896792655866
DIENCEPHALIC SYNDROME	0.041030029999999995	1.9599210061175234
LESCH-NYHAN SYNDROME	0.041030029999999995	1.9599210061175234
ISOLATED CEREBELLAR AGENESIS	0.041030029999999995	1.9599210061175234
NEURONAL CEROID LIPOFUSCINOSIS	0.041030029999999995	1.9599210061175234
HSD10 DISEASE, ATYPICAL TYPE	0.041030029999999995	1.9599210061175234
HUNTINGTON DISEASE	0.041030029999999995	1.9599210061175234
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.041007768	1.9588575956974437
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.04079267	1.9485828021237162
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.04057057	1.9379735372643263
OSTEOGENESIS IMPERFECTA	0.04052675	1.935880345070997
THORACOMELIC DYSPLASIA	0.0404762	1.933465674478281
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.040471919999999995	1.9332612275913013
CLARK-BARAITSER SYNDROME	0.04046539	1.9329493027847648
ATKIN-FLAITZ SYNDROME	0.04046539	1.9329493027847648
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.040436	1.9315454023155283
PAGOD SYNDROME	0.040403999999999995	1.930016827459605
DIASTROPHIC DWARFISM	0.040403999999999995	1.930016827459605
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.040357149999999994	1.9277788983346054
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.040225409999999996	1.9214859467246281
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.04	1.9107185699035794
SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1	0.04	1.9107185699035794
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.04	1.9107185699035794
SJOGREN-LARSSON SYNDROME; SLS	0.04	1.9107185699035794
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.04	1.9107185699035794
SPONDYLO-OCULAR SYNDROME	0.04	1.9107185699035794
CZECH DYSPLASIA, METATARSAL TYPE	0.04	1.9107185699035794
FRYNS-SMEETS-THIRY SYNDROME	0.04	1.9107185699035794
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.04	1.9107185699035794
TIBIAL HEMIMELIA-POLYSYNDACTYLY-TRIPHALANGEAL THUMB SYNDROME	0.04	1.9107185699035794
MEIER-GORLIN SYNDROME 5; MGORS5	0.04	1.9107185699035794
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.03999055	1.9102671626414394
NEURALGIC AMYOTROPHY	0.0398475	1.9034339553558217
SECKEL SYNDROME 5; SCKL5	0.03981138	1.9017085764871988
SECKEL SYNDROME 1; SCKL1	0.03981138	1.9017085764871988
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.039717699999999995	1.8972336735964843
SMITH-FINEMAN-MYERS SYNDROME	0.039627090000000004	1.8929054183560108
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.03956598	1.8899863180608403
YOU-HOOVER-FONG SYNDROME; YHFS	0.039548998	1.889175122491988
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.03942240799999999	1.883128175897885
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.03856605	1.8422216975707482
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.038547160000000004	1.8413193607261114
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.0385305	1.8405235464417464
WEILL-MARCHESANI SYNDROME 2; WMS2	0.0384615	1.837227556908663
WEILL-MARCHESANI SYNDROME 1; WMS1	0.0384615	1.837227556908663
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.038460869999999994	1.8371974630911865
WHITE FORELOCK WITH MALFORMATIONS	0.03837333	1.8330158555009528
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0382206	1.8257202543214186
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.038204888	1.8249697240671603
FOCAL DERMAL HYPOPLASIA	0.03815013	1.8223540458808907
49,XXXXY SYNDROME	0.03801506	1.815902026949969
PSEUDOTRISOMY 13 SYNDROME	0.037998538	1.81511280464467
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.037939919999999995	1.8123127421164047
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.037728648	1.802220708773888
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.037722330000000005	1.801918910775772
HAMAMY SYNDROME; HMMS	0.03769521	1.8006234435853772
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.03724335	1.7790390112604617
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.037128	1.7735289765845021
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.037128	1.7735289765845021
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.037037	1.7691820918379717
SECKEL SYNDROME 4	0.037037	1.7691820918379717
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.037037	1.7691820918379717
CHST3-RELATED SKELETAL DYSPLASIA	0.03693182	1.7641578573584098
CDAGS SYNDROME	0.0369048	1.76286716696444
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.03685724	1.7605953225848248
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.03671448	1.753775968008839
SPONDYLOPERIPHERAL DYSPLASIA	0.03671448	1.753775968008839
MARFANOID HABITUS WITH SITUS INVERSUS	0.03671448	1.753775968008839
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.03649083	1.7430926628048657
SOTOS SYNDROME	0.03628323	1.733176033427066
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.03616616	1.7275838378526007
THUMBS, CONGENITAL CLASPED	0.0361093	1.7248677514054827
PYCNODYSOSTOSIS	0.036017289999999993	1.7204726210150616
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.036017289999999993	1.7204726210150616
9P13 MICRODELETION SYNDROME	0.03601185	1.720212763289555
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.035803818	1.710275498151201
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.03580089	1.7101356335518836
JUVENILE PAGET DISEASE	0.03576748	1.7085397058663716
SPINOCEREBELLAR ATAXIA TYPE 27	0.035728130000000004	1.7066600364732294
JAWAD SYNDROME	0.035714300000000004	1.705999405527685
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.035714300000000004	1.705999405527685
DUPLICATION OF THE PITUITARY GLAND	0.035714300000000004	1.705999405527685
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.035714300000000004	1.705999405527685
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.035714300000000004	1.705999405527685
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.035714300000000004	1.705999405527685
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.035714300000000004	1.705999405527685
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.03550554	1.6960273653113582
JACOBSEN SYNDROME	0.035342728	1.6882501675162795
AARSKOG-SCOTT SYNDROME	0.03532819	1.687555716852048
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.03509096	1.6762237226935923
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.03486235	1.6653034883869509
FRANK-TER HAAR SYNDROME	0.03478357	1.6615403281635261
15Q OVERGROWTH SYNDROME	0.03456473000000001	1.6510867868675838
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.0344828	1.6471731575567785
NORMAL PRESSURE HYDROCEPHALUS	0.0344828	1.6471731575567785
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.0344828	1.6471731575567785
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.0344828	1.6471731575567785
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.0344828	1.6471731575567785
DYSTONIA 7, TORSION	0.0344828	1.6471731575567785
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.0344828	1.6471731575567785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.0344828	1.6471731575567785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.0344828	1.6471731575567785
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0344828	1.6471731575567785
PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	0.0344828	1.6471731575567785
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.0344828	1.6471731575567785
SPINAL MUSCULAR ATROPHY, TYPE IV	0.0344828	1.6471731575567785
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.0344828	1.6471731575567785
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.0344828	1.6471731575567785
SPINAL MUSCULAR ATROPHY, TYPE II	0.0344828	1.6471731575567785
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.034469230000000003	1.646524946281939
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.034459048	1.6460385728699696
RAPID-ONSET DYSTONIA-PARKINSONISM	0.034459048	1.6460385728699696
STUVE-WIEDEMANN SYNDROME	0.034453038	1.6457514874048416
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.03426613	1.636823272743253
EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	0.03408286	1.6280688379355974
MAN1B1-CDG	0.03403588	1.6258246989752458
ACHONDROGENESIS TYPE 1B	0.033997089999999994	1.6239717796420816
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.033740587999999995	1.6117192012766464
OCULODENTODIGITAL DYSPLASIA	0.03355636	1.6029190047592419
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.03350343	1.6003906464116167
PYRIDOXINE-DEPENDENT EPILEPSY	0.03350343	1.6003906464116167
SARCOSINEMIA	0.03350343	1.6003906464116167
LEIGH SYNDROME	0.03350343	1.6003906464116167
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.03350343	1.6003906464116167
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.03350343	1.6003906464116167
SIALIDOSIS TYPE 2	0.033482578	1.599394588821126
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.033422738	1.5965361538405503
GRANT SYNDROME	0.0333333	1.5922638826541744
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.0333333	1.5922638826541744
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0333333	1.5922638826541744
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.0333333	1.5922638826541744
LINEAR NEVUS SEBACEUS SYNDROME	0.03325803	1.5886683879852581
SPINOCEREBELLAR ATAXIA TYPE 43	0.03324228	1.5879160425483585
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.03322226	1.5869597279041223
GRISCELLI SYNDROME TYPE 1	0.033219637999999996	1.5868344803018648
VAN MALDERGEM SYNDROME 2; VMLDS2	0.03320487800000001	1.5861294251495708
VAN MALDERGEM SYNDROME 1; VMLDS1	0.03320487800000001	1.5861294251495708
BRADDOCK SYNDROME	0.033135859999999996	1.58283257579313
MACS SYNDROME	0.03284042	1.5687200084358226
RIN2 SYNDROME	0.03284042	1.5687200084358226
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.03270882	1.5624337443408398
AMYOTROPHIC LATERAL SCLEROSIS	0.03270391	1.562199203636384
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.03268223	1.5611635941714963
LINEAR VERRUCOUS NEVUS SYNDROME	0.03249533	1.552235761653622
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.03249533	1.552235761653622
LERI PLEONOSTEOSIS	0.03249533	1.552235761653622
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.032461199999999996	1.5506054410338512
FG SYNDROME TYPE 1	0.03245694	1.5504019495061567
AUTOSOMAL DOMINANT OMODYSPLASIA	0.0322581	1.540903767495166
MERRF	0.0322581	1.540903767495166
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	1.540903767495166
FLYNN-AIRD SYNDROME	0.0322581	1.540903767495166
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.540903767495166
SANDHOFF DISEASE	0.0322581	1.540903767495166
ATYPICAL RETT SYNDROME	0.0322581	1.540903767495166
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.0322581	1.540903767495166
OXOGLUTARIC ACIDURIA	0.0322581	1.540903767495166
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.0322581	1.540903767495166
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.0322581	1.540903767495166
LOWRY-WOOD SYNDROME	0.0322581	1.540903767495166
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.0322581	1.540903767495166
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.0322581	1.540903767495166
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.540903767495166
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.540903767495166
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0322581	1.540903767495166
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.540903767495166
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.032211538	1.53867959554387
KETOADIPICACIDURIA	0.032211538	1.53867959554387
PARKINSON DISEASE, LATE-ONSET; PD	0.03200783	1.528948879082922
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.03192304	1.5248986333943688
BETA-THALASSEMIA MAJOR	0.03188453	1.5230590890911941
COOPER-JABS SYNDROME	0.03154833	1.5069994995111544
PELVISCAPULAR DYSPLASIA	0.03154833	1.5069994995111544
JACOBSEN SYNDROME	0.03154833	1.5069994995111544
MARDEN-WALKER SYNDROME	0.031513718	1.505346154732617
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.031274300000000005	1.493909644268388
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.031274300000000005	1.493909644268388
RITSCHER-SCHINZEL SYNDROME 1	0.031264537999999994	1.4934433334014023
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.03125	1.492748882737171
PALLISTER-HALL SYNDROME	0.03125	1.492748882737171
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.03125	1.492748882737171
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.03125	1.492748882737171
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.03125	1.492748882737171
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.03125	1.492748882737171
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.03125	1.492748882737171
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.03125	1.492748882737171
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.03125	1.492748882737171
PROTEUS-LIKE SYNDROME	0.03125	1.492748882737171
PALLISTER-HALL SYNDROME	0.03125	1.492748882737171
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.03125	1.492748882737171
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.03125	1.492748882737171
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.03125	1.492748882737171
O'SULLIVAN-MCLEOD SYNDROME	0.031214230000000003	1.491040222656035
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.031100119999999995	1.4855894202557423
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.031061988000000002	1.4837679322430535
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.031005628	1.4810757297780592
ELLIS VAN CREVELD SYNDROME	0.03082324	1.47236342631487
JOUBERT SYNDROME 21	0.030778268	1.4702152054267275
RAINE SYNDROME	0.03067771	1.4654117544779184
SIALIDOSIS TYPE 1	0.03061628	1.4624773684341887
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.03057943	1.460717118951665
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.03057943	1.460717118951665
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.03057943	1.460717118951665
PARKINSONISM WITH SPASTICITY, X-LINKED	0.03057943	1.460717118951665
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.03055218	1.4594154419259184
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.030302999999999997	1.4475126205947038
ACROCALLOSAL SYNDROME	0.030302999999999997	1.4475126205947038
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.030302999999999997	1.4475126205947038
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.030302999999999997	1.4475126205947038
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.030302999999999997	1.4475126205947038
HYPEROSTOSIS CORTICALIS GENERALISATA	0.030302999999999997	1.4475126205947038
CAUDAL REGRESSION SEQUENCE	0.030302999999999997	1.4475126205947038
DYSTONIA, JUVENILE-ONSET	0.030302999999999997	1.4475126205947038
CLEIDORHIZOMELIC SYNDROME	0.030302999999999997	1.4475126205947038
OSTEOGLOSPHONIC DYSPLASIA	0.030302999999999997	1.4475126205947038
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.030302999999999997	1.4475126205947038
CLEIDORHIZOMELIC SYNDROME	0.030302999999999997	1.4475126205947038
AURICULOOSTEODYSPLASIA	0.030302999999999997	1.4475126205947038
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.030302999999999997	1.4475126205947038
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.030302999999999997	1.4475126205947038
184705 STEINFELD SYNDROME	0.030302999999999997	1.4475126205947038
OCULOCEREBROCUTANEOUS SYNDROME	0.030302999999999997	1.4475126205947038
3C SYNDROME	0.030302999999999997	1.4475126205947038
BARTSOCAS-PAPAS SYNDROME; BPS	0.030302999999999997	1.4475126205947038
LEGIUS SYNDROME	0.030268388000000004	1.4458592758161666
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.03010045	1.437837219436355
VASCULAR EHLERS-DANLOS SYNDROME	0.02985986	1.426344724918027
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.029840610000000004	1.4254251916062612
GAPO SYNDROME; GAPOS	0.02981673	1.4242844926200287
EPIDERMAL NEVUS SYNDROME	0.02968256	1.4178754648569296
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.02967914	1.4177120984192029
SIFRIM-HITZ-WEISS SYNDROME	0.029495108000000003	1.4089212644227906
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.029306850000000002	1.3999285630094678
TYPICAL NEMALINE MYOPATHY	0.029271520000000002	1.3982409208326005
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 TYPE	0.02914866	1.3923721487451415
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.02902313	1.3863758361931418
PHACE SYNDROME	0.02902313	1.3863758361931418
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.028739338000000003	1.3728196700833897
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.02872878	1.3723153359168636
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.0285714	1.364797613703578
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0285714	1.364797613703578
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.0285714	1.364797613703578
WAISMAN SYNDROME; WSMN	0.0285714	1.364797613703578
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.0285714	1.364797613703578
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.0285714	1.364797613703578
ATYPICAL JUVENILE PARKINSONISM	0.0285714	1.364797613703578
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0285714	1.364797613703578
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0285714	1.364797613703578
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.02855605	1.3640643754523774
HURLER SYNDROME	0.02853357	1.3629905516160918
SMITH-KINGSMORE SYNDROME; SKS	0.028522668	1.3624697852698646
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.028361180000000003	1.35475583225945
TRISOMY 1Q	0.028282799999999997	1.3510117792217236
WAARDENBURG SYNDROME TYPE 1	0.02827233	1.3505116486360513
SICKLE CELL ANEMIA	0.0279941	1.3372211679434447
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.027969288000000005	1.3360359492145337
PRIMROSE SYNDROME; PRIMS	0.027848708000000003	1.330276088085559
ANAPLASTIC THYROID CARCINOMA	0.027777800000000002	1.326888957276691
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.027777800000000002	1.326888957276691
POEMS SYNDROME	0.027777800000000002	1.326888957276691
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.027777800000000002	1.326888957276691
PRIMARY HYPEROXALURIA TYPE 3	0.027777800000000002	1.326888957276691
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.027777800000000002	1.326888957276691
HEREDITARY PAINFUL CALLOSITIES	0.027777800000000002	1.326888957276691
EPENDYMOMA	0.027777800000000002	1.326888957276691
MEESTER-LOEYS SYNDROME; MRLS	0.027777800000000002	1.326888957276691
NOONAN SYNDROME 5; NS5	0.027777800000000002	1.326888957276691
OSTEOSARCOMA	0.027777800000000002	1.326888957276691
BUERGER DISEASE	0.027777800000000002	1.326888957276691
FIBROMATOSIS, GINGIVAL, 5; GINGF5	0.027777800000000002	1.326888957276691
THYROID LYMPHOMA	0.027777800000000002	1.326888957276691
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.027777800000000002	1.326888957276691
PENTALOGY OF CANTRELL	0.027777800000000002	1.326888957276691
NOONAN SYNDROME 10; NS10	0.027777800000000002	1.326888957276691
INFANTILE DIGITAL FIBROMATOSIS	0.027777800000000002	1.326888957276691
INTERSTITIAL CYSTITIS	0.027777800000000002	1.326888957276691
CLUSTER HEADACHE, FAMILIAL	0.027777800000000002	1.326888957276691
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.027777800000000002	1.326888957276691
VULVOVAGINAL GINGIVAL SYNDROME	0.027777800000000002	1.326888957276691
SUBEPENDYMOMA	0.027777800000000002	1.326888957276691
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.027777800000000002	1.326888957276691
NOONAN SYNDROME 8; NS8	0.027777800000000002	1.326888957276691
ACATALASEMIA	0.027777800000000002	1.326888957276691
TUFTED ANGIOMA	0.027777800000000002	1.326888957276691
OROMANDIBULAR DYSTONIA	0.027777800000000002	1.326888957276691
RETINAL CAPILLARY MALFORMATION	0.027777800000000002	1.326888957276691
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.02756113	1.3165390724631658
GAUCHER DISEASE, PERINATAL LETHAL	0.02756113	1.3165390724631658
INFANTILE SIALIC ACID STORAGE DISEASE	0.027300758	1.3041016320760925
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.027027	1.2910247697196007
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.027027	1.2910247697196007
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.027027	1.2910247697196007
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.027027	1.2910247697196007
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.027027	1.2910247697196007
PYLE DISEASE; PYL	0.02695842	1.2877488427315011
WITTEVEEN-KOLK SYNDROME	0.026917277999999996	1.2857835731464267
SWEENEY-COX SYNDROME; SWCOS	0.026529050000000002	1.2672387119225137
MANDIBULOACRAL DYSPLASIA	0.026529050000000002	1.2672387119225137
ATELOSTEOGENESIS, TYPE II	0.0263158	1.2570521935467154
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.0263158	1.2570521935467154
HYDROPS FETALIS, NONIMMUNE, WITH GRACILE BONES AND DYSMORPHIC FEATURES	0.0263158	1.2570521935467154
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.02575941	1.230474575918999
DISTAL MONOSOMY 10Q	0.025258610000000004	1.2065523794238062
COLE-CARPENTER SYNDROME 2; CLCRP2	0.02519521	1.2035238904905088
BOHRING-OPITZ SYNDROME	0.025141419999999998	1.200954451693631
9Q31.1Q31.3 MICRODELETION SYNDROME	0.025	1.194199106189737
PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA	0.025	1.194199106189737
MUCOLIPIDOSIS TYPE II	0.02481017	1.185131313536617
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.02481017	1.185131313536617
SHWACHMAN-DIAMOND SYNDROME	0.024607818	1.1754653704351887
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.024563	1.1733245058135404
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.02442669	1.1668132546069516
THANATOPHORIC DYSPLASIA TYPE 2	0.02389609	1.1414675727771804
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.02389609	1.1414675727771804
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.02389609	1.1414675727771804
THANATOPHORIC DYSPLASIA	0.02389609	1.1414675727771804
ACHONDROGENESIS	0.02389609	1.1414675727771804
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.02386362	1.1399165469780612
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.023699598	1.132081549946243
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.023323888	1.1141346480987813
RAYNAUD-CLAES SYNDROME; MRXSRC	0.022934978	1.0955572091232513
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.02292322	1.0949955533996283
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.02290158	1.0939618546533103
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.02284133	1.091083834807393
DYSTONIA 16	0.02284133	1.091083834807393
DYSTONIA, DOPA-RESPONSIVE; DRD	0.02284133	1.091083834807393
SPINOCEREBELLAR ATAXIA 15	0.02284133	1.091083834807393
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 17	0.02284133	1.091083834807393
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.02280565	1.089379473843039
PSEUDOXANTHOMA ELASTICUM	0.02280565	1.089379473843039
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.022738059999999997	1.0861508371395443
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.022738059999999997	1.0861508371395443
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.022738059999999997	1.0861508371395443
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.022285430000000002	1.0645296234821582
TONNE-KALSCHEUER SYNDROME; TOKAS	0.022008798000000003	1.051315475996419
CRANIOECTODERMAL DYSPLASIA 1	0.021980999999999997	1.0499876221262643
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.021858598	1.0441407277664307
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.021794838	1.0410950423660046
SPINOCEREBELLAR ATAXIA TYPE 1	0.021794838	1.0410950423660046
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.021794838	1.0410950423660046
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.021794838	1.0410950423660046
SPINOCEREBELLAR ATAXIA 2; SCA2	0.021794838	1.0410950423660046
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.02161918	1.0327042173022014
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.021532660000000002	1.0285713330355002
GALACTORRHEA	0.0212766	1.0163398681102622
CENTRIFUGAL LIPODYSTROPHY	0.0212766	1.0163398681102622
104600 AMENORRHEA-GALACTORRHEA SYNDROME	0.0212766	1.0163398681102622
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.0212766	1.0163398681102622
HERNIA, HIATUS	0.0212766	1.0163398681102622
INTERMEDIATE NEMALINE MYOPATHY	0.0212766	1.0163398681102622
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.0212766	1.0163398681102622
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.0212766	1.0163398681102622
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.0212766	1.0163398681102622
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	0.0212766	1.0163398681102622
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.0212766	1.0163398681102622
SERTOLI CELL-ONLY SYNDROME	0.0212766	1.0163398681102622
NIPPLES, SUPERNUMERARY	0.0212766	1.0163398681102622
FIBROSCLEROSIS, MULTIFOCAL	0.0212766	1.0163398681102622
ACROPECTORAL SYNDROME	0.0212766	1.0163398681102622
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.0212766	1.0163398681102622
FASCIAL DYSTROPHY, CONGENITAL	0.0212766	1.0163398681102622
OCULOCEREBROCUTANEOUS SYNDROME	0.0212766	1.0163398681102622
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.0212766	1.0163398681102622
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0212766	1.0163398681102622
ACHONDROPLASIA, SO-CALLED, AND SEVERE COMBINED IMMUNODEFICIENCY	0.0212766	1.0163398681102622
CRISS-CROSS HEART	0.0212766	1.0163398681102622
BREAST, UNILATERAL GIANT	0.0212766	1.0163398681102622
INFANTILE MYOFIBROMATOSIS	0.0212766	1.0163398681102622
PYCNODYSOSTOSIS	0.0212766	1.0163398681102622
WERNER SYNDROME	0.0212766	1.0163398681102622
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.0212766	1.0163398681102622
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.0212766	1.0163398681102622
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.0212473	1.014940266757808
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.021183040000000004	1.011870697375258
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.021025378	1.0043395045960544
BRACHYOLMIA, MAROTEAUX TYPE	0.021014659999999998	1.0038275275552486
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.0208333	0.9951643295593058
GILLESPIE SYNDROME; GLSP	0.0208333	0.9951643295593058
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.0208333	0.9951643295593058
SPINOCEREBELLAR ATAXIA 20	0.0208333	0.9951643295593058
PRIMARY PROGRESSIVE FREEZING GAIT	0.0208333	0.9951643295593058
DYSTONIA 27; DYT27	0.0208333	0.9951643295593058
PRIMARY DYSTONIA, DYT13 TYPE	0.0208333	0.9951643295593058
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.0208333	0.9951643295593058
GRACILE BONE DYSPLASIA; GCLEB	0.0208333	0.9951643295593058
SEVERE CONGENITAL NEMALINE MYOPATHY	0.0208333	0.9951643295593058
MANGANESE POISONING	0.0208333	0.9951643295593058
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.0208333	0.9951643295593058
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.0208333	0.9951643295593058
LEBER HEREDITARY OPTIC NEUROPATHY	0.0208333	0.9951643295593058
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.0208333	0.9951643295593058
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.0208333	0.9951643295593058
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.0208333	0.9951643295593058
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.020440649999999998	0.9764082383974897
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.02039983	0.9744583500969033
DESBUQUOIS DYSPLASIA 1	0.020189328	0.9644030980868572
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.020169720000000002	0.9634664638438906
MENTAL RETARDATION, X-LINKED 90	0.020126898	0.9614209440788801
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.019691780000000002	0.9406362430113977
CRYPTOCOCCOSIS	0.01952463	0.9326518277874131
SCLERODERMA	0.01952463	0.9326518277874131
RHEUMATIC FEVER	0.01952463	0.9326518277874131
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.01952463	0.9326518277874131
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.019420308	0.927668578221176
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.01925172	0.9196154726646033
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.019246518000000004	0.9193669837145875
VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR	0.01919532	0.9169213594810393
NEUROFIBROMATOSIS TYPE 1	0.01919532	0.9169213594810393
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.01919532	0.9169213594810393
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.01919532	0.9169213594810393
SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE	0.01919532	0.9169213594810393
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.01919532	0.9169213594810393
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.01919532	0.9169213594810393
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.01919532	0.9169213594810393
PSEUDOACHONDROPLASIA	0.01919532	0.9169213594810393
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.01897798	0.9065394701314681
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.018872930000000003	0.901521445487259
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.9012811726270935
LETTERER-SIWE DISEASE	0.0188679	0.9012811726270935
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.9012811726270935
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.9012811726270935
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.9012811726270935
TRACHEOBRONCHOMEGALY	0.0188679	0.9012811726270935
SPINAL ARACHNOIDITIS	0.0188679	0.9012811726270935
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.9012811726270935
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.9012811726270935
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.9012811726270935
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	0.9012811726270935
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.9012811726270935
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.9012811726270935
THROMBOCYTOPENIA 3	0.0188679	0.9012811726270935
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.0188679	0.9012811726270935
HHHH SYNDROME	0.0188679	0.9012811726270935
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.9012811726270935
PUBIC BONE DYSPLASIA	0.0188679	0.9012811726270935
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0188679	0.9012811726270935
RAYNAUD DISEASE	0.0188679	0.9012811726270935
VESICOURETERAL REFLUX 1	0.0188679	0.9012811726270935
CARPAL DISPLACEMENT	0.0188679	0.9012811726270935
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.9012811726270935
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.9012811726270935
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.9012811726270935
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.9012811726270935
MONOPHALANGY OF GREAT TOE	0.0188679	0.9012811726270935
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.9012811726270935
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.9012811726270935
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.9012811726270935
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.9012811726270935
TOE, MISSHAPEN	0.0188679	0.9012811726270935
KNUCKLE PADS	0.0188679	0.9012811726270935
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.9012811726270935
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.9012811726270935
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	0.9012811726270935
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.9012811726270935
NEPHROSIALIDOSIS	0.0188679	0.9012811726270935
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.9012811726270935
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.9012811726270935
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.9012811726270935
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.9012811726270935
BAND HETEROTOPIA; BH	0.0188679	0.9012811726270935
VAN DEN BOSCH SYNDROME	0.0188679	0.9012811726270935
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.9012811726270935
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.9012811726270935
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.9012811726270935
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.0188679	0.9012811726270935
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.9012811726270935
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.01859832	0.8884038848252285
STÜVE-WIEDEMANN SYNDROME	0.018340020000000002	0.8760654196600761
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.018301498	0.8742253021413303
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.018284980000000003	0.8734362709078889
SPONDYLOEPIPHYSEAL DYSPLASIA AND SPONDYLOEPIMETAPHYSEAL DYSPLASIA	0.018181799999999998	0.8685075723568223
FRASER SYNDROME 2; FRASRS2	0.018181799999999998	0.8685075723568223
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.018181799999999998	0.8685075723568223
DISTAL MONOSOMY 17Q	0.018181799999999998	0.8685075723568223
BRACHYOLMIA	0.018181799999999998	0.8685075723568223
SPONDYLOSPINAL THORACIC DYSOSTOSIS	0.018181799999999998	0.8685075723568223
AUTOSOMAL DOMINANT BRACHYOLMIA	0.018181799999999998	0.8685075723568223
SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE	0.018181799999999998	0.8685075723568223
BRUCK SYNDROME 2	0.018122680000000002	0.8656835303105049
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.018093968	0.8643120165210281
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.018067808	0.8630624065763112
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.017747558	0.8477647160260205
OLIVER SYNDROME	0.01768375	0.8447167377633106
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.017619089999999997	0.8416280611950612
METATROPIC DYSPLASIA	0.017619089999999997	0.8416280611950612
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.017619089999999997	0.8416280611950612
MOSAIC TRISOMY 14	0.01734434	0.8285038130180361
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.017337340000000003	0.8281694372683032
MENKES DISEASE	0.01731908	0.827297194241142
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.8235865787783893
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.8235865787783893
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.8235865787783893
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.8235865787783893
MYOPATHY, CONGENITAL	0.0172414	0.8235865787783893
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.8235865787783893
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.8235865787783893
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.8235865787783893
269800 SENILE PLAQUE FORMATION	0.0172414	0.8235865787783893
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.8235865787783893
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.8235865787783893
PALMOMENTAL REFLEX	0.0172414	0.8235865787783893
ALCOHOL DEPENDENCE	0.0172414	0.8235865787783893
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.8235865787783893
ERYTHERMALGIA, PRIMARY	0.0172414	0.8235865787783893
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.8235865787783893
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.8235865787783893
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.8235865787783893
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.8235865787783893
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.8235865787783893
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.8235865787783893
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.8235865787783893
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.8235865787783893
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.8235865787783893
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.8235865787783893
RHEUMATOID ARTHRITIS	0.0172414	0.8235865787783893
MOSAIC TRISOMY 15	0.0172414	0.8235865787783893
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.8235865787783893
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.8235865787783893
CARDIAC ARRHYTHMIA	0.0172414	0.8235865787783893
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.8235865787783893
JUMPING FRENCHMAN OF MAINE	0.0172414	0.8235865787783893
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.8235865787783893
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.8235865787783893
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.8235865787783893
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.8235865787783893
TRANSSEXUALITY	0.0172414	0.8235865787783893
DIASTEMATOMYELIA	0.0172414	0.8235865787783893
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.8235865787783893
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.8235865787783893
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.8235865787783893
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.8235865787783893
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.8235865787783893
MOTION SICKNESS	0.0172414	0.8235865787783893
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.8235865787783893
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.8235865787783893
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.8235865787783893
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.8235865787783893
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.8235865787783893
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.017215848000000002	0.822366011755935
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.017182410000000002	0.820768746567424
ANTLEY-BIXLER SYNDROME	0.017060620000000002	0.8149510862017101
TEMTAMY SYNDROME	0.01704707	0.8143038302861552
PACHYDERMOPERIOSTOSIS	0.01704707	0.8143038302861552
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.01702011	0.8130160059700402
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.016926788	0.8085582040105267
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.01692414	0.808431714441199
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.01678602	0.8018340032193219
3Q29 MICRODELETION SYNDROME	0.01665726	0.7956834001428024
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.01655401	0.7907513578342388
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.016502228	0.7882778371095701
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.016502228	0.7882778371095701
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.016502228	0.7882778371095701
SIMPSON-GOLABI-BEHMEL SYNDROME	0.01646743	0.7866156074896824
CHROMOSOME 17P13.1 DELETION SYNDROME	0.016394118	0.7831136424947631
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.016377678000000003	0.782328337162533
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.01636973	0.7819486773826928
OROFACIODIGITAL SYNDROME XIV; OFD14	0.016362837999999998	0.7816194605730985
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.016221370000000002	0.7748618222069207
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.0161547	0.7716771320305338
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.016025868	0.7655230896605882
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.016004348	0.7644951230699802
COWDEN SYNDROME 6; CWS6	0.01598981	0.7638006724057487
COWDEN SYNDROME 5; CWS5	0.01598981	0.7638006724057487
SLC39A8-CDG	0.01591156	0.760062829203375
TRISOMY 13	0.015815290000000003	0.7554642072852595
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.015815290000000003	0.7554642072852595
HYPOPHOSPHATASIA	0.015815290000000003	0.7554642072852595
HEART DEFECTS-LIMB SHORTENING SYNDROME	0.015815290000000003	0.7554642072852595
OTOPALATODIGITAL SYNDROME TYPE 2	0.015815290000000003	0.7554642072852595
OSTEOPETROSIS AND RELATED DISORDERS	0.01578282	0.7539131814861402
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.01567881	0.7489448355247484
AUTOIMMUNE HYPOPARATHYROIDISM	0.01567881	0.7489448355247484
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.01567881	0.7489448355247484
PLAGUE	0.01567881	0.7489448355247484
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.015590748000000001	0.7447382930571772
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.015590748000000001	0.7447382930571772
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.015566828000000001	0.7435956833523749
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.01556548	0.7435312921365691
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.01556548	0.7435312921365691
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.01556548	0.7435312921365691
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.01554069	0.7423471243028713
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.015524498000000001	0.7415736654257744
ANGELMAN SYNDROME	0.01552179	0.7414443097785919
CLASSIC HOMOCYSTINURIA	0.015508210000000001	0.7407956208241097
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.015311088000000002	0.7313795041756964
NEMALINE MYOPATHY 4	0.015311088000000002	0.7313795041756964
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.015307028	0.7311855662408511
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.01525696	0.7287939198069028
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.015148788000000002	0.7236267635783126
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0151244	0.7224617984662423
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.01504255	0.7185519905925771
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.01504255	0.7185519905925771
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.014965118	0.7148532215849577
ALAGILLE SYNDROME	0.014879900000000001	0.7107825312077067
CARDIOFACIOCUTANEOUS SYNDROME	0.01482263	0.7080468598952472
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.01477799	0.7059144979712348
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.014758829999999999	0.704999263776251
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.014725260000000002	0.7033956932164596
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.014666230000000002	0.7005759502869243
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.014666230000000002	0.7005759502869243
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.014666230000000002	0.7005759502869243
COFFIN-LOWRY SYNDROME	0.01460529	0.6976649705456761
SPINOCEREBELLAR ATAXIA 5; SCA5	0.014597467999999999	0.6972913295293314
SPINOCEREBELLAR ATAXIA TYPE 10	0.014597467999999999	0.6972913295293314
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.014562960000000002	0.6956429526190757
LAMB-SHAFFER SYNDROME	0.014502218	0.6927414309347487
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.014494198	0.692358331861483
VERVERI-BRADY SYNDROME; VERBRAS	0.014494198	0.692358331861483
SPINOCEREBELLAR ATAXIA TYPE 29	0.014494198	0.692358331861483
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.014494198	0.692358331861483
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.014349550000000003	0.6854487913689977
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.014349550000000003	0.6854487913689977
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.014349550000000003	0.6854487913689977
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.01422897	0.6796889302400233
NON-FUNCTIONING PARAGANGLIOMA	0.014189130000000001	0.6777858545443993
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.014187250000000002	0.677696050771614
ROBERTS SYNDROME; RBS	0.014187250000000002	0.677696050771614
MONOSOMY 9Q22.3	0.014179190000000001	0.6773110409797783
COFFIN-SIRIS SYNDROME 6; CSS6	0.014158838	0.6763388673714114
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.0140236	0.6698788234224958
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.01401163	0.6693070408904522
MOWAT-WILSON SYNDROME; MOWS	0.014000708	0.66878531918494
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.013979160000000001	0.667756015091333
ZTTK SYNDROME; ZTTKS	0.013836918	0.6609614043208274
BETHLEM MYOPATHY 2; BTHLM2	0.013782038000000002	0.6583398984429197
20Q11.2 MICRODUPLICATION SYNDROME	0.013735669999999998	0.6561249934766873
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.013635930000000001	0.6513606167226328
SPINOCEREBELLAR ATAXIA 34; SCA34	0.013635930000000001	0.6513606167226328
SPINOCEREBELLAR ATAXIA TYPE 6	0.013635930000000001	0.6513606167226328
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.013635930000000001	0.6513606167226328
PARKINSONIAN-PYRAMIDAL SYNDROME	0.013635930000000001	0.6513606167226328
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.013635930000000001	0.6513606167226328
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.013635930000000001	0.6513606167226328
SPINOCEREBELLAR ATAXIA 40; SCA40	0.013635930000000001	0.6513606167226328
SPINOCEREBELLAR ATAXIA TYPE 40	0.013635930000000001	0.6513606167226328
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.013635930000000001	0.6513606167226328
SPINOCEREBELLAR ATAXIA TYPE 35	0.013635930000000001	0.6513606167226328
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.013635930000000001	0.6513606167226328
CAMPOMELIA, CUMMING TYPE	0.01363457	0.6512956522912561
CRANIODIAPHYSEAL DYSPLASIA	0.01363457	0.6512956522912561
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.013619738000000001	0.6505871578455359
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.013619738000000001	0.6505871578455359
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.013619738000000001	0.6505871578455359
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.013619738000000001	0.6505871578455359
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.013619738000000001	0.6505871578455359
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.013619738000000001	0.6505871578455359
PERICARDIAL AND DIAPHRAGMATIC DEFECT	0.01358556	0.6489545443634818
1Q41Q42 MICRODELETION SYNDROME	0.01355083	0.6472955629651629
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.013534810000000001	0.6465303201779166
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.01353266	0.6464276190547842
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.01353266	0.6464276190547842
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.01353266	0.6464276190547842
EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	0.0135135	0.6455123848598003
SATOYOSHI SYNDROME	0.0135135	0.6455123848598003
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE	0.0135135	0.6455123848598003
HYPOCHONDROPLASIA	0.0135135	0.6455123848598003
TIBIA VARA	0.0135135	0.6455123848598003
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.0135135	0.6455123848598003
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.0135135	0.6455123848598003
METAPHYSEAL ACROSCYPHODYSPLASIA	0.0135135	0.6455123848598003
PACMAN DYSPLASIA	0.0135135	0.6455123848598003
OROFACIODIGITAL SYNDROME TYPE 4	0.0135135	0.6455123848598003
METAPHYSEAL ACROSCYPHODYSPLASIA	0.0135135	0.6455123848598003
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.0135135	0.6455123848598003
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.0135135	0.6455123848598003
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.0135135	0.6455123848598003
BLOUNT DISEASE, ADOLESCENT	0.0135135	0.6455123848598003
HYPOCHONDROPLASIA	0.0135135	0.6455123848598003
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.013474228000000001	0.6436364413678691
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.013433849999999999	0.6417076665074799
KOOLEN-DE VRIES SYNDROME; KDVS	0.013399648	0.6400739065942839
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.013332798	0.6368806181843325
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.01332289	0.6364073331945673
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.013229968000000002	0.6319686384207529
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.013169898	0.6290992168084001
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01304168	0.6229745039685027
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.01293386	0.6178241620633277
PRUNE BELLY SYNDROME	0.01293386	0.6178241620633277
MONOSOMY 9P	0.01287538	0.6150306915141286
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.01287323	0.6149279903909963
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.01287323	0.6149279903909963
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.01287323	0.6149279903909963
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.012866337999999998	0.6145987735814018
MYOPATHY, SCAPULOHUMEROPERONEAL	0.012820500000000002	0.612409185636221
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.012820500000000002	0.612409185636221
MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL	0.012820500000000002	0.612409185636221
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7	0.012820500000000002	0.612409185636221
%601846 VACUOLAR NEUROMYOPATHY;;MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV	0.012820500000000002	0.612409185636221
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.012820500000000002	0.612409185636221
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.012820500000000002	0.612409185636221
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.012820500000000002	0.612409185636221
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.012820500000000002	0.612409185636221
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.012820500000000002	0.612409185636221
PURE MITOCHONDRIAL MYOPATHY	0.012820500000000002	0.612409185636221
VAN DEN BOSCH SYNDROME	0.012820500000000002	0.612409185636221
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.012820500000000002	0.612409185636221
OTOFACIOCERVICAL SYNDROME 2	0.012820500000000002	0.612409185636221
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.012820500000000002	0.612409185636221
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.012820500000000002	0.612409185636221
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.012820500000000002	0.612409185636221
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	0.012820500000000002	0.612409185636221
CALPAIN-3-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R1	0.012820500000000002	0.612409185636221
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.012820500000000002	0.612409185636221
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.012820500000000002	0.612409185636221
DELTA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R6	0.012820500000000002	0.612409185636221
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Z	0.012820500000000002	0.612409185636221
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.012820500000000002	0.612409185636221
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.012760730000000001	0.6095540944131426
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.012752470000000002	0.6091595310284575
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.012692688	0.6063038665898081
DISTAL TRISOMY 17Q	0.01267535	0.6054756656256833
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.012658200000000001	0.6046564450388372
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.012658200000000001	0.6046564450388372
OTOONYCHOPERONEAL SYNDROME	0.012658200000000001	0.6046564450388372
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.012658200000000001	0.6046564450388372
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.012658200000000001	0.6046564450388372
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.012658200000000001	0.6046564450388372
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.012658200000000001	0.6046564450388372
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.012658200000000001	0.6046564450388372
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.012658200000000001	0.6046564450388372
TIBIAL HEMIMELIA	0.012658200000000001	0.6046564450388372
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.012658200000000001	0.6046564450388372
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.012658200000000001	0.6046564450388372
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.012589438	0.6013718242812444
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.012589438	0.6013718242812444
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.012589438	0.6013718242812444
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.012589438	0.6013718242812444
PEROXISOME BIOGENESIS DISORDER 6B	0.012589438	0.6013718242812444
CEREBELLAR ATAXIA, CAYMAN TYPE	0.012589438	0.6013718242812444
DESANTO-SHINAWI SYNDROME	0.012571308	0.6005057910894356
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.01254017	0.5990183922186941
WHITE-SUTTON SYNDROME; WHSUS	0.012507848	0.5974744360782835
STICKLER SYNDROME	0.01239163	0.5919229388093573
DISTAL MONOSOMY 15Q	0.01236548	0.5906738065442827
MENTAL RETARDATION, X-LINKED 105; MRX105	0.01226843	0.5860379256140542
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.01226843	0.5860379256140542
SPINOCEREBELLAR ATAXIA TYPE 38	0.012208360000000001	0.5831685040017015
CORTICOBASAL SYNDROME	0.012208360000000001	0.5831685040017015
SNEDDON SYNDROME	0.012208360000000001	0.5831685040017015
SPINOCEREBELLAR ATAXIA TYPE 21	0.012208360000000001	0.5831685040017015
7Q11.23 MICRODUPLICATION SYNDROME	0.012154318	0.5805870276778333
MICROTRIPLICATION 11Q24.1	0.012081688	0.5771176404345308
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.011904799999999998	0.5686680607747031
THORACOPELVIC DYSOSTOSIS	0.011904799999999998	0.5686680607747031
SOTOS SYNDROME 2	0.011870598	0.5670343008615072
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.01183091	0.5651384858964489
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.01179384	0.5633677274617906
MENTAL RETARDATION, X-LINKED 104; MRX104	0.011715340000000001	0.5596179422683549
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.0116279	0.5554411114745457
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.0116279	0.5554411114745457
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.0116279	0.5554411114745457
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.0116279	0.5554411114745457
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0116279	0.5554411114745457
FRIEDREICH ATAXIA	0.0116279	0.5554411114745457
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.0116279	0.5554411114745457
EPISODIC ATAXIA, TYPE 8	0.0116279	0.5554411114745457
UNVERRICHT-LUNDBORG DISEASE	0.0116279	0.5554411114745457
BOUCHER-NEUHAUSER SYNDROME	0.0116279	0.5554411114745457
BRAIN-LUNG-THYROID SYNDROME	0.0116279	0.5554411114745457
DEMENTIA, FAMILIAL DANISH	0.0116279	0.5554411114745457
MYOCLONUS AND ATAXIA	0.0116279	0.5554411114745457
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0116279	0.5554411114745457
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.0116279	0.5554411114745457
MEDULLOBLASTOMA	0.0116279	0.5554411114745457
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0116279	0.5554411114745457
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.011417658	0.545398279135204
ALAGILLE SYNDROME 1; ALGS1	0.01134633	0.5419910857813519
TOWNES-BROCKS SYNDROME	0.01134633	0.5419910857813519
SMITH-LEMLI-OPITZ SYNDROME	0.01134633	0.5419910857813519
CHARGE SYNDROME	0.01134633	0.5419910857813519
TRISOMY X	0.011195400000000001	0.5347814669374633
RUVALCABA SYNDROME	0.011178770000000001	0.5339870856920259
RICHIERI COSTA-DA SILVA SYNDROME	0.0111463	0.5324360598929065
DYSMORPHISM-PECTUS CARINATUM-JOINT LAXITY SYNDROME	0.0111463	0.5324360598929065
MENTAL RETARDATION, BUENOS AIRES TYPE	0.01107172	0.5288735251193214
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.011062538	0.5284349196716001
ASPARTYLGLUCOSAMINURIA	0.010902809999999999	0.520805038278261
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.010827978	0.5172304659776855
ARTERIAL TORTUOSITY SYNDROME	0.010787928	0.5153173590095695
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.010779960000000002	0.5149367438704447
HEREDITARY FOLATE MALABSORPTION	0.010779960000000002	0.5149367438704447
FRYNS SYNDROME	0.01077691	0.5147910515794896
IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION	0.0107527	0.5136345891650554
THYMIC CARCINOMA	0.0107527	0.5136345891650554
YAO SYNDROME	0.0107527	0.5136345891650554
TAKAYASU ARTERITIS	0.0107527	0.5136345891650554
FAMILIAL AORTIC DISSECTION	0.0107527	0.5136345891650554
THYMOMA	0.0107527	0.5136345891650554
PULMONARY ARTERIAL HYPERTENSION	0.0107527	0.5136345891650554
CHRONIC GRAFT VERSUS HOST DISEASE	0.0107527	0.5136345891650554
ADENOCARCINOMA OF THE ESOPHAGUS	0.0107527	0.5136345891650554
NOCARDIOSIS	0.0107527	0.5136345891650554
EBSTEIN MALFORMATION	0.0107527	0.5136345891650554
EBOLA HEMORRHAGIC FEVER	0.0107527	0.5136345891650554
HUGHES-STOVIN SYNDROME	0.0107527	0.5136345891650554
THYMIC TUMOR	0.0107527	0.5136345891650554
CRYPTOGENIC ORGANIZING PNEUMONIA	0.0107527	0.5136345891650554
ANEURYSM OF SINUS OF VALSALVA	0.0107527	0.5136345891650554
DPM3-CDG	0.0107527	0.5136345891650554
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.0107527	0.5136345891650554
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.0107527	0.5136345891650554
SAPHO SYNDROME	0.0107527	0.5136345891650554
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13; CMH13	0.0107527	0.5136345891650554
FAMILIAL THROMBOCYTOSIS	0.0107527	0.5136345891650554
BRONCHIAL NEUROENDOCRINE TUMOR	0.0107527	0.5136345891650554
CARCINOMA OF ESOPHAGUS	0.0107527	0.5136345891650554
HYPERKALEMIC PERIODIC PARALYSIS	0.0107527	0.5136345891650554
FAMILIAL MEDITERRANEAN FEVER	0.0107527	0.5136345891650554
PERIPARTUM CARDIOMYOPATHY	0.0107527	0.5136345891650554
WHIPPLE DISEASE	0.0107527	0.5136345891650554
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.0107527	0.5136345891650554
GLUTAMATE MONOSODIUM SENSITIVITY	0.0107527	0.5136345891650554
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.0107527	0.5136345891650554
MALIGNANT ATROPHIC PAPULOSIS	0.0107527	0.5136345891650554
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.0107527	0.5136345891650554
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10	0.0107527	0.5136345891650554
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.0107527	0.5136345891650554
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18; CMH18	0.0107527	0.5136345891650554
PULMONARY BLASTOMA	0.0107527	0.5136345891650554
CLASSIC HODGKIN LYMPHOMA	0.0107527	0.5136345891650554
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.0107527	0.5136345891650554
MARBURG HEMORRHAGIC FEVER	0.0107527	0.5136345891650554
HODGKIN LYMPHOMA	0.0107527	0.5136345891650554
ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE	0.0107527	0.5136345891650554
PLEURAL MESOTHELIOMA	0.0107527	0.5136345891650554
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.0107527	0.5136345891650554
MYOTONIA PERMANENS	0.0107527	0.5136345891650554
FAMILIAL ATRIAL MYXOMA	0.0107527	0.5136345891650554
POTASSIUM-AGGRAVATED MYOTONIA	0.0107527	0.5136345891650554
IDIOPATHIC BRONCHIECTASIS	0.0107527	0.5136345891650554
LASSA FEVER	0.0107527	0.5136345891650554
THYMIC NEUROENDOCRINE TUMOR	0.0107527	0.5136345891650554
THYMIC EPITHELIAL NEOPLASM	0.0107527	0.5136345891650554
VIRAL HEMORRHAGIC FEVER	0.0107527	0.5136345891650554
WISKOTT-ALDRICH SYNDROME	0.0107527	0.5136345891650554
LEGIONELLOSIS	0.0107527	0.5136345891650554
SARCOIDOSIS	0.0107527	0.5136345891650554
MIXED CONNECTIVE TISSUE DISEASE	0.0107527	0.5136345891650554
ANTISYNTHETASE SYNDROME	0.0107527	0.5136345891650554
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.0107527	0.5136345891650554
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.0107527	0.5136345891650554
ESSENTIAL THROMBOCYTHEMIA	0.0107527	0.5136345891650554
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.0107527	0.5136345891650554
PORPHYRIA	0.0107527	0.5136345891650554
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5	0.0107527	0.5136345891650554
DESMOID TUMOR	0.0107527	0.5136345891650554
EOSINOPHILIC ESOPHAGITIS	0.0107527	0.5136345891650554
LYMPHANGIOLEIOMYOMATOSIS	0.0107527	0.5136345891650554
EISENMENGER SYNDROME	0.0107527	0.5136345891650554
GRANULOMATOSIS WITH POLYANGIITIS	0.0107527	0.5136345891650554
YELLOW FEVER	0.0107527	0.5136345891650554
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.0107527	0.5136345891650554
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.0107527	0.5136345891650554
MALAKOPLAKIA	0.0107527	0.5136345891650554
SYSTEMIC SCLEROSIS	0.0107527	0.5136345891650554
MYOTONIA FLUCTUANS	0.0107527	0.5136345891650554
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.01067669	0.5100037462025961
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.01067669	0.5100037462025961
LANDAU-KLEFFNER SYNDROME	0.01067669	0.5100037462025961
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.010566788	0.5047539513958575
XP22.13P22.2 DUPLICATION SYNDROME	0.01053335	0.5031566862073467
MALAN OVERGROWTH SYNDROME	0.01053335	0.5031566862073467
CORNELIA DE LANGE SYNDROME	0.01053335	0.5031566862073467
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.010527100000000001	0.5028581364307992
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.010478057999999998	0.5005154999281688
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.01046072	0.4996872989640442
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.010370569999999999	0.495381016987124
YOUNG-ONSET PARKINSON DISEASE	0.010370569999999999	0.495381016987124
COG5-CDG	0.01036096	0.4949219668507047
2Q33.1 DELETION SYNDROME	0.010300980000000001	0.49205684435513436
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.0102673	0.49044801931927545
GM1 GANGLIOSIDOSIS	0.01022336	0.48834909497023643
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.01020631	0.487534651179815
SAUL-WILSON SYNDROME; SWILS	0.010202099999999999	0.4873335480503326
WIEACKER-WOLFF SYNDROME	0.010109638	0.48291682654007206
DEXTROCARDIA	0.010101	0.48250420686490136
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.010101	0.48250420686490136
PHAVER SYNDROME	0.010101	0.48250420686490136
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.010101	0.48250420686490136
COLE-CARPENTER SYNDROME	0.010101	0.48250420686490136
PROXIMAL SPINAL MUSCULAR ATROPHY	0.010101	0.48250420686490136
GOLDENHAR SYNDROME	0.010101	0.48250420686490136
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.010101	0.48250420686490136
GROWTH DELAY-HYDROCEPHALY-LUNG HYPOPLASIA SYNDROME	0.010101	0.48250420686490136
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.010101	0.48250420686490136
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.010101	0.48250420686490136
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.010101	0.48250420686490136
NEUROGENIC THORACIC OUTLET SYNDROME	0.010101	0.48250420686490136
HEREDITARY ACROKERATOTIC POIKILODERMA	0.010101	0.48250420686490136
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.010101	0.48250420686490136
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.010101	0.48250420686490136
ISOLATED SPINA BIFIDA	0.010101	0.48250420686490136
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.010101	0.48250420686490136
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.010101	0.48250420686490136
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.010101	0.48250420686490136
VACTERL/VATER ASSOCIATION	0.010101	0.48250420686490136
HOLZGREVE SYNDROME	0.010101	0.48250420686490136
THORACIC OUTLET SYNDROME	0.010101	0.48250420686490136
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.010101	0.48250420686490136
CENANI-LENZ SYNDROME	0.010101	0.48250420686490136
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.010101	0.48250420686490136
CAT-EYE SYNDROME	0.010101	0.48250420686490136
JUBERG-HAYWARD SYNDROME	0.010101	0.48250420686490136
RADIO-RENAL SYNDROME	0.010101	0.48250420686490136
KINDLER SYNDROME	0.010101	0.48250420686490136
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.01001726	0.47850411753880817
FETAL ALCOHOL SYNDROME	0.01001726	0.47850411753880817
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.01001726	0.47850411753880817
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.01001726	0.47850411753880817
NANCE-HORAN SYNDROME	0.01001726	0.47850411753880817
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.009999638000000002	0.4776623504728373
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.009959588	0.4757492435047212
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.009959588	0.4757492435047212
LOEYS-DIETZ SYNDROME 5	0.00982639	0.46938664620287085
MARFANOID HYPERMOBILITY SYNDROME	0.00982639	0.46938664620287085
CATEL-MANZKE SYNDROME; CATMANS	0.00982639	0.46938664620287085
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.00982639	0.46938664620287085
LOEYS-DIETZ SYNDROME	0.00982639	0.46938664620287085
MARTSOLF SYNDROME	0.00982639	0.46938664620287085
COHEN SYNDROME	0.00976001	0.4662158087361158
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.009733468	0.4649479514290563
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.009733468	0.4649479514290563
16P12.1P12.3 TRIPLICATION SYNDROME	0.00970501	0.46358857070249837
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.00966794	0.4618178122678402
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.009663729999999999	0.4616167091383578
2Q32Q33 MICRODELETION SYNDROME	0.00960525	0.4588232385891588
CRI-DU-CHAT SYNDROME	0.00960525	0.4588232385891588
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.00954267	0.4558339193865447
MCDONOUGH SYNDROME	0.00954267	0.4558339193865447
TEMPLE-BARAITSER SYNDROME	0.009520658000000001	0.4547824509575268
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.009520658000000001	0.4547824509575268
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.009421218	0.4500324045927465
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.009384148000000002	0.4482616461580884
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.009384148000000002	0.4482616461580884
DYSTONIA 11, MYOCLONIC	0.009324078	0.44539222454573557
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.009258878	0.4422777532767928
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00924786	0.4417514458467128
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.009240448	0.4413973896957097
PITT-HOPKINS SYNDROME	0.009236938	0.44122972414120065
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.009236938	0.44122972414120065
CRANIOLENTICULOSUTURAL DYSPLASIA	0.0091481	0.4369861137333733
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.0090381	0.43173163766613853
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.009037738	0.43171434566308087
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.009037738	0.43171434566308087
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.00896098	0.4280477722633643
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.008940960000000001	0.4270914576191277
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00890091	0.4251783506510116
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.00889829	0.42505319858468293
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.00887827	0.4240968839404463
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.008874759999999999	0.42392921838593717
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00877193	0.4190172386223576
FAMILIAL DYSAUTONOMIA	0.00877193	0.4190172386223576
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.00877193	0.4190172386223576
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.4190172386223576
NEUROCUTANEOUS MELANOCYTOSIS	0.00877193	0.4190172386223576
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00877193	0.4190172386223576
ARGININEMIA	0.00877193	0.4190172386223576
20Q11.2 MICRODELETION SYNDROME	0.00877193	0.4190172386223576
PFAPA SYNDROME	0.00877193	0.4190172386223576
INFANTILE REFSUM DISEASE	0.00877193	0.4190172386223576
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.4190172386223576
PINEOBLASTOMA	0.00877193	0.4190172386223576
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.4190172386223576
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00877193	0.4190172386223576
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.4190172386223576
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.4190172386223576
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00877193	0.4190172386223576
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.4190172386223576
KEIPERT SYNDROME	0.00877193	0.4190172386223576
CAFFEY DISEASE	0.00877193	0.4190172386223576
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.00877193	0.4190172386223576
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.4190172386223576
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	0.4190172386223576
LOCKED-IN SYNDROME	0.00877193	0.4190172386223576
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.4190172386223576
PELIZAEUS-MERZBACHER DISEASE	0.00877193	0.4190172386223576
MILROY DISEASE	0.00877193	0.4190172386223576
BREATH-HOLDING SPELLS	0.00877193	0.4190172386223576
L-2-HYDROXYGLUTARIC ACIDURIA	0.00877193	0.4190172386223576
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.4190172386223576
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.00877193	0.4190172386223576
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00877193	0.4190172386223576
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.00877193	0.4190172386223576
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00877193	0.4190172386223576
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.4190172386223576
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.00877193	0.4190172386223576
NEUROFERRITINOPATHY	0.00877193	0.4190172386223576
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.4190172386223576
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.00877193	0.4190172386223576
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.4190172386223576
ABETAL34V AMYLOIDOSIS	0.00877193	0.4190172386223576
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.4190172386223576
HISTIDINEMIA	0.00877193	0.4190172386223576
HISTIDINEMIA	0.00877193	0.4190172386223576
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.4190172386223576
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.00877193	0.4190172386223576
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.4190172386223576
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00871784	0.41643346943620546
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.008662027999999999	0.4137674438156189
PRADER-WILLI SYNDROME; PWS	0.008548118	0.40832619500817613
CRANIOECTODERMAL DYSPLASIA	0.00854715	0.4082799556187844
OPSISMODYSPLASIA	0.00854715	0.4082799556187844
CRANIOECTODERMAL DYSPLASIA 4	0.00854715	0.4082799556187844
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.00854715	0.4082799556187844
CLAPO SYNDROME	0.00854715	0.4082799556187844
TYSHCHENKO SYNDROME	0.00854715	0.4082799556187844
ACROCRANIOFACIAL DYSOSTOSIS	0.00851468	0.40672892981966524
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00851468	0.40672892981966524
NEUROFIBROMATOSIS, TYPE I	0.00851468	0.40672892981966524
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00851468	0.40672892981966524
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.008473538	0.40476366023459076
ACROMEGALY	0.00845968	0.4041016917860478
FABRY DISEASE	0.00845968	0.4041016917860478
CONGENITAL HYPOTHYROIDISM	0.00845968	0.4041016917860478
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00845968	0.4041016917860478
SOMATOMAMMOTROPINOMA	0.00845968	0.4041016917860478
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.0084562	0.40393545927046615
MARSHALL SYNDROME	0.0084562	0.40393545927046615
CHILDHOOD DISINTEGRATIVE DISORDER	0.00842261	0.40233093335138964
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00842261	0.40233093335138964
XQ28 (MECP2) DUPLICATION	0.00842261	0.40233093335138964
INSULINOMA	0.00836254	0.39946151173903693
CHOREOACANTHOCYTOSIS	0.00836254	0.39946151173903693
MELAS	0.00836254	0.39946151173903693
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.00836254	0.39946151173903693
NEUROLEPTIC MALIGNANT SYNDROME	0.00836254	0.39946151173903693
INHERITED CREUTZFELDT-JAKOB DISEASE	0.00836254	0.39946151173903693
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.00835992	0.39933635967270825
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.00835992	0.39933635967270825
HAREL-YOON SYNDROME; HAYOS	0.008330778	0.397944305658605
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.008310758	0.39698799101436827
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.008310758	0.39698799101436827
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.008310758	0.39698799101436827
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.008310758	0.39698799101436827
OPITZ G/BBB SYNDROME	0.00829734	0.3963470404700941
MARFAN SYNDROME	0.00829734	0.3963470404700941
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.00829734	0.3963470404700941
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.00829734	0.3963470404700941
%605967 ACROPECTORAL SYNDROME; ACRPS;;ACRP SYNDROME;;SYNDACTYLY, PREAXIAL POLYDACTYLY, AND STERNAL DEFORMITY	0.00829734	0.3963470404700941
MARDEN-WALKER SYNDROME	0.00829734	0.3963470404700941
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00829734	0.3963470404700941
CUTIS LAXA	0.00829734	0.3963470404700941
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00829734	0.3963470404700941
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00829734	0.3963470404700941
TEEBI-SHALTOUT SYNDROME; TBSH	0.00829734	0.3963470404700941
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00827891	0.39546667688901105
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.0082754	0.395299011334502
21Q22.11Q22.12 MICRODELETION SYNDROME	0.0082754	0.395299011334502
PITT-HOPKINS SYNDROME	0.0082754	0.395299011334502
DE BARSY SYNDROME	0.0082747	0.39526557375952864
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.008204878	0.3919303189598335
CHROMOSOME 16Q22 DELETION SYNDROME	0.008204878	0.3919303189598335
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.008204878	0.3919303189598335
HARTNUP DISEASE	0.008179470000000001	0.3907166305242307
11Q22.2Q22.3 MICRODELETION SYNDROME	0.0080762	0.3857836328563821
SMITH-MAGENIS SYNDROME	0.0080762	0.3857836328563821
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.0080762	0.3857836328563821
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.007991608	0.3817428452247501
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.007955068000000001	0.37999740381114316
TETRASOMY 5P	0.00789548	0.37715100635755777
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.00789548	0.37715100635755777
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.007894468000000002	0.3771026651777393
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.007894468000000002	0.3771026651777393
SALT-AND-PEPPER SYNDROME	0.007894468000000002	0.3771026651777393
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.007891848	0.37697751311141053
PYRUVATE DEHYDROGENASE DEFICIENCY	0.00779834	0.37251082631054694
XQ25 DUPLICATION SYNDROME	0.007792408	0.3722274667466302
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.007792408	0.3722274667466302
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.007792408	0.3722274667466302
TENORIO SYNDROME; TNORS	0.007792408	0.3722274667466302
LUSCAN-LUMISH SYNDROME; LLS	0.007792408	0.3722274667466302
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.007792408	0.3722274667466302
MUCOLIPIDOSIS IV; ML4	0.007711398	0.36835778396293306
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.007711398	0.36835778396293306
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.007707187999999999	0.36815668083345066
RUBINSTEIN-TAYBI SYNDROME	0.00770049	0.36783673100892034
1Q21.1 MICRODELETION SYNDROME	0.00770049	0.36783673100892034
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.007651328	0.3654883623505803
COFFIN-SIRIS SYNDROME 7; CSS7	0.007645198	0.3651955447297426
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.007645198	0.3651955447297426
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.0076190500000000005	0.36394650800059664
49,XXXYY SYNDROME	0.0076190500000000005	0.36394650800059664
KOOLEN-DE VRIES SYNDROME	0.00761176	0.3635982795412317
CHROMOSOME 16P13.2 DELETION SYNDROME	0.0076081280000000005	0.36342478629508446
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0076081280000000005	0.36342478629508446
CHRISTIANSON SYNDROME	0.00757469	0.36182752110657357
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.007548058	0.36055536468273175
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.007548058	0.36055536468273175
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.00744636	0.3556974582546804
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.007416698	0.3542805648991684
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.007409290000000001	0.3539266998200223
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00736924	0.3520135928519063
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.00736924	0.3520135928519063
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.00734922	0.3510572782076696
HSD10 DISEASE	0.00734922	0.3510572782076696
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00734922	0.3510572782076696
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00734922	0.3510572782076696
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.0072908980000000005	0.34827135499682166
NON-DISTAL TRISOMY 13Q	0.00724334	0.34599960615313474
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.00724334	0.34599960615313474
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.007232418	0.34547788444762256
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.007232418	0.34547788444762256
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.007232418	0.34547788444762256
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.007232418	0.34547788444762256
HADZISELIMOVIC SYNDROME	0.007232418	0.34547788444762256
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.007228207999999999	0.34527678131814016
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.007228207999999999	0.34527678131814016
SHOX-RELATED SHORT STATURE	0.007210869999999999	0.3444485803540155
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00707065	0.33775055640721857
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.007047758	0.33665705216966274
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.00703358	0.33597979797256045
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.007030070000000001	0.3358121324180514
SCHAAF-YANG SYNDROME; SHFYNG	0.007030070000000001	0.3358121324180514
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.007030070000000001	0.3358121324180514
COFFIN-SIRIS SYNDROME 5	0.007030070000000001	0.3358121324180514
MENTAL RETARDATION, X-LINKED 103	0.007030070000000001	0.3358121324180514
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.0069935299999999995	0.3340666910044444
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0069935299999999995	0.3340666910044444
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.0069935299999999995	0.3340666910044444
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.0069935299999999995	0.3340666910044444
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.0069935299999999995	0.3340666910044444
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.0069935299999999995	0.3340666910044444
CONGENITAL MYASTHENIC SYNDROME	0.0069935299999999995	0.3340666910044444
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.0069935299999999995	0.3340666910044444
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.0069935299999999995	0.3340666910044444
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00696738	0.33281755873936997
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.0069596200000000006	0.3324468793368087
ODONTOCHONDRODYSPLASIA	0.0069596200000000006	0.3324468793368087
MENTAL RETARDATION, X-LINKED 63	0.00693414	0.3312297516077801
PHENYLKETONURIA	0.00693414	0.3312297516077801
GM2 GANGLIOSIDOSIS, AB VARIANT	0.00693414	0.3312297516077801
STIFF-PERSON SYNDROME; SPS	0.00693414	0.3312297516077801
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.00693293	0.3311719523710405
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.00693293	0.3311719523710405
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.00693293	0.3311719523710405
SUMMITT SYNDROME	0.00692715	0.33089585353768947
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.00692715	0.33089585353768947
ADNP SYNDROME	0.00683087	0.3262967539399315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00683087	0.3262967539399315
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00683087	0.3262967539399315
17Q24.2 MICRODELETION SYNDROME	0.00683087	0.3262967539399315
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.00683087	0.3262967539399315
22Q11.2 MICRODUPLICATION SYNDROME	0.00683087	0.3262967539399315
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00674565	0.32222596802675196
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00670981	0.3205139641881184
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00670981	0.3205139641881184
MARINESCO-SJÖGREN SYNDROME	0.00670981	0.3205139641881184
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00668979	0.3195576495438816
COCKAYNE SYNDROME	0.00668979	0.3195576495438816
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00668717	0.319432497477553
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00668717	0.319432497477553
SHPRINTZEN OMPHALOCELE SYNDROME	0.006675828	0.31889071322705675
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.006675828	0.31889071322705675
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.006675828	0.31889071322705675
PIERPONT SYNDROME	0.006646590000000001	0.3174940734883858
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.006643358	0.31733968742793756
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.006643358	0.31733968742793756
GIANT AXONAL NEUROPATHY	0.006643358	0.31733968742793756
CODAS SYNDROME	0.006643358	0.31733968742793756
4Q21 MICRODELETION SYNDROME	0.00658652	0.31462465187603306
GABRIELE-DE VRIES SYNDROME; GADEVS	0.00658652	0.31462465187603306
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.006568778	0.31377715265435235
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.006568778	0.31377715265435235
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.006568778	0.31377715265435235
PETTIGREW SYNDROME	0.006503138	0.31064166348114053
NEURAMINIDASE DEFICIENCY	0.006503138	0.31064166348114053
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.006466068	0.3088709050464824
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.006466068	0.3088709050464824
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.006466068	0.3088709050464824
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.006466068	0.3088709050464824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.006466068	0.3088709050464824
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.006466068	0.3088709050464824
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.006466068	0.3088709050464824
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.006466068	0.3088709050464824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.006466068	0.3088709050464824
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.006466068	0.3088709050464824
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.006466068	0.3088709050464824
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.006466068	0.3088709050464824
JOUBERT SYNDROME 24	0.006466068	0.3088709050464824
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.006466068	0.3088709050464824
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.006466068	0.3088709050464824
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.006426018	0.3069577980783665
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.006426018	0.3069577980783665
JABERI-ELAHI SYNDROME; JABELS	0.0064059979999999996	0.3060014834341297
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0064059979999999996	0.3060014834341297
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.0064059979999999996	0.3060014834341297
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.0064059979999999996	0.3060014834341297
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.0064059979999999996	0.3060014834341297
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.0064059979999999996	0.3060014834341297
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.0064059979999999996	0.3060014834341297
ASPARTYLGLUCOSAMINURIA; AGU	0.0063998679999999995	0.305708665813292
DISTAL MONOSOMY 12Q	0.0063998679999999995	0.305708665813292
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0063998679999999995	0.305708665813292
KLEEFSTRA SYNDROME	0.0063998679999999995	0.305708665813292
COFFIN-SIRIS SYNDROME 2; CSS2	0.0063998679999999995	0.305708665813292
SHUKLA-VERNON SYNDROME; SHUVER	0.0063998679999999995	0.305708665813292
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00636643	0.3041114006247811
FRAGILE X MENTAL RETARDATION SYNDROME	0.00636643	0.3041114006247811
FOUNTAIN SYNDROME	0.00636643	0.3041114006247811
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.006362798	0.30393790737863385
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.006329360000000001	0.30234064219012297
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.006329360000000001	0.30234064219012297
TRISOMY 17P	0.00630795	0.30131793007558205
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.00630795	0.30131793007558205
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.006302728	0.3010684857662811
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.006302728	0.3010684857662811
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.006302728	0.3010684857662811
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.006302728	0.3010684857662811
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.00627088	0.2995471716409239
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.00627088	0.2995471716409239
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.006266669999999999	0.2993460685114415
WRINKLY SKIN SYNDROME	0.006266669999999999	0.2993460685114415
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.00617144	0.2947971252761436
FRAGILE X SYNDROME	0.00617144	0.2947971252761436
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.00617144	0.2947971252761436
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00617144	0.2947971252761436
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.006119658	0.29232360455147494
MEHMO SYNDROME; MEHMO	0.006119658	0.29232360455147494
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.006119658	0.29232360455147494
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.006024158	0.28776176396583014
ZIMMERMANN-LABAND SYNDROME 1	0.006024158	0.28776176396583014
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.005987088000000001	0.285991005531172
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.005987088000000001	0.285991005531172
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.005987088000000001	0.285991005531172
OROFACIODIGITAL SYNDROME TYPE 6	0.005927018	0.2831215839188193
XQ25 MICRODUPLICATION SYNDROME	0.0058876480000000005	0.2812409591663917
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0058876480000000005	0.2812409591663917
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.0058876480000000005	0.2812409591663917
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.005743948	0.2743767027040131
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.0057404380000000005	0.27420903714950406
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.0057404380000000005	0.27420903714950406
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.0057404380000000005	0.27420903714950406
PALLISTER-KILLIAN SYNDROME	0.0057404380000000005	0.27420903714950406
HELSMOORTEL-VAN DER AA SYNDROME	0.0057404380000000005	0.27420903714950406
HENNEKAM SYNDROME	0.00571429	0.2729600004203581
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.00571429	0.2729600004203581
FAMILIAL VISCERAL MYOPATHY	0.00571429	0.2729600004203581
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00571429	0.2729600004203581
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00571429	0.2729600004203581
3Q13 MICRODELETION SYNDROME	0.00571429	0.2729600004203581
CRANIOECTODERMAL DYSPLASIA 3	0.00571429	0.2729600004203581
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00571429	0.2729600004203581
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.00571429	0.2729600004203581
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00571429	0.2729600004203581
ACHONDROGENESIS TYPE 2	0.00571429	0.2729600004203581
LETHAL RECESSIVE CHONDRODYSPLASIA	0.00571429	0.2729600004203581
BOOMERANG DYSPLASIA	0.00571429	0.2729600004203581
ATELOSTEOGENESIS TYPE I	0.00571429	0.2729600004203581
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.00571429	0.2729600004203581
THANATOPHORIC DYSPLASIA TYPE 1	0.00571429	0.2729600004203581
RUVALCABA SYNDROME	0.00571429	0.2729600004203581
SHORT STATURE, BRUSSELS TYPE	0.00571429	0.2729600004203581
FACIOCARDIOMELIC SYNDROME	0.00571429	0.2729600004203581
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.00571429	0.2729600004203581
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00571429	0.2729600004203581
TRIPLOIDY	0.00571429	0.2729600004203581
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00571429	0.2729600004203581
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00571429	0.2729600004203581
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.00571429	0.2729600004203581
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.005703368	0.27243827871484594
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.005703368	0.27243827871484594
OPTIC ATROPHY 11; OPA11	0.005703368	0.27243827871484594
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.005703368	0.27243827871484594
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.005703368	0.27243827871484594
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.005703368	0.27243827871484594
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.005703368	0.27243827871484594
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.005703368	0.27243827871484594
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.005703368	0.27243827871484594
CHITAYAT SYNDROME	0.005699158	0.2722371755853636
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.005699157999999999	0.27223717558536353
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.005699157999999999	0.27223717558536353
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.005699157999999999	0.27223717558536353
MEGALENCEPHALY	0.00568182	0.27140897462123886
CARPENTER SYNDROME	0.00568182	0.27140897462123886
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00568182	0.27140897462123886
MESOMELIA-SYNOSTOSES SYNDROME	0.00568182	0.27140897462123886
SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE	0.00568182	0.27140897462123886
SPONDYLOMETAPHYSEAL DYSPLASIA, 'CORNER FRACTURE' TYPE	0.00568182	0.27140897462123886
TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM	0.00568182	0.27140897462123886
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00568182	0.27140897462123886
NON-ERUPTION OF TEETH-MAXILLARY HYPOPLASIA-GENU VALGUM SYNDROME	0.00568182	0.27140897462123886
CAMURATI-ENGELMANN DISEASE	0.00568182	0.27140897462123886
PROLIDASE DEFICIENCY	0.00568182	0.27140897462123886
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.00568182	0.27140897462123886
DYSSPONDYLOENCHONDROMATOSIS	0.00568182	0.27140897462123886
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.00568182	0.27140897462123886
AROMATASE DEFICIENCY	0.00568182	0.27140897462123886
LOWE OCULOCEREBRORENAL SYNDROME	0.00568182	0.27140897462123886
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00568182	0.27140897462123886
POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8	0.00568182	0.27140897462123886
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00568182	0.27140897462123886
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.00568182	0.27140897462123886
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00568182	0.27140897462123886
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.00568182	0.27140897462123886
RING CHROMOSOME 7 SYNDROME	0.00568182	0.27140897462123886
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.00568182	0.27140897462123886
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00568182	0.27140897462123886
MULTIPLE EPIPHYSEAL DYSPLASIA, BEIGHTON TYPE	0.00568182	0.27140897462123886
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.00568182	0.27140897462123886
SATOYOSHI SYNDROME	0.00568182	0.27140897462123886
MULTIPLE OSTEOCHONDROMAS	0.00568182	0.27140897462123886
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.00568182	0.27140897462123886
EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5	0.00568182	0.27140897462123886
NIEVERGELT SYNDROME	0.00568182	0.27140897462123886
SCHEIE SYNDROME	0.00568182	0.27140897462123886
OCULOFACIOCARDIODENTAL SYNDROME	0.00568182	0.27140897462123886
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	0.00568182	0.27140897462123886
137370 GENU VALGUM, ST. HELENA FAMILIAL;;GENU VALGUM, HEREDITARY PUBERTAL	0.00568182	0.27140897462123886
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00568182	0.27140897462123886
EPIPHYSEAL DYSPLASIA, MULTIPLE, 1	0.00568182	0.27140897462123886
CAMURATI-ENGELMANN DISEASE	0.00568182	0.27140897462123886
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00568182	0.27140897462123886
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.005643298	0.26956885710249323
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.005643298	0.26956885710249323
CHROMOSOME 18Q DELETION SYNDROME	0.005643298	0.26956885710249323
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.005643298	0.26956885710249323
PHELAN-MCDERMID SYNDROME	0.005640678	0.2694437050361645
CK SYNDROME	0.005640678	0.2694437050361645
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.005640678	0.2694437050361645
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.005640678	0.2694437050361645
WIEDEMANN-STEINER SYNDROME; WDSTS	0.005640678	0.2694437050361645
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.005640678	0.2694437050361645
DUBOWITZ SYNDROME	0.005640678	0.2694437050361645
EMANUEL SYNDROME	0.005640678	0.2694437050361645
FRONTOOCULAR SYNDROME	0.0056072399999999994	0.2678464398476536
19P13.13 MICRODELETION SYNDROME	0.0056072399999999994	0.2678464398476536
MONOSOMY 18Q	0.0056072399999999994	0.2678464398476536
DUBOWITZ SYNDROME	0.0056072399999999994	0.2678464398476536
C SYNDROME	0.0056072399999999994	0.2678464398476536
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.0056072399999999994	0.2678464398476536
SANDHOFF DISEASE	0.005541600000000001	0.2647109506744419
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.005541600000000001	0.2647109506744419
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.0055045300000000005	0.2629401922397837
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.0055045300000000005	0.2629401922397837
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.0055045300000000005	0.2629401922397837
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.0055045300000000005	0.2629401922397837
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.0055045300000000005	0.2629401922397837
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.0055045300000000005	0.2629401922397837
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.0055045300000000005	0.2629401922397837
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0055045300000000005	0.2629401922397837
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.0055045300000000005	0.2629401922397837
PEHO-LIKE SYNDROME; PEHOL	0.0055045300000000005	0.2629401922397837
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.0055045300000000005	0.2629401922397837
COG4-CDG	0.0055045300000000005	0.2629401922397837
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.0055045300000000005	0.2629401922397837
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.0055045300000000005	0.2629401922397837
ALLAN-HERNDON-DUDLEY SYNDROME	0.0055045300000000005	0.2629401922397837
HUNTER-MACDONALD SYNDROME	0.00546448	0.26102708527166774
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.00546448	0.26102708527166774
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.00546448	0.26102708527166774
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00546448	0.26102708527166774
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00546448	0.26102708527166774
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00546448	0.26102708527166774
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.00546448	0.26102708527166774
GERODERMA OSTEODYSPLASTICA	0.00546448	0.26102708527166774
20P12.3 MICRODELETION SYNDROME	0.00546448	0.26102708527166774
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.00546448	0.26102708527166774
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00546448	0.26102708527166774
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.00546448	0.26102708527166774
EPISODIC ATAXIA, TYPE 1; EA1	0.00544446	0.260070770627431
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00544446	0.260070770627431
TYPHOID	0.00544446	0.260070770627431
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.00544446	0.260070770627431
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00544446	0.260070770627431
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00544446	0.260070770627431
BEHR SYNDROME	0.00544446	0.260070770627431
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00544446	0.260070770627431
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.00544446	0.260070770627431
ADULT-ONSET DYSTONIA-PARKINSONISM	0.00544446	0.260070770627431
KUFOR-RAKEB SYNDROME	0.00544446	0.260070770627431
CLASSIC PHENYLKETONURIA	0.00544446	0.260070770627431
CEREBROTENDINOUS XANTHOMATOSIS	0.00544446	0.260070770627431
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00544446	0.260070770627431
SPINOCEREBELLAR ATAXIA 42	0.00544446	0.260070770627431
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00544446	0.260070770627431
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00544446	0.260070770627431
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00544446	0.260070770627431
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00544446	0.260070770627431
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00544446	0.260070770627431
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00544446	0.260070770627431
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00544446	0.260070770627431
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.00544446	0.260070770627431
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.00544446	0.260070770627431
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00544446	0.260070770627431
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00544446	0.260070770627431
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00544446	0.260070770627431
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.00544184	0.2599456185611023
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00543833	0.2597779530065933
49,XYYYY SYNDROME	0.00543833	0.2597779530065933
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.00543833	0.2597779530065933
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00543833	0.2597779530065933
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00543833	0.2597779530065933
KLEEFSTRA SYNDROME	0.00543833	0.2597779530065933
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00543833	0.2597779530065933
2Q23.1 MICRODELETION SYNDROME	0.00543833	0.2597779530065933
12Q14 MICRODELETION SYNDROME	0.00534119	0.25513777295958245
ACERULOPLASMINEMIA	0.00534119	0.25513777295958245
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.00534119	0.25513777295958245
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00534119	0.25513777295958245
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00534119	0.25513777295958245
PROGRESSIVE SUPRANUCLEAR PALSY	0.00534119	0.25513777295958245
CRIGLER-NAJJAR SYNDROME TYPE 1	0.00534119	0.25513777295958245
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00534119	0.25513777295958245
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.005323448	0.2542902737379017
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.005323448	0.2542902737379017
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.005323448	0.2542902737379017
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.005323448	0.2542902737379017
AU-KLINE SYNDROME; AUKS	0.005323448	0.2542902737379017
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00515812	0.24639289174477624
FRIED SYNDROME	0.00506262	0.24183105115913148
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00506262	0.24183105115913148
OGDEN SYNDROME; OGDNS	0.00506262	0.24183105115913148
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00506262	0.24183105115913148
RABSON-MENDENHALL SYNDROME	0.00506262	0.24183105115913148
PRADER-WILLI-LIKE SYNDROME	0.00506262	0.24183105115913148
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.005039728	0.24073754692157562
RECOMBINANT CHROMOSOME 8 SYNDROME	0.005039728	0.24073754692157562
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00502555	0.24006029272447332
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.00502555	0.24006029272447332
MENTAL RETARDATION, X-LINKED 91; MRX91	0.00502555	0.24006029272447332
CHROMOSOME 1P35 DELETION SYNDROME	0.00502555	0.24006029272447332
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00502555	0.24006029272447332
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.00502555	0.24006029272447332
OROFACIODIGITAL SYNDROME TYPE 1	0.0049654799999999995	0.23719087111212062
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.0049654799999999995	0.23719087111212062
ALEXANDER DISEASE	0.0049654799999999995	0.23719087111212062
ADIPOSIS DOLOROSA	0.00492611	0.235310246359693
CHILDHOOD ABSENCE EPILEPSY	0.00492611	0.235310246359693
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.00492611	0.235310246359693
PANIC DISORDER 1	0.00492611	0.235310246359693
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.00492611	0.235310246359693
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00492611	0.235310246359693
OBSESSIVE-COMPULSIVE DISORDER 1	0.00492611	0.235310246359693
FAMILIAL COLORECTAL CANCER TYPE X	0.00492611	0.235310246359693
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00492611	0.235310246359693
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00492611	0.235310246359693
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00492611	0.235310246359693
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.00492611	0.235310246359693
PROGRESSIVE NON-FLUENT APHASIA	0.00492611	0.235310246359693
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.00492611	0.235310246359693
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00492611	0.235310246359693
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.00492611	0.235310246359693
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.00492611	0.235310246359693
GENIOSPASM 1; GSM1	0.00492611	0.235310246359693
ROLANDIC EPILEPSY	0.00492611	0.235310246359693
AUTOIMMUNE HEPATITIS	0.00492611	0.235310246359693
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.00492611	0.235310246359693
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.00492611	0.235310246359693
ACQUIRED METHEMOGLOBINEMIA	0.00492611	0.235310246359693
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00492611	0.235310246359693
LYNCH SYNDROME	0.00492611	0.235310246359693
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00492611	0.235310246359693
ACTH-DEPENDENT CUSHING SYNDROME	0.00492611	0.235310246359693
HUNTINGTON DISEASE-LIKE 1	0.00492611	0.235310246359693
WOLFRAM-LIKE SYNDROME	0.00492611	0.235310246359693
ADRENOCORTICAL CARCINOMA	0.00492611	0.235310246359693
ADIPOSIS DOLOROSA	0.00492611	0.235310246359693
MCLEOD SYNDROME; MCLDS	0.00492611	0.235310246359693
DYSTONIA-APHONIA SYNDROME	0.00492611	0.235310246359693
PORPHYRIA VARIEGATA	0.00492611	0.235310246359693
HYPERTELORISM, TEEBI TYPE; TBHS	0.00492611	0.235310246359693
EARLY-ONSET SCHIZOPHRENIA	0.00492611	0.235310246359693
CUSHING DISEASE	0.00492611	0.235310246359693
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.00492611	0.235310246359693
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00492611	0.235310246359693
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00492611	0.235310246359693
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00492611	0.235310246359693
CENTRAL DIABETES INSIPIDUS	0.00492611	0.235310246359693
ACUTE INTERMITTENT PORPHYRIA	0.00492611	0.235310246359693
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.00492611	0.235310246359693
NORRIE DISEASE	0.00492611	0.235310246359693
HEREDITARY COPROPORPHYRIA	0.00492611	0.235310246359693
ALAZAMI SYNDROME; ALAZS	0.00492611	0.235310246359693
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.00492611	0.235310246359693
DYSTONIA 12; DYT12	0.00492611	0.235310246359693
CHILDHOOD-ONSET BENIGN CHOREA WITH STRIATAL INVOLVEMENT	0.00492611	0.235310246359693
CREUTZFELDT-JAKOB DISEASE; CJD	0.00492611	0.235310246359693
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00492611	0.235310246359693
DYSTONIA 26, MYOCLONIC; DYT26	0.00492611	0.235310246359693
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00492611	0.235310246359693
CUSHING SYNDROME	0.00492611	0.235310246359693
USHER SYNDROME	0.00492611	0.235310246359693
ACTH-INDEPENDENT CUSHING SYNDROME	0.00492611	0.235310246359693
USHER SYNDROME TYPE 3	0.00492611	0.235310246359693
USHER SYNDROME TYPE 1	0.00492611	0.235310246359693
POSTERIOR CORTICAL ATROPHY	0.00492611	0.235310246359693
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.00492611	0.235310246359693
RABIES	0.00492611	0.235310246359693
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00492611	0.235310246359693
MYOCLONUS-DYSTONIA SYNDROME	0.00492611	0.235310246359693
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00492611	0.235310246359693
CUTANEOUS MASTOCYTOSIS	0.00492611	0.235310246359693
USHER SYNDROME TYPE 2	0.00492611	0.235310246359693
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.004874328	0.2328367256350243
ALLAN-HERNDON-DUDLEY SYNDROME	0.0048408900000000005	0.23123946044651345
FANCONI ANEMIA	0.00478241	0.2284459898973144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.00478241	0.2284459898973144
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.0047789	0.22827832434280534
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.0047789	0.22827832434280534
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.0047789	0.22827832434280534
COSTELLO SYNDROME	0.0047789	0.22827832434280534
TETRASOMY 12P	0.0047789	0.22827832434280534
2Q31.1 MICRODELETION SYNDROME	0.0047789	0.22827832434280534
X SMALL RINGS	0.0047789	0.22827832434280534
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.0047789	0.22827832434280534
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.0047789	0.22827832434280534
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.004741830000000001	0.22650756590814727
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.004741830000000001	0.22650756590814727
MENTAL RETARDATION, X-LINKED 101; MRX101	0.004741830000000001	0.22650756590814727
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004741830000000001	0.22650756590814727
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.004741830000000001	0.22650756590814727
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.004741830000000001	0.22650756590814727
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.004741830000000001	0.22650756590814727
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.004741830000000001	0.22650756590814727
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.004741830000000001	0.22650756590814727
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.004741830000000001	0.22650756590814727
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.004741830000000001	0.22650756590814727
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.004741830000000001	0.22650756590814727
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.004741830000000001	0.22650756590814727
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.004741830000000001	0.22650756590814727
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.004741830000000001	0.22650756590814727
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.004741830000000001	0.22650756590814727
PITT-HOPKINS-LIKE SYNDROME	0.004741830000000001	0.22650756590814727
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.004741830000000001	0.22650756590814727
XQ12-Q13.3 DUPLICATION SYNDROME	0.00473762	0.22630646277866487
8P INVERTED DUPLICATION/DELETION SYNDROME	0.00473762	0.22630646277866487
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.00473762	0.22630646277866487
16P13.11 MICRODELETION SYNDROME	0.00473762	0.22630646277866487
PRIMARY CILIARY DYSKINESIA	0.00473762	0.22630646277866487
JOUBERT SYNDROME	0.00468176	0.2236381442957945
GLUTATHIONURIA	0.00468176	0.2236381442957945
COCKAYNE SYNDROME A; CSA	0.00468176	0.2236381442957945
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00468176	0.2236381442957945
JOUBERT SYNDROME WITH OCULAR DEFECT	0.00468176	0.2236381442957945
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.00468176	0.2236381442957945
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.00468176	0.2236381442957945
ATAXIA-TELANGIECTASIA	0.00468176	0.2236381442957945
GAUCHER DISEASE	0.00468176	0.2236381442957945
JOUBERT SYNDROME WITH RENAL DEFECT	0.00468176	0.2236381442957945
6Q16 MICRODELETION SYNDROME	0.00467914	0.22351299222946583
1Q44 MICRODELETION SYNDROME	0.00467914	0.22351299222946583
16Q24.3 MICRODELETION SYNDROME	0.00467914	0.22351299222946583
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.00467914	0.22351299222946583
BARDET-BIEDL SYNDROME 1; BBS1	0.00467914	0.22351299222946583
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.00467914	0.22351299222946583
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004498618	0.21488982378756247
LISSENCEPHALY, X-LINKED, 2	0.004498618	0.21488982378756247
COFFIN-SIRIS SYNDROME 4; CSS4	0.004495108	0.21472215823305343
PERIPHERAL HYPOTHYROIDISM	0.004495108	0.21472215823305343
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.004495108	0.21472215823305343
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.004495108	0.21472215823305343
OGDEN SYNDROME	0.004495108	0.21472215823305343
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.004495108	0.21472215823305343
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.004495108	0.21472215823305343
COFFIN-SIRIS SYNDROME 3; CSS3	0.004495108	0.21472215823305343
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.004495108	0.21472215823305343
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.004495108	0.21472215823305343
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.004495108	0.21472215823305343
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.004495108	0.21472215823305343
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.004495108	0.21472215823305343
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.004458038000000001	0.21295139979839536
AICARDI-GOUTIERES SYNDROME 7	0.004458038000000001	0.21295139979839536
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.004458038000000001	0.21295139979839536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.004458038000000001	0.21295139979839536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.004458038000000001	0.21295139979839536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.004458038000000001	0.21295139979839536
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.004458038000000001	0.21295139979839536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.004458038000000001	0.21295139979839536
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.004458038000000001	0.21295139979839536
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.004458038000000001	0.21295139979839536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.004458038000000001	0.21295139979839536
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.004458038000000001	0.21295139979839536
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004458038000000001	0.21295139979839536
IMMUNODEFICIENCY 49; IMD49	0.004458038000000001	0.21295139979839536
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.004458038000000001	0.21295139979839536
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.004458038000000001	0.21295139979839536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.004458038000000001	0.21295139979839536
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.004458038000000001	0.21295139979839536
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.004458038000000001	0.21295139979839536
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.004458038000000001	0.21295139979839536
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.004458038000000001	0.21295139979839536
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.004458038000000001	0.21295139979839536
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.004458038000000001	0.21295139979839536
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.004458038000000001	0.21295139979839536
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.004458038000000001	0.21295139979839536
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.004458038000000001	0.21295139979839536
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.004458038000000001	0.21295139979839536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.004458038000000001	0.21295139979839536
AL-RAQAD SYNDROME; ARS	0.004458038000000001	0.21295139979839536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.004458038000000001	0.21295139979839536
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.004458038000000001	0.21295139979839536
ADENYLOSUCCINATE LYASE DEFICIENCY	0.004458038000000001	0.21295139979839536
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.004458038000000001	0.21295139979839536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004458038000000001	0.21295139979839536
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.004458038000000001	0.21295139979839536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.004458038000000001	0.21295139979839536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.004458038000000001	0.21295139979839536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.004458038000000001	0.21295139979839536
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.004458038000000001	0.21295139979839536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.004458038000000001	0.21295139979839536
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.004458038000000001	0.21295139979839536
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.004458038000000001	0.21295139979839536
CEREBELLAR HYPOPLASIA	0.004397968	0.2100819781860426
SPINOCEREBELLAR ATAXIA TYPE 14	0.004397968	0.2100819781860426
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.004397968	0.2100819781860426
MENTAL RETARDATION, X-LINKED 12; MRX12	0.004397968	0.2100819781860426
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.004397968	0.2100819781860426
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.004397968	0.2100819781860426
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.004397968	0.2100819781860426
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.004397968	0.2100819781860426
METHYLMALONIC ACIDURIA, CBLA TYPE	0.004397968	0.2100819781860426
PEROXISOME BIOGENESIS DISORDER 5B	0.004397968	0.2100819781860426
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.004397968	0.2100819781860426
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.004397968	0.2100819781860426
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004397968	0.2100819781860426
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0043953479999999994	0.2099568261197139
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.0043953479999999994	0.2099568261197139
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0043953479999999994	0.2099568261197139
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.0043953479999999994	0.2099568261197139
SPINOCEREBELLAR ATAXIA 47; SCA47	0.0043953479999999994	0.2099568261197139
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0043953479999999994	0.2099568261197139
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0043953479999999994	0.2099568261197139
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0043953479999999994	0.2099568261197139
TEMPLE SYNDROME	0.0043953479999999994	0.2099568261197139
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00436191	0.20835956093120303
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.00436191	0.20835956093120303
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00436191	0.20835956093120303
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00436191	0.20835956093120303
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00436191	0.20835956093120303
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00436191	0.20835956093120303
OROFACIODIGITAL SYNDROME IV; OFD4	0.00436191	0.20835956093120303
DISTAL TRISOMY 15Q	0.00436191	0.20835956093120303
NON-DISTAL TRISOMY 10Q	0.00436191	0.20835956093120303
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00436191	0.20835956093120303
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00436191	0.20835956093120303
NOONAN SYNDROME 3; NS3	0.00436191	0.20835956093120303
DISTAL TRISOMY 18Q	0.00436191	0.20835956093120303
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00436191	0.20835956093120303
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.00436191	0.20835956093120303
%157700 MITRAL VALVE PROLAPSE 1; MVP1;;MITRAL VALVE PROLAPSE, MYXOMATOUS 1; MMVP1;;MYXOMATOUS MITRAL VALVE PROLAPSE 1;;MITRAL VALVE PROLAPSE, FAMILIAL; MVP PROLAPSED MITRAL VALVE; PMV;;MITRAL REGURGITATION, FAMILIAL;;FLOPPY MITRAL VALVE;;BARLOW SYNDROME;;MYXOMATOUS VALVULAR DISEASE, FAMILIAL;;CLICK-MURMUR SYNDROME	0.00436191	0.20835956093120303
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00436191	0.20835956093120303
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00436191	0.20835956093120303
GORDON SYNDROME	0.00436191	0.20835956093120303
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00436191	0.20835956093120303
NEMALINE MYOPATHY 1; NEM1	0.00436191	0.20835956093120303
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00436191	0.20835956093120303
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00436191	0.20835956093120303
COWDEN SYNDROME	0.00436191	0.20835956093120303
ELSAHY-WATERS SYNDROME; ESWS	0.00436191	0.20835956093120303
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.00436191	0.20835956093120303
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.00436191	0.20835956093120303
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.004214898	0.2013370969712364
LEIGH SYNDROME; LS	0.004214898	0.2013370969712364
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.004214898	0.2013370969712364
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.004214898	0.2013370969712364
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.004214898	0.2013370969712364
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.004214898	0.2013370969712364
SCHINDLER DISEASE, TYPE I	0.004214898	0.2013370969712364
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.004111628	0.19640409930338784
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.004111628	0.19640409930338784
ADENYLOSUCCINASE DEFICIENCY	0.004111628	0.19640409930338784
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.004111628	0.19640409930338784
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.004111628	0.19640409930338784
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.004111628	0.19640409930338784
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.004111628	0.19640409930338784
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.004111628	0.19640409930338784
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.004111628	0.19640409930338784
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.004111628	0.19640409930338784
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.004111628	0.19640409930338784
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.004111628	0.19640409930338784
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.004111628	0.19640409930338784
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.004111628	0.19640409930338784
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.004111628	0.19640409930338784
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.004111628	0.19640409930338784
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.00407819	0.19480683411487693
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.00407819	0.19480683411487693
MCDONOUGH SYNDROME	0.00407819	0.19480683411487693
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00407819	0.19480683411487693
DISTAL MONOSOMY 7Q36	0.00407819	0.19480683411487693
HYPERTELORISM, TEEBI TYPE	0.00407819	0.19480683411487693
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.00407819	0.19480683411487693
QAZI-MARKOUIZOS SYNDROME	0.00407819	0.19480683411487693
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00391279	0.18690601282832564
SPINOCEREBELLAR ATAXIA TYPE 3	0.00391279	0.18690601282832564
MASA SYNDROME	0.00391279	0.18690601282832564
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00391279	0.18690601282832564
MACHADO-JOSEPH DISEASE TYPE 1	0.00391279	0.18690601282832564
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00391279	0.18690601282832564
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.00391279	0.18690601282832564
MACHADO-JOSEPH DISEASE TYPE 2	0.00391279	0.18690601282832564
MACHADO-JOSEPH DISEASE TYPE 3	0.00391279	0.18690601282832564
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.00391279	0.18690601282832564
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.00391279	0.18690601282832564
224550 DYSTONIA WITH RINGBINDEN	0.00391279	0.18690601282832564
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.003794398	0.18125066800512504
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.003794398	0.18125066800512504
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.003794398	0.18125066800512504
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.003794398	0.18125066800512504
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0037359179999999995	0.17845719745592598
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0037359179999999995	0.17845719745592598
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0037359179999999995	0.17845719745592598
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.0037359179999999995	0.17845719745592598
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0037359179999999995	0.17845719745592598
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0037359179999999995	0.17845719745592598
KABUKI SYNDROME 1	0.0037359179999999995	0.17845719745592598
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.0037359179999999995	0.17845719745592598
ACROCALLOSAL SYNDROME; ACLS	0.0037359179999999995	0.17845719745592598
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0037359179999999995	0.17845719745592598
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.0035370799999999997	0.16895911098086377
HYPEREKPLEXIA 4; HKPX4	0.0035370799999999997	0.16895911098086377
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.0035370799999999997	0.16895911098086377
NEMALINE MYOPATHY 3; NEM3	0.0035370799999999997	0.16895911098086377
KEPPEN-LUBINSKY SYNDROME	0.0035370799999999997	0.16895911098086377
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.0035370799999999997	0.16895911098086377
ATHYREOSIS	0.00353357	0.16879144542635477
THYROID ECTOPIA	0.00353357	0.16879144542635477
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.00353357	0.16879144542635477
SCHEIE SYNDROME	0.00353357	0.16879144542635477
FAMILIAL THYROID DYSHORMONOGENESIS	0.00353357	0.16879144542635477
HURLER-SCHEIE SYNDROME	0.00353357	0.16879144542635477
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00353357	0.16879144542635477
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.00353357	0.16879144542635477
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.00353357	0.16879144542635477
CARPENTER-WAZIRI SYNDROME	0.00353357	0.16879144542635477
X-LINKED ACROGIGANTISM	0.00353357	0.16879144542635477
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00353357	0.16879144542635477
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.00353357	0.16879144542635477
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00353357	0.16879144542635477
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00353357	0.16879144542635477
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.16879144542635477
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.00353357	0.16879144542635477
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.00353357	0.16879144542635477
ALPHA-MANNOSIDOSIS	0.00353357	0.16879144542635477
MUCOLIPIDOSIS TYPE III	0.00353357	0.16879144542635477
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00353357	0.16879144542635477
FUCOSIDOSIS	0.00353357	0.16879144542635477
LEUKOCYTE ADHESION DEFICIENCY	0.00353357	0.16879144542635477
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00353357	0.16879144542635477
PITUITARY GIGANTISM	0.00353357	0.16879144542635477
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.00353357	0.16879144542635477
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.00353357	0.16879144542635477
MULTIPLE SULFATASE DEFICIENCY	0.00353357	0.16879144542635477
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00353357	0.16879144542635477
GALACTOSIALIDOSIS	0.00353357	0.16879144542635477
INFANTILE SYSTEMIC HYALINOSIS	0.00353357	0.16879144542635477
PRIMARY CONGENITAL HYPOTHYROIDISM	0.00353357	0.16879144542635477
MUCOPOLYSACCHARIDOSIS TYPE 2	0.00353357	0.16879144542635477
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.00353357	0.16879144542635477
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00353357	0.16879144542635477
THYROID HYPOPLASIA	0.00353357	0.16879144542635477
THYROID HEMIAGENESIS	0.00353357	0.16879144542635477
GRFOMA	0.00353357	0.16879144542635477
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00353357	0.16879144542635477
PERMANENT CONGENITAL HYPOTHYROIDISM	0.00353357	0.16879144542635477
NF1-MICRODELETION SYNDROME	0.00353357	0.16879144542635477
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.00353357	0.16879144542635477
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.00353357	0.16879144542635477
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.00353357	0.16879144542635477
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00353357	0.16879144542635477
MUCOPOLYSACCHARIDOSIS, TYPE II	0.00353357	0.16879144542635477
ATKIN-FLAITZ SYNDROME	0.00353357	0.16879144542635477
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00353357	0.16879144542635477
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00353357	0.16879144542635477
CHROMOSOME 2Q37 DELETION SYNDROME	0.00353357	0.16879144542635477
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.00353357	0.16879144542635477
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00353357	0.16879144542635477
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00353357	0.16879144542635477
BECKWITH-WIEDEMANN SYNDROME	0.00353357	0.16879144542635477
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.16879144542635477
FOUNTAIN SYNDROME	0.00353357	0.16879144542635477
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00353357	0.16879144542635477
CHOPS SYNDROME; CHOPS	0.00353357	0.16879144542635477
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00353357	0.16879144542635477
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.00353357	0.16879144542635477
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00353357	0.16879144542635477
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.00353357	0.16879144542635477
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00353357	0.16879144542635477
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.00353357	0.16879144542635477
268650 RUDIGER SYNDROME	0.00353357	0.16879144542635477
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.0034965000000000005	0.16702068699169664
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0034965000000000005	0.16702068699169664
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0034965000000000005	0.16702068699169664
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.0034965000000000005	0.16702068699169664
16P13.2 MICRODELETION SYNDROME	0.0034965000000000005	0.16702068699169664
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0034965000000000005	0.16702068699169664
HOLMES-GANG SYNDROME	0.0034965000000000005	0.16702068699169664
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.0034965000000000005	0.16702068699169664
LISSENCEPHALY 8; LIS8	0.0034965000000000005	0.16702068699169664
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0034965000000000005	0.16702068699169664
TRANSKETOLASE DEFICIENCY	0.0034965000000000005	0.16702068699169664
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0034965000000000005	0.16702068699169664
HALL-RIGGS SYNDROME	0.0034965000000000005	0.16702068699169664
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.0034965000000000005	0.16702068699169664
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.0034965000000000005	0.16702068699169664
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.0034965000000000005	0.16702068699169664
MENTAL RETARDATION, X-LINKED 98; MRX98	0.0034965000000000005	0.16702068699169664
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.0034965000000000005	0.16702068699169664
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.0034965000000000005	0.16702068699169664
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.0034965000000000005	0.16702068699169664
INFANTILE DYSTONIA-PARKINSONISM	0.0034965000000000005	0.16702068699169664
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.0034965000000000005	0.16702068699169664
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0034965000000000005	0.16702068699169664
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.0034965000000000005	0.16702068699169664
WARBURG MICRO SYNDROME 2; WARBM2	0.0034965000000000005	0.16702068699169664
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0034965000000000005	0.16702068699169664
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0034965000000000005	0.16702068699169664
14Q12 MICRODELETION SYNDROME	0.0034965000000000005	0.16702068699169664
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0034965000000000005	0.16702068699169664
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.0034965000000000005	0.16702068699169664
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.0034965000000000005	0.16702068699169664
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.0034965000000000005	0.16702068699169664
19P13.3 MICRODUPLICATION SYNDROME	0.0034965000000000005	0.16702068699169664
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0034965000000000005	0.16702068699169664
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.0034965000000000005	0.16702068699169664
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.0034965000000000005	0.16702068699169664
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.0034965000000000005	0.16702068699169664
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.0034965000000000005	0.16702068699169664
FOIX-CHAVANY-MARIE SYNDROME	0.0034965000000000005	0.16702068699169664
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.0034965000000000005	0.16702068699169664
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.0034965000000000005	0.16702068699169664
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.0034965000000000005	0.16702068699169664
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.0034965000000000005	0.16702068699169664
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.0034965000000000005	0.16702068699169664
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.0034965000000000005	0.16702068699169664
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.0034965000000000005	0.16702068699169664
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.0034965000000000005	0.16702068699169664
AMISH INFANTILE EPILEPSY SYNDROME	0.0034965000000000005	0.16702068699169664
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.0034965000000000005	0.16702068699169664
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0034965000000000005	0.16702068699169664
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.0034965000000000005	0.16702068699169664
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.0034965000000000005	0.16702068699169664
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.0034965000000000005	0.16702068699169664
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0034965000000000005	0.16702068699169664
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.0034965000000000005	0.16702068699169664
OPTICOCOCHLEODENTATE DEGENERATION	0.0034965000000000005	0.16702068699169664
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.0034965000000000005	0.16702068699169664
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00343643	0.1641512653793439
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00343643	0.1641512653793439
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00343643	0.1641512653793439
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00343643	0.1641512653793439
MYOCLONIC-ATONIC EPILEPSY	0.00343643	0.1641512653793439
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00343643	0.1641512653793439
PEDIATRIC-ONSET GRAVES DISEASE	0.00343643	0.1641512653793439
SPONTANEOUS PERIODIC HYPOTHERMIA	0.00343643	0.1641512653793439
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00343643	0.1641512653793439
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.00343643	0.1641512653793439
MOHR-TRANEBJAERG SYNDROME	0.00343643	0.1641512653793439
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.00343643	0.1641512653793439
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.00343643	0.1641512653793439
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00343643	0.1641512653793439
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.00343643	0.1641512653793439
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00343643	0.1641512653793439
CHÉDIAK-HIGASHI SYNDROME	0.00343643	0.1641512653793439
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00343643	0.1641512653793439
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.00343643	0.1641512653793439
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.00343643	0.1641512653793439
SPINOCEREBELLAR ATAXIA TYPE 37	0.00343643	0.1641512653793439
ATAXIA WITH VITAMIN E DEFICIENCY	0.00343643	0.1641512653793439
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.00343643	0.1641512653793439
PRIMARY DYSTONIA, DYT2 TYPE	0.00343643	0.1641512653793439
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.00343643	0.1641512653793439
CLASSIC GALACTOSEMIA	0.00343643	0.1641512653793439
PARKINSON DISEASE 21; PARK21	0.00343643	0.1641512653793439
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00343643	0.1641512653793439
CITRULLINEMIA TYPE II	0.00343643	0.1641512653793439
PERRY SYNDROME	0.00343643	0.1641512653793439
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00343643	0.1641512653793439
PERRY SYNDROME	0.00343643	0.1641512653793439
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00343643	0.1641512653793439
SNEDDON SYNDROME	0.00343643	0.1641512653793439
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00343643	0.1641512653793439
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.00343643	0.1641512653793439
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.00343643	0.1641512653793439
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.00343643	0.1641512653793439
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00343643	0.1641512653793439
MYOPATHY, SPHEROID BODY	0.00343643	0.1641512653793439
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00343643	0.1641512653793439
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00343643	0.1641512653793439
PRIMARY ORTHOSTATIC TREMOR	0.00343643	0.1641512653793439
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00343643	0.1641512653793439
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.00343643	0.1641512653793439
SÉZARY SYNDROME	0.00343643	0.1641512653793439
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00343643	0.1641512653793439
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.00343643	0.1641512653793439
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.00343643	0.1641512653793439
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00343643	0.1641512653793439
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00343643	0.1641512653793439
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.00343643	0.1641512653793439
OPTIC ATROPHY 2	0.00343643	0.1641512653793439
THYROTOXIC PERIODIC PARALYSIS	0.00343643	0.1641512653793439
MERCURY POISONING	0.00343643	0.1641512653793439
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00343643	0.1641512653793439
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.00343643	0.1641512653793439
ENCEPHALITIS LETHARGICA	0.00343643	0.1641512653793439
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.00343643	0.1641512653793439
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00343643	0.1641512653793439
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00343643	0.1641512653793439
CYSTATHIONINURIA	0.00343643	0.1641512653793439
SCRUB TYPHUS	0.00343643	0.1641512653793439
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00343643	0.1641512653793439
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.00343643	0.1641512653793439
SPINOCEREBELLAR ATAXIA 18	0.00343643	0.1641512653793439
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.00343643	0.1641512653793439
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00343643	0.1641512653793439
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.00343643	0.1641512653793439
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.00343643	0.1641512653793439
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.00343643	0.1641512653793439
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00343643	0.1641512653793439
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.00343643	0.1641512653793439
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.00343643	0.1641512653793439
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00343643	0.1641512653793439
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.00343643	0.1641512653793439
AICARDI-GOUTIERES SYNDROME 6	0.00343643	0.1641512653793439
TYROSINEMIA TYPE 2	0.00343643	0.1641512653793439
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00343643	0.1641512653793439
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.00343643	0.1641512653793439
DYSTONIA 13, TORSION	0.00343643	0.1641512653793439
TETANUS	0.00343643	0.1641512653793439
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00343643	0.1641512653793439
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.00343643	0.1641512653793439
KALLMANN SYNDROME	0.00343643	0.1641512653793439
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.00343643	0.1641512653793439
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00343643	0.1641512653793439
MONOMELIC AMYOTROPHY	0.00343643	0.1641512653793439
NIEMANN-PICK DISEASE TYPE C	0.00343643	0.1641512653793439
AICARDI-GOUTIÈRES SYNDROME	0.00343643	0.1641512653793439
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00343643	0.1641512653793439
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00343643	0.1641512653793439
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00343643	0.1641512653793439
WILSON DISEASE	0.00343643	0.1641512653793439
NIPAH VIRUS DISEASE	0.00343643	0.1641512653793439
SPINOCEREBELLAR ATAXIA TYPE 31	0.00343643	0.1641512653793439
GALACTOSEMIA	0.00343643	0.1641512653793439
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.00343643	0.1641512653793439
SPASTIC PARAPARESIS AND DEAFNESS	0.00343643	0.1641512653793439
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00343643	0.1641512653793439
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.00343643	0.1641512653793439
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00343643	0.1641512653793439
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.00343643	0.1641512653793439
TSH-SECRETING PITUITARY ADENOMA	0.00343643	0.1641512653793439
DYSTONIA 3, TORSION, X-LINKED	0.00343643	0.1641512653793439
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00343381	0.16402611331301523
CHROMOSOME 17Q12 DELETION SYNDROME	0.00343381	0.16402611331301523
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00343381	0.16402611331301523
PMM2-CDG	0.00343381	0.16402611331301523
48,XYYY SYNDROME	0.00343381	0.16402611331301523
HYPOGLOSSIA WITH SITUS INVERSUS	0.00343381	0.16402611331301523
DIGEORGE SYNDROME; DGS	0.00343381	0.16402611331301523
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00343381	0.16402611331301523
MOEBIUS SYNDROME; MBS	0.00343381	0.16402611331301523
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.00343381	0.16402611331301523
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.00343381	0.16402611331301523
GLASS SYNDROME	0.00343381	0.16402611331301523
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.0032533600000000003	0.15540638416453773
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.0032533600000000003	0.15540638416453773
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.0032533600000000003	0.15540638416453773
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.0032533600000000003	0.15540638416453773
SPASTIC PARAPLEGIA 16, X-LINKED	0.0032533600000000003	0.15540638416453773
STURGE-WEBER SYNDROME	0.0032533600000000003	0.15540638416453773
ALG11-CDG	0.0032533600000000003	0.15540638416453773
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.0032533600000000003	0.15540638416453773
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.0032533600000000003	0.15540638416453773
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.0032533600000000003	0.15540638416453773
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.0032533600000000003	0.15540638416453773
GAUCHER DISEASE, TYPE II	0.0032533600000000003	0.15540638416453773
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.0032533600000000003	0.15540638416453773
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.0032533600000000003	0.15540638416453773
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.0032533600000000003	0.15540638416453773
DYSEQUILIBRIUM SYNDROME	0.0032533600000000003	0.15540638416453773
NEONATAL ADRENOLEUKODYSTROPHY	0.0032533600000000003	0.15540638416453773
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.0032533600000000003	0.15540638416453773
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.0032533600000000003	0.15540638416453773
TOLUENE EMBRYOPATHY	0.0032533600000000003	0.15540638416453773
19P13.12 MICRODELETION SYNDROME	0.00315009	0.15047338649668915
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00315009	0.15047338649668915
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00315009	0.15047338649668915
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.00315009	0.15047338649668915
CHROMOSOME 19P13.13 DELETION SYNDROME	0.00315009	0.15047338649668915
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00315009	0.15047338649668915
5Q14.3 MICRODELETION SYNDROME	0.00315009	0.15047338649668915
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.00315009	0.15047338649668915
MONOSOMY 22Q13.3	0.00315009	0.15047338649668915
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00315009	0.15047338649668915
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00315009	0.15047338649668915
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00315009	0.15047338649668915
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.00315009	0.15047338649668915
16P11.2P12.2 MICRODELETION SYNDROME	0.00315009	0.15047338649668915
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.00315009	0.15047338649668915
DISTAL MONOSOMY 6P	0.00315009	0.15047338649668915
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.00315009	0.15047338649668915
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00315009	0.15047338649668915
PRADER-WILLI SYNDROME	0.00315009	0.15047338649668915
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.00315009	0.15047338649668915
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.00315009	0.15047338649668915
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00315009	0.15047338649668915
COACH SYNDROME	0.002969568	0.1418502180547858
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.002969568	0.1418502180547858
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.002969568	0.1418502180547858
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.002969568	0.1418502180547858
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.002969568	0.1418502180547858
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.002969568	0.1418502180547858
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.002969568	0.1418502180547858
PEHO SYNDROME; PEHO	0.002969568	0.1418502180547858
GLYCINE ENCEPHALOPATHY; GCE	0.002969568	0.1418502180547858
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.002969568	0.1418502180547858
GM2-GANGLIOSIDOSIS, AB VARIANT	0.002969568	0.1418502180547858
PEROXISOME BIOGENESIS DISORDER 10B	0.002969568	0.1418502180547858
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.002969568	0.1418502180547858
GLUTAMINE DEFICIENCY, CONGENITAL	0.002969568	0.1418502180547858
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.002969568	0.1418502180547858
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.002969568	0.1418502180547858
WARBURG MICRO SYNDROME 1	0.002969568	0.1418502180547858
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.002969568	0.1418502180547858
LESCH-NYHAN SYNDROME; LNS	0.002969568	0.1418502180547858
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.002969568	0.1418502180547858
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.002969568	0.1418502180547858
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.002969568	0.1418502180547858
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.002969568	0.1418502180547858
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.002969568	0.1418502180547858
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.002969568	0.1418502180547858
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.002969568	0.1418502180547858
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.002969568	0.1418502180547858
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.002969568	0.1418502180547858
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.002969568	0.1418502180547858
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.002969568	0.1418502180547858
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.002969568	0.1418502180547858
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.002969568	0.1418502180547858
SPINOCEREBELLAR ATAXIA 1	0.002969568	0.1418502180547858
METACHROMATIC LEUKODYSTROPHY	0.002969568	0.1418502180547858
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.002969568	0.1418502180547858
SPINOCEREBELLAR ATAXIA 13	0.002969568	0.1418502180547858
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.002969568	0.1418502180547858
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.002969568	0.1418502180547858
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0028662979999999998	0.1369172203869372
RING CHROMOSOME 22 SYNDROME	0.0028662979999999998	0.1369172203869372
COHEN-GIBSON SYNDROME; COGIS	0.0028662979999999998	0.1369172203869372
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.0028662979999999998	0.1369172203869372
CHROMOSOME 9P DELETION SYNDROME	0.0028662979999999998	0.1369172203869372
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.0028662979999999998	0.1369172203869372
SHASHI-PENA SYNDROME; SHAPNS	0.0028662979999999998	0.1369172203869372
EPILEPSY, PYRIDOXINE-DEPENDENT	0.0028662979999999998	0.1369172203869372
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0028662979999999998	0.1369172203869372
KLEEFSTRA SYNDROME 2; KLEFS2	0.0028662979999999998	0.1369172203869372
HYPERPROLINEMIA, TYPE I	0.0028662979999999998	0.1369172203869372
AL KAISSI SYNDROME; ALKAS	0.0028662979999999998	0.1369172203869372
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.0028662979999999998	0.1369172203869372
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0028662979999999998	0.1369172203869372
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.0028662979999999998	0.1369172203869372
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.0028662979999999998	0.1369172203869372
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0028662979999999998	0.1369172203869372
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0028662979999999998	0.1369172203869372
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.0028662979999999998	0.1369172203869372
ALG13-CDG	0.0028662979999999998	0.1369172203869372
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.0028662979999999998	0.1369172203869372
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.0028662979999999998	0.1369172203869372
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.0028662979999999998	0.1369172203869372
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.0028662979999999998	0.1369172203869372
SALLA DISEASE	0.0028662979999999998	0.1369172203869372
CHROMOSOME 5Q12 DELETION SYNDROME	0.0028662979999999998	0.1369172203869372
COFFIN-SIRIS SYNDROME 8; CSS8	0.0028662979999999998	0.1369172203869372
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0028662979999999998	0.1369172203869372
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.0028662979999999998	0.1369172203869372
SMITH-MAGENIS SYNDROME; SMS	0.0028662979999999998	0.1369172203869372
MENTAL RETARDATION, X-LINKED 19	0.0028662979999999998	0.1369172203869372
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.0028662979999999998	0.1369172203869372
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0028662979999999998	0.1369172203869372
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.0028662979999999998	0.1369172203869372
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.0028662979999999998	0.1369172203869372
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0028662979999999998	0.1369172203869372
MENTAL RETARDATION, X-LINKED 93	0.0028662979999999998	0.1369172203869372
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0028662979999999998	0.1369172203869372
JOUBERT SYNDROME 30; JBTS30	0.0028662979999999998	0.1369172203869372
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.0028662979999999998	0.1369172203869372
GALACTOSE EPIMERASE DEFICIENCY	0.0028662979999999998	0.1369172203869372
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0028662979999999998	0.1369172203869372
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.0028662979999999998	0.1369172203869372
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.0028662979999999998	0.1369172203869372
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0028662979999999998	0.1369172203869372
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0028662979999999998	0.1369172203869372
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.0028662979999999998	0.1369172203869372
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0028662979999999998	0.1369172203869372
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.0028662979999999998	0.1369172203869372
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.0028662979999999998	0.1369172203869372
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00283286	0.13531995519842632
NEUROFACIODIGITORENAL SYNDROME	0.00283286	0.13531995519842632
CATEL-MANZKE SYNDROME	0.00283286	0.13531995519842632
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.00283286	0.13531995519842632
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.00283286	0.13531995519842632
LATERAL MENINGOCELE SYNDROME	0.00283286	0.13531995519842632
AYME-GRIPP SYNDROME; AYGRP	0.00283286	0.13531995519842632
GROWTH FACTORS, COMBINED DEFECT OF	0.00283286	0.13531995519842632
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.00283286	0.13531995519842632
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00283286	0.13531995519842632
ACROPECTOROVERTEBRAL DYSPLASIA	0.00283286	0.13531995519842632
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00283286	0.13531995519842632
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.00283286	0.13531995519842632
169300 PECTUS EXCAVATUM;;FUNNEL CHEST	0.00283286	0.13531995519842632
227320 FACIOTHORACOGENITAL SYNDROME	0.00283286	0.13531995519842632
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00283286	0.13531995519842632
ACROOTOOCULAR SYNDROME	0.00283286	0.13531995519842632
16P13.11 MICRODUPLICATION SYNDROME	0.00283286	0.13531995519842632
RING CHROMOSOME 10 SYNDROME	0.00283286	0.13531995519842632
LICHTENSTEIN SYNDROME	0.00283286	0.13531995519842632
CHROMOSOME 15Q25 DELETION SYNDROME	0.00283286	0.13531995519842632
STICKLER SYNDROME, TYPE I	0.00283286	0.13531995519842632
HYPOPHOSPHATEMIC RICKETS	0.00283286	0.13531995519842632
ENG-STROM SYNDROME	0.00283286	0.13531995519842632
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00283286	0.13531995519842632
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.00283286	0.13531995519842632
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00283286	0.13531995519842632
ACROCRANIOFACIAL DYSOSTOSIS	0.00283286	0.13531995519842632
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00283286	0.13531995519842632
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.00283286	0.13531995519842632
TRISOMY XQ28	0.00283286	0.13531995519842632
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00283286	0.13531995519842632
DYSOSTOSIS, STANESCU TYPE	0.00283286	0.13531995519842632
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.00283286	0.13531995519842632
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.00283286	0.13531995519842632
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00283286	0.13531995519842632
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00283286	0.13531995519842632
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00283286	0.13531995519842632
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.00283286	0.13531995519842632
RING CHROMOSOME 12 SYNDROME	0.00283286	0.13531995519842632
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.00283286	0.13531995519842632
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.00283286	0.13531995519842632
PETERS-PLUS SYNDROME; PTRPLS	0.00283286	0.13531995519842632
OSTEOFIBROUS DYSPLASIA, SUSCEPTIBILITY TO; OSFD	0.00283286	0.13531995519842632
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00283286	0.13531995519842632
LYMPHEDEMA, HEREDITARY, III	0.00283286	0.13531995519842632
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.00283286	0.13531995519842632
TREACHER-COLLINS SYNDROME	0.00277438	0.1325264846492273
MUENKE SYNDROME	0.00277438	0.1325264846492273
MOEBIUS SYNDROME	0.00277438	0.1325264846492273
8Q21.11 MICRODELETION SYNDROME	0.00277438	0.1325264846492273
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00277438	0.1325264846492273
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.00277438	0.1325264846492273
15Q26 OVERGROWTH SYNDROME	0.00277438	0.1325264846492273
GERMAN SYNDROME	0.00277438	0.1325264846492273
FETAL TRIMETHADIONE SYNDROME	0.00277438	0.1325264846492273
BRANCHIO-OCULO-FACIAL SYNDROME	0.00277438	0.1325264846492273
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.00277438	0.1325264846492273
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00277438	0.1325264846492273
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00277438	0.1325264846492273
OROFACIODIGITAL SYNDROME IX; OFD9	0.00277438	0.1325264846492273
15Q24 MICRODELETION SYNDROME	0.00277438	0.1325264846492273
MOWAT-WILSON SYNDROME	0.00277438	0.1325264846492273
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.00277438	0.1325264846492273
CHROMOSOME 16P13.3 DELETION SYNDROME	0.00277438	0.1325264846492273
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00277438	0.1325264846492273
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00277438	0.1325264846492273
KABUKI SYNDROME	0.00277438	0.1325264846492273
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.00277438	0.1325264846492273
MATERNAL PHENYLKETONURIA	0.00277438	0.1325264846492273
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.002490588	0.11897031853947539
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.002490588	0.11897031853947539
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.002490588	0.11897031853947539
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.002490588	0.11897031853947539
LATHOSTEROLOSIS	0.002490588	0.11897031853947539
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.002490588	0.11897031853947539
CLASSIC MULTIMINICORE MYOPATHY	0.002490588	0.11897031853947539
FUMARASE DEFICIENCY; FMRD	0.002490588	0.11897031853947539
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.002490588	0.11897031853947539
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.002490588	0.11897031853947539
RING CHROMOSOME 13 SYNDROME	0.002490588	0.11897031853947539
RING CHROMOSOME 14 SYNDROME	0.002490588	0.11897031853947539
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.002490588	0.11897031853947539
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.002490588	0.11897031853947539
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.002490588	0.11897031853947539
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.002490588	0.11897031853947539
WARSAW BREAKAGE SYNDROME; WABS	0.002490588	0.11897031853947539
MYOPATHY, CENTRONUCLEAR, 5	0.002490588	0.11897031853947539
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.002490588	0.11897031853947539
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.002490588	0.11897031853947539
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.002490588	0.11897031853947539
IMMUNODEFICIENCY 23; IMD23	0.002490588	0.11897031853947539
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.002490588	0.11897031853947539
MEND SYNDROME; MEND	0.002490588	0.11897031853947539
ADDUCTED THUMBS SYNDROME	0.002490588	0.11897031853947539
MEND SYNDROME	0.002490588	0.11897031853947539
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.002490588	0.11897031853947539
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.002490588	0.11897031853947539
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.002490588	0.11897031853947539
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.002490588	0.11897031853947539
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.002490588	0.11897031853947539
NEMALINE MYOPATHY 7; NEM7	0.002490588	0.11897031853947539
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.002490588	0.11897031853947539
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.002490588	0.11897031853947539
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.002490588	0.11897031853947539
JOUBERT SYNDROME 2	0.002490588	0.11897031853947539
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.002490588	0.11897031853947539
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.002490588	0.11897031853947539
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.002490588	0.11897031853947539
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.002490588	0.11897031853947539
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.002490588	0.11897031853947539
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.002490588	0.11897031853947539
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.002490588	0.11897031853947539
OROFACIODIGITAL SYNDROME VI	0.002490588	0.11897031853947539
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.002206868	0.10541759172314928
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.002206868	0.10541759172314928
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.002206868	0.10541759172314928
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.002206868	0.10541759172314928
SSR4-CDG	0.002206868	0.10541759172314928
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.002206868	0.10541759172314928
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.002206868	0.10541759172314928
ADAMS-OLIVER SYNDROME 2; AOS2	0.002206868	0.10541759172314928
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.002206868	0.10541759172314928
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.002206868	0.10541759172314928
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.002206868	0.10541759172314928
CRANIOSYNOSTOSIS 6; CRS6	0.002206868	0.10541759172314928
MULTIMINICORE MYOPATHY	0.002206868	0.10541759172314928
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.002206868	0.10541759172314928
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.002206868	0.10541759172314928
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.002206868	0.10541759172314928
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.002206868	0.10541759172314928
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.002206868	0.10541759172314928
MARINESCO-SJOGREN SYNDROME; MSS	0.002206868	0.10541759172314928
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.002206868	0.10541759172314928
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.002206868	0.10541759172314928
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002206868	0.10541759172314928
BOHRING-OPITZ SYNDROME	0.002206868	0.10541759172314928
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.002206868	0.10541759172314928
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.002206868	0.10541759172314928
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.002206868	0.10541759172314928
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.002206868	0.10541759172314928
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.002206868	0.10541759172314928
SENGERS SYNDROME	0.002206868	0.10541759172314928
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.002206868	0.10541759172314928
JOUBERT SYNDROME 14	0.002206868	0.10541759172314928
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.002206868	0.10541759172314928
JOUBERT SYNDROME 31; JBTS31	0.002206868	0.10541759172314928
MENTAL RETARDATION, X-LINKED 1	0.002206868	0.10541759172314928
JOHANSON-BLIZZARD SYNDROME; JBS	0.002206868	0.10541759172314928
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.002206868	0.10541759172314928
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.002206868	0.10541759172314928
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.002206868	0.10541759172314928
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.002206868	0.10541759172314928
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.002206868	0.10541759172314928
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.002206868	0.10541759172314928
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.002206868	0.10541759172314928
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.002206868	0.10541759172314928
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.002206868	0.10541759172314928
CYCLIC VOMITING SYNDROME	0.002206868	0.10541759172314928
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.002206868	0.10541759172314928
%613364 SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41	0.00200803	0.09591950524808711
WORSTER-DROUGHT SYNDROME	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00200803	0.09591950524808711
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00200803	0.09591950524808711
ERDHEIM-CHESTER DISEASE	0.00200803	0.09591950524808711
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.00200803	0.09591950524808711
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.00200803	0.09591950524808711
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.00200803	0.09591950524808711
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00200803	0.09591950524808711
PRIMARY LATERAL SCLEROSIS, ADULT	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	0.00200803	0.09591950524808711
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00200803	0.09591950524808711
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00200803	0.09591950524808711
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.00200803	0.09591950524808711
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.00200803	0.09591950524808711
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.00200803	0.09591950524808711
TRIPLE A SYNDROME	0.00200803	0.09591950524808711
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.00200803	0.09591950524808711
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00200803	0.09591950524808711
GABA-TRANSAMINASE DEFICIENCY	0.00200803	0.09591950524808711
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00200803	0.09591950524808711
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.00200803	0.09591950524808711
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00200803	0.09591950524808711
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00200803	0.09591950524808711
TAY-SACHS DISEASE	0.00200803	0.09591950524808711
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.00200803	0.09591950524808711
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00200803	0.09591950524808711
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.00200803	0.09591950524808711
HYPEREKPLEXIA 2; HKPX2	0.00200803	0.09591950524808711
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 73	0.00200803	0.09591950524808711
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT	0.00200803	0.09591950524808711
EARLY-ONSET LAFORA BODY DISEASE	0.00200803	0.09591950524808711
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.00200803	0.09591950524808711
MEHMO SYNDROME	0.00200803	0.09591950524808711
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.00200803	0.09591950524808711
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.00200803	0.09591950524808711
SPINOCEREBELLAR ATAXIA 14	0.00200803	0.09591950524808711
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	0.00200803	0.09591950524808711
RETINITIS PIGMENTOSA	0.00200803	0.09591950524808711
NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00200803	0.09591950524808711
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00200803	0.09591950524808711
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE	0.00200803	0.09591950524808711
MT-ATP6-RELATED MITOCHONDRIAL SPASTIC PARAPLEGIA	0.00200803	0.09591950524808711
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 41	0.00200803	0.09591950524808711
HEREDITARY HYPEREKPLEXIA	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38	0.00200803	0.09591950524808711
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00200803	0.09591950524808711
MICROHYDRANENCEPHALY; MHAC	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	0.00200803	0.09591950524808711
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.00200803	0.09591950524808711
AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16	0.00200803	0.09591950524808711
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00200803	0.09591950524808711
LIGNEOUS CONJUNCTIVITIS	0.00200803	0.09591950524808711
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.00200803	0.09591950524808711
HARTNUP DISORDER	0.00200803	0.09591950524808711
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 14	0.00200803	0.09591950524808711
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.00200803	0.09591950524808711
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.00200803	0.09591950524808711
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00200803	0.09591950524808711
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 28	0.00200803	0.09591950524808711
SPINOCEREBELLAR ATAXIA TYPE 23	0.00200803	0.09591950524808711
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00200803	0.09591950524808711
BEHÇET DISEASE	0.00200803	0.09591950524808711
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.00200803	0.09591950524808711
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.00200803	0.09591950524808711
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.00200803	0.09591950524808711
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00200803	0.09591950524808711
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.00200803	0.09591950524808711
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00200803	0.09591950524808711
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.00200803	0.09591950524808711
HUNTINGTON DISEASE; HD	0.00200803	0.09591950524808711
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00200803	0.09591950524808711
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00200803	0.09591950524808711
HUNTINGTON DISEASE-LIKE 2	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA TYPE 2	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE	0.00200803	0.09591950524808711
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.00200803	0.09591950524808711
PEHO SYNDROME	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00200803	0.09591950524808711
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00200803	0.09591950524808711
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00200803	0.09591950524808711
SPINOCEREBELLAR ATAXIA TYPE 8	0.00200803	0.09591950524808711
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00200803	0.09591950524808711
L1 SYNDROME	0.00200803	0.09591950524808711
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00200803	0.09591950524808711
JUVENILE PRIMARY LATERAL SCLEROSIS	0.00200803	0.09591950524808711
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.00200803	0.09591950524808711
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00200803	0.09591950524808711
JUVENILE HUNTINGTON DISEASE	0.00200803	0.09591950524808711
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00200803	0.09591950524808711
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00200803	0.09591950524808711
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00200803	0.09591950524808711
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.00200803	0.09591950524808711
SPINOCEREBELLAR ATAXIA TYPE 7	0.00200803	0.09591950524808711
ATAXIA-PANCYTOPENIA SYNDROME	0.00200803	0.09591950524808711
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00200803	0.09591950524808711
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00200803	0.09591950524808711
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.00200803	0.09591950524808711
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00200803	0.09591950524808711
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.00200803	0.09591950524808711
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.00200803	0.09591950524808711
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.00200803	0.09591950524808711
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.00200803	0.09591950524808711
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00200803	0.09591950524808711
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.00200803	0.09591950524808711
AMYOTROPHIC LATERAL SCLEROSIS 1	0.00200803	0.09591950524808711
EARLY MYOCLONIC ENCEPHALOPATHY	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.00200803	0.09591950524808711
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.00200803	0.09591950524808711
DERMATOLEUKODYSTROPHY	0.00200803	0.09591950524808711
X-LINKED IMMUNONEUROLOGIC DISORDER	0.00200803	0.09591950524808711
H SYNDROME	0.00200803	0.09591950524808711
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.00200803	0.09591950524808711
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.00200803	0.09591950524808711
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.00200803	0.09591950524808711
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.00200803	0.09591950524808711
AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24	0.00200803	0.09591950524808711
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.00200803	0.09591950524808711
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00200803	0.09591950524808711
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.00200803	0.09591950524808711
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00200803	0.09591950524808711
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.00200803	0.09591950524808711
CENTRAL BILATERAL MACROGYRIA	0.00200803	0.09591950524808711
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.00200803	0.09591950524808711
MAST SYNDROME	0.00200803	0.09591950524808711
RICHARDS-RUNDLE SYNDROME	0.00200803	0.09591950524808711
DISTAL HEREDITARY MOTOR NEUROPATHY TYPE 5	0.00200803	0.09591950524808711
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00200803	0.09591950524808711
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00200803	0.09591950524808711
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 39	0.00200803	0.09591950524808711
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00200803	0.09591950524808711
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00200803	0.09591950524808711
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00200803	0.09591950524808711
GEMIGNANI SYNDROME	0.00200803	0.09591950524808711
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00190476	0.09098650758023853
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.00190476	0.09098650758023853
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00190476	0.09098650758023853
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00190476	0.09098650758023853
13Q12.3 MICRODELETION SYNDROME	0.00190476	0.09098650758023853
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.00190476	0.09098650758023853
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	0.09098650758023853
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.00190476	0.09098650758023853
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00190476	0.09098650758023853
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.00190476	0.09098650758023853
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00190476	0.09098650758023853
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.00190476	0.09098650758023853
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00190476	0.09098650758023853
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00190476	0.09098650758023853
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00190476	0.09098650758023853
3Q27.3 MICRODELETION SYNDROME	0.00190476	0.09098650758023853
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00190476	0.09098650758023853
ABLEPHARON-MACROSTOMIA SYNDROME	0.00190476	0.09098650758023853
FORSYTHE-WAKELING SYNDROME; FWS	0.00190476	0.09098650758023853
MENTAL RETARDATION, X-LINKED 95	0.00190476	0.09098650758023853
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.00190476	0.09098650758023853
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00190476	0.09098650758023853
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.00190476	0.09098650758023853
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00190476	0.09098650758023853
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.00190476	0.09098650758023853
TEMPLE SYNDROME	0.00190476	0.09098650758023853
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	0.09098650758023853
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00190476	0.09098650758023853
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00190476	0.09098650758023853
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.00190476	0.09098650758023853
CHROMOSOME 13Q14 DELETION SYNDROME	0.00190476	0.09098650758023853
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00190476	0.09098650758023853
EPISODIC ATAXIA TYPE 1	0.00190476	0.09098650758023853
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00190476	0.09098650758023853
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.00190476	0.09098650758023853
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.00190476	0.09098650758023853
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.00190476	0.09098650758023853
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.00190476	0.09098650758023853
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.00190476	0.09098650758023853
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00190476	0.09098650758023853
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.00190476	0.09098650758023853
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.00190476	0.09098650758023853
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.00190476	0.09098650758023853
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00190476	0.09098650758023853
LARYNGOTRACHEAL ANGIOMA	0.00190476	0.09098650758023853
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.00190476	0.09098650758023853
17Q11.2 MICRODUPLICATION SYNDROME	0.00190476	0.09098650758023853
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.00190476	0.09098650758023853
CLEFT LIP/PALATE	0.00190476	0.09098650758023853
FAMILIAL MULTIPLE LIPOMATOSIS	0.00190476	0.09098650758023853
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00190476	0.09098650758023853
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00190476	0.09098650758023853
LIG4 SYNDROME	0.00190476	0.09098650758023853
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00190476	0.09098650758023853
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.00190476	0.09098650758023853
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.00190476	0.09098650758023853
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00190476	0.09098650758023853
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.00190476	0.09098650758023853
8P23.1 DUPLICATION SYNDROME	0.00190476	0.09098650758023853
SPEECH-LANGUAGE DISORDER 1	0.00190476	0.09098650758023853
9Q21.13 MICRODELETION SYNDROME	0.00190476	0.09098650758023853
7Q11.23 DUPLICATION SYNDROME	0.00190476	0.09098650758023853
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00190476	0.09098650758023853
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00190476	0.09098650758023853
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.00190476	0.09098650758023853
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	0.09098650758023853
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00190476	0.09098650758023853
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00190476	0.09098650758023853
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.00190476	0.09098650758023853
15Q11Q13 MICRODUPLICATION SYNDROME	0.00190476	0.09098650758023853
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.00190476	0.09098650758023853
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00190476	0.09098650758023853
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.00190476	0.09098650758023853
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.00190476	0.09098650758023853
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00190476	0.09098650758023853
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.00190476	0.09098650758023853
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00190476	0.09098650758023853
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.00190476	0.09098650758023853
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00190476	0.09098650758023853
FRAXE INTELLECTUAL DISABILITY	0.00190476	0.09098650758023853
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00190476	0.09098650758023853
15Q14 MICRODELETION SYNDROME	0.00190476	0.09098650758023853
MENTAL RETARDATION, X-LINKED 9	0.00190476	0.09098650758023853
MAXILLOFACIAL DYSOSTOSIS	0.00190476	0.09098650758023853
DUCHENNE MUSCULAR DYSTROPHY	0.00190476	0.09098650758023853
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00190476	0.09098650758023853
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.00190476	0.09098650758023853
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00190476	0.09098650758023853
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.00190476	0.09098650758023853
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00190476	0.09098650758023853
19Q13.11 MICRODELETION SYNDROME	0.00190476	0.09098650758023853
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00190476	0.09098650758023853
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00190476	0.09098650758023853
20P13 MICRODELETION SYNDROME	0.00190476	0.09098650758023853
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00190476	0.09098650758023853
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.00190476	0.09098650758023853
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.00190476	0.09098650758023853
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.00190476	0.09098650758023853
MICROTIA	0.00190476	0.09098650758023853
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.00190476	0.09098650758023853
SHORT SYNDROME	0.00190476	0.09098650758023853
BILATERAL POLYMICROGYRIA	0.00190476	0.09098650758023853
UNILATERAL POLYMICROGYRIA	0.00190476	0.09098650758023853
RETINITIS PIGMENTOSA 71; RP71	0.00190476	0.09098650758023853
BRACHYDACTYLY, TYPE A1, D	0.00190476	0.09098650758023853
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.00190476	0.09098650758023853
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.00190476	0.09098650758023853
11P15.4 MICRODUPLICATION SYNDROME	0.00190476	0.09098650758023853
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00190476	0.09098650758023853
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.00190476	0.09098650758023853
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00190476	0.09098650758023853
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00190476	0.09098650758023853
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00190476	0.09098650758023853
OKAMOTO SYNDROME	0.00190476	0.09098650758023853
CRANIOSYNOSTOSIS 7	0.00190476	0.09098650758023853
BARDET-BIEDL SYNDROME 21; BBS21	0.00190476	0.09098650758023853
POSTORGASMIC ILLNESS SYNDROME	0.00190476	0.09098650758023853
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00190476	0.09098650758023853
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.00190476	0.09098650758023853
1P21.3 MICRODELETION SYNDROME	0.00190476	0.09098650758023853
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00190476	0.09098650758023853
47,XYY SYNDROME	0.00190476	0.09098650758023853
ABLEPHARON MACROSTOMIA SYNDROME	0.00190476	0.09098650758023853
PARTINGTON SYNDROME	0.00190476	0.09098650758023853
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.00190476	0.09098650758023853
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00190476	0.09098650758023853
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.00190476	0.09098650758023853
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00190476	0.09098650758023853
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00190476	0.09098650758023853
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.00190476	0.09098650758023853
HYPERLYSINEMIA, TYPE I	0.00190476	0.09098650758023853
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.00190476	0.09098650758023853
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.00190476	0.09098650758023853
DISTAL TRISOMY 5Q	0.00190476	0.09098650758023853
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00190476	0.09098650758023853
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.00190476	0.09098650758023853
20Q13.33 MICRODELETION SYNDROME	0.00190476	0.09098650758023853
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	0.09098650758023853
OROFACIODIGITAL SYNDROME XVII	0.00190476	0.09098650758023853
17Q12 MICRODUPLICATION SYNDROME	0.00190476	0.09098650758023853
7P22.1 MICRODUPLICATION SYNDROME	0.00190476	0.09098650758023853
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.00190476	0.09098650758023853
GERODERMA OSTEODYSPLASTICUM; GO	0.00190476	0.09098650758023853
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.00190476	0.09098650758023853
FG SYNDROME 2; FGS2	0.00190476	0.09098650758023853
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00190476	0.09098650758023853
AUTISM	0.00190476	0.09098650758023853
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.00190476	0.09098650758023853
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00190476	0.09098650758023853
MILD CANAVAN DISEASE	0.00190476	0.09098650758023853
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.00190476	0.09098650758023853
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.00190476	0.09098650758023853
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00190476	0.09098650758023853
MONOSOMY 22	0.00152905	0.0730396057327767
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00152905	0.0730396057327767
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00152905	0.0730396057327767
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00152905	0.0730396057327767
OROFACIODIGITAL SYNDROME I; OFD1	0.00152905	0.0730396057327767
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00152905	0.0730396057327767
CHROMOSOME 18P DELETION SYNDROME	0.00152905	0.0730396057327767
ASCHER SYNDROME	0.00152905	0.0730396057327767
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00152905	0.0730396057327767
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00152905	0.0730396057327767
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00152905	0.0730396057327767
PFEIFFER SYNDROME TYPE 1	0.00152905	0.0730396057327767
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.00152905	0.0730396057327767
SHELDON-HALL SYNDROME	0.00152905	0.0730396057327767
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.00152905	0.0730396057327767
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.00152905	0.0730396057327767
HOLOPROSENCEPHALY 5; HPE5	0.00152905	0.0730396057327767
17P13.3 MICRODUPLICATION SYNDROME	0.00152905	0.0730396057327767
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00152905	0.0730396057327767
FETAL GAUCHER DISEASE	0.00152905	0.0730396057327767
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00152905	0.0730396057327767
EVEN-PLUS SYNDROME	0.00152905	0.0730396057327767
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.00152905	0.0730396057327767
PFEIFFER SYNDROME TYPE 3	0.00152905	0.0730396057327767
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00152905	0.0730396057327767
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.00152905	0.0730396057327767
CEREBROOCULONASAL SYNDROME	0.00152905	0.0730396057327767
17Q21.31 MICRODUPLICATION SYNDROME	0.00152905	0.0730396057327767
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00152905	0.0730396057327767
CORNELIA DE LANGE SYNDROME 3	0.00152905	0.0730396057327767
PFEIFFER SYNDROME TYPE 2	0.00152905	0.0730396057327767
608028 THAI SYMPHALANGISM SYNDROME	0.00152905	0.0730396057327767
HENNEKAM-BEEMER SYNDROME	0.00152905	0.0730396057327767
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00152905	0.0730396057327767
CRISPONI SYNDROME	0.00152905	0.0730396057327767
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00152905	0.0730396057327767
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00152905	0.0730396057327767
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00152905	0.0730396057327767
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00152905	0.0730396057327767
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00152905	0.0730396057327767
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00152905	0.0730396057327767
DISTAL MONOSOMY 3P	0.00152905	0.0730396057327767
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00152905	0.0730396057327767
CEREBROOCULONASAL SYNDROME	0.00152905	0.0730396057327767
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.00152905	0.0730396057327767
EMERY-NELSON SYNDROME	0.00152905	0.0730396057327767
NATIVE AMERICAN MYOPATHY	0.00152905	0.0730396057327767
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00152905	0.0730396057327767
PERRAULT SYNDROME 5; PRLTS5	0.00152905	0.0730396057327767
LIPOID PROTEINOSIS	0.00152905	0.0730396057327767
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.00152905	0.0730396057327767
ADULT-ONSET NEMALINE MYOPATHY	0.00152905	0.0730396057327767
FRONTOMETAPHYSEAL DYSPLASIA	0.00152905	0.0730396057327767
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00152905	0.0730396057327767
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00152905	0.0730396057327767
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00152905	0.0730396057327767
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00152905	0.0730396057327767
VICI SYNDROME	0.00152905	0.0730396057327767
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00152905	0.0730396057327767
CAREY-FINEMAN-ZITER SYNDROME	0.00152905	0.0730396057327767
ZELLWEGER SYNDROME	0.00152905	0.0730396057327767
LAING EARLY-ONSET DISTAL MYOPATHY	0.00152905	0.0730396057327767
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.00152905	0.0730396057327767
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.00152905	0.0730396057327767
LERI-WEILL DYSCHONDROSTEOSIS	0.00152905	0.0730396057327767
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00152905	0.0730396057327767
601095 HARROD SYNDROME	0.00152905	0.0730396057327767
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00152905	0.0730396057327767
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.00152905	0.0730396057327767
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00152905	0.0730396057327767
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.00152905	0.0730396057327767
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00152905	0.0730396057327767
FRASER SYNDROME	0.00152905	0.0730396057327767
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.00152905	0.0730396057327767
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00152905	0.0730396057327767
BRANCHIOOTORENAL SYNDROME 1	0.00152905	0.0730396057327767
NASODIGITOACOUSTIC SYNDROME	0.00152905	0.0730396057327767
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00152905	0.0730396057327767
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00152905	0.0730396057327767
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00152905	0.0730396057327767
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00152905	0.0730396057327767
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00152905	0.0730396057327767
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00152905	0.0730396057327767
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.00152905	0.0730396057327767
ALAZAMI-YUAN SYNDROME	0.00152905	0.0730396057327767
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00152905	0.0730396057327767
LANGER MESOMELIC DYSPLASIA	0.00152905	0.0730396057327767
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00152905	0.0730396057327767
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00152905	0.0730396057327767
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.00152905	0.0730396057327767
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00152905	0.0730396057327767
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00152905	0.0730396057327767
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00152905	0.0730396057327767
CZEIZEL-LOSONCI SYNDROME	0.00152905	0.0730396057327767
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00152905	0.0730396057327767
MENTAL RETARDATION, X-LINKED 45	0.00152905	0.0730396057327767
ZIMMERMANN-LABAND SYNDROME	0.00152905	0.0730396057327767
MCKUSICK-KAUFMAN SYNDROME	0.00152905	0.0730396057327767
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.00152905	0.0730396057327767
OROFACIODIGITAL SYNDROME TYPE 2	0.00152905	0.0730396057327767
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.00152905	0.0730396057327767
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.00152905	0.0730396057327767
DISTAL NEBULIN MYOPATHY	0.00152905	0.0730396057327767
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00152905	0.0730396057327767
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.00152905	0.0730396057327767
NEU-LAXOVA SYNDROME 2; NLS2	0.00152905	0.0730396057327767
6Q25 MICRODELETION SYNDROME	0.00152905	0.0730396057327767
MICRO SYNDROME	0.00152905	0.0730396057327767
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00152905	0.0730396057327767
3Q29 MICRODUPLICATION SYNDROME	0.00152905	0.0730396057327767
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.00152905	0.0730396057327767
MONOSOMY 5P	0.00152905	0.0730396057327767
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.00152905	0.0730396057327767
POLYVALVULAR HEART DISEASE SYNDROME	0.00152905	0.0730396057327767
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.00152905	0.0730396057327767
FEINGOLD SYNDROME 1; FGLDS1	0.00152905	0.0730396057327767
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.00152905	0.0730396057327767
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00152905	0.0730396057327767
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.00152905	0.0730396057327767
MYOPATHY, DISTAL, 1; MPD1	0.00152905	0.0730396057327767
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00152905	0.0730396057327767
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.00152905	0.0730396057327767
PGM3-CDG	0.00152905	0.0730396057327767
OCULOCUTANEOUS ALBINISM TYPE 5	0.00152905	0.0730396057327767
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.00152905	0.0730396057327767
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00152905	0.0730396057327767
MENTAL RETARDATION, X-LINKED 2	0.00152905	0.0730396057327767
PFEIFFER SYNDROME	0.00152905	0.0730396057327767
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00152905	0.0730396057327767
14Q11.2 MICRODELETION SYNDROME	0.00152905	0.0730396057327767
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	0.0594868789164506
OCULOCUTANEOUS ALBINISM TYPE 2	0.00124533	0.0594868789164506
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00124533	0.0594868789164506
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00124533	0.0594868789164506
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	0.0594868789164506
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	0.0594868789164506
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00124533	0.0594868789164506
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.00124533	0.0594868789164506
HADDAD SYNDROME	0.00124533	0.0594868789164506
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00124533	0.0594868789164506
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.00124533	0.0594868789164506
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.00124533	0.0594868789164506
BRANCHIOOCULOFACIAL SYNDROME	0.00124533	0.0594868789164506
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00124533	0.0594868789164506
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.00124533	0.0594868789164506
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00124533	0.0594868789164506
HERMANSKY-PUDLAK SYNDROME	0.00124533	0.0594868789164506
15Q13.3 MICRODELETION SYNDROME	0.00124533	0.0594868789164506
APERT SYNDROME	0.00124533	0.0594868789164506
ACRO-RENAL-OCULAR SYNDROME	0.00124533	0.0594868789164506
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.00124533	0.0594868789164506
DOWN SYNDROME	0.00124533	0.0594868789164506
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00124533	0.0594868789164506
GAUCHER DISEASE TYPE 3	0.00124533	0.0594868789164506
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00124533	0.0594868789164506
TETRASOMY X	0.00124533	0.0594868789164506
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	0.0594868789164506
ABDUCENS PALSY	0.00124533	0.0594868789164506
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00124533	0.0594868789164506
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00124533	0.0594868789164506
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00124533	0.0594868789164506
SAETHRE-CHOTZEN SYNDROME	0.00124533	0.0594868789164506
RETINOBLASTOMA	0.00124533	0.0594868789164506
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	0.0594868789164506
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.00124533	0.0594868789164506
POTOCKI-SHAFFER SYNDROME	0.00124533	0.0594868789164506
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00124533	0.0594868789164506
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	0.0594868789164506
GAUCHER DISEASE TYPE 2	0.00124533	0.0594868789164506
MASA SYNDROME	0.00124533	0.0594868789164506
FANCONI ANEMIA	0.00124533	0.0594868789164506
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.00124533	0.0594868789164506
LAMBOTTE SYNDROME	0.00124533	0.0594868789164506
RICHARDS-RUNDLE SYNDROME; RRNS	0.00124533	0.0594868789164506
OPTIC ATROPHY 1; OPA1	0.00124533	0.0594868789164506
OCULOECTODERMAL SYNDROME; OES	0.00124533	0.0594868789164506
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.00124533	0.0594868789164506
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.00124533	0.0594868789164506
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00124533	0.0594868789164506
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00124533	0.0594868789164506
HEMIFACIAL MICROSOMIA	0.00124533	0.0594868789164506
IVIC SYNDROME	0.00124533	0.0594868789164506
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00124533	0.0594868789164506
PETERS ANOMALY	0.00124533	0.0594868789164506
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.00124533	0.0594868789164506
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00124533	0.0594868789164506
GLYCEROL KINASE DEFICIENCY; GKD	0.00124533	0.0594868789164506
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00124533	0.0594868789164506
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00124533	0.0594868789164506
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00124533	0.0594868789164506
GAUCHER DISEASE, TYPE IIIC	0.00124533	0.0594868789164506
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00124533	0.0594868789164506
3MC SYNDROME 2	0.00124533	0.0594868789164506
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00124533	0.0594868789164506
HYPERTRYPTOPHANEMIA; HYPTRP	0.00124533	0.0594868789164506
AASE-SMITH SYNDROME	0.00124533	0.0594868789164506
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00124533	0.0594868789164506
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00124533	0.0594868789164506
VITREORETINOCHOROIDOPATHY; VRCP	0.00124533	0.0594868789164506
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	0.0594868789164506
OCULOCUTANEOUS ALBINISM TYPE 4	0.00124533	0.0594868789164506
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00124533	0.0594868789164506
ADAMS-OLIVER SYNDROME	0.00124533	0.0594868789164506
ROBINOW-SORAUF SYNDROME	0.00124533	0.0594868789164506
CROUZON SYNDROME	0.00124533	0.0594868789164506
XERODERMA PIGMENTOSUM	0.00124533	0.0594868789164506
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00124533	0.0594868789164506
COATS DISEASE	0.00124533	0.0594868789164506
MUSCLE-EYE-BRAIN DISEASE	0.00124533	0.0594868789164506
MENTAL RETARDATION, X-LINKED 21	0.00124533	0.0594868789164506
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00124533	0.0594868789164506
PRIMARY CUTIS VERTICIS GYRATA	0.00124533	0.0594868789164506
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00124533	0.0594868789164506
SCHIZENCEPHALY	0.00124533	0.0594868789164506
PELGER-HUET ANOMALY; PHA	0.00124533	0.0594868789164506
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00124533	0.0594868789164506
CHAR SYNDROME	0.00124533	0.0594868789164506
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.00124533	0.0594868789164506
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.00124533	0.0594868789164506
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00124533	0.0594868789164506
CHANARIN-DORFMAN SYNDROME	0.00124533	0.0594868789164506
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.00124533	0.0594868789164506
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00124533	0.0594868789164506
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00124533	0.0594868789164506
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.00124533	0.0594868789164506
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.00124533	0.0594868789164506
HAND-FOOT-GENITAL SYNDROME	0.00124533	0.0594868789164506
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00124533	0.0594868789164506
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00124533	0.0594868789164506
URBAN-ROGERS-MEYER SYNDROME	0.00124533	0.0594868789164506
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.00124533	0.0594868789164506
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00124533	0.0594868789164506
PROXIMAL SYMPHALANGISM	0.00124533	0.0594868789164506
2Q23.1 MICRODUPLICATION SYNDROME	0.00124533	0.0594868789164506
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.00124533	0.0594868789164506
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.00124533	0.0594868789164506
1Q21.1 MICRODUPLICATION SYNDROME	0.00124533	0.0594868789164506
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00124533	0.0594868789164506
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00124533	0.0594868789164506
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	0.0594868789164506
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00124533	0.0594868789164506
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00124533	0.0594868789164506
CONGENITAL RUBELLA SYNDROME	0.00124533	0.0594868789164506
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.00124533	0.0594868789164506
CROSSED POLYSYNDACTYLY	0.00124533	0.0594868789164506
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00124533	0.0594868789164506
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00124533	0.0594868789164506
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.0594868789164506
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.00124533	0.0594868789164506
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00124533	0.0594868789164506
RAHMAN SYNDROME	0.00124533	0.0594868789164506
LAURENCE-MOON SYNDROME	0.00124533	0.0594868789164506
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00124533	0.0594868789164506
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.00124533	0.0594868789164506
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.00124533	0.0594868789164506
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	0.0594868789164506
DUANE RETRACTION SYNDROME	0.00124533	0.0594868789164506
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.00124533	0.0594868789164506
NEPHRONOPHTHISIS 11; NPHP11	0.00124533	0.0594868789164506
6P22 MICRODELETION SYNDROME	0.00124533	0.0594868789164506
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.0594868789164506
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00124533	0.0594868789164506
BAKER-GORDON SYNDROME; BAGOS	0.00124533	0.0594868789164506
TRISOMY 20P	0.00124533	0.0594868789164506
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00124533	0.0594868789164506
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.00124533	0.0594868789164506
MIETENS SYNDROME	0.00124533	0.0594868789164506
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00124533	0.0594868789164506
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00124533	0.0594868789164506
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.00124533	0.0594868789164506
MORNING GLORY DISC ANOMALY	0.00124533	0.0594868789164506
NANOPHTHALMOS	0.00124533	0.0594868789164506
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.00124533	0.0594868789164506
ISOLATED COMPLEX I DEFICIENCY	0.00124533	0.0594868789164506
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00124533	0.0594868789164506
THAUVIN-ROBINET-FAIVRE SYNDROME	0.00124533	0.0594868789164506
DESMOSTEROLOSIS	0.00124533	0.0594868789164506
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.00124533	0.0594868789164506
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.00124533	0.0594868789164506
FRONTORHINY	0.00124533	0.0594868789164506
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00124533	0.0594868789164506
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.00124533	0.0594868789164506
OCULAR ALBINISM	0.00124533	0.0594868789164506
MICROFORM HOLOPROSENCEPHALY	0.00124533	0.0594868789164506
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.00124533	0.0594868789164506
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.00124533	0.0594868789164506
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00124533	0.0594868789164506
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.00124533	0.0594868789164506
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00124533	0.0594868789164506
ISOLATED PLAGIOCEPHALY	0.00124533	0.0594868789164506
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.00124533	0.0594868789164506
GORLIN SYNDROME	0.00124533	0.0594868789164506
STIFF SKIN SYNDROME	0.00124533	0.0594868789164506
LEBER CONGENITAL AMAUROSIS 16	0.00124533	0.0594868789164506
ARTERIAL TORTUOSITY SYNDROME	0.00124533	0.0594868789164506
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.00124533	0.0594868789164506
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00124533	0.0594868789164506
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.00124533	0.0594868789164506
SPINOCEREBELLAR ATAXIA TYPE 34	0.00124533	0.0594868789164506
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00124533	0.0594868789164506
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00124533	0.0594868789164506
JACKSON-WEISS SYNDROME	0.00124533	0.0594868789164506
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00124533	0.0594868789164506
CRANIOFACIAL DYSSYNOSTOSIS	0.00124533	0.0594868789164506
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.00124533	0.0594868789164506
RENAL COLOBOMA SYNDROME	0.00124533	0.0594868789164506
CROUZON DISEASE	0.00124533	0.0594868789164506
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00124533	0.0594868789164506
CODAS SYNDROME	0.00124533	0.0594868789164506
XQ21 MICRODELETION SYNDROME	0.00124533	0.0594868789164506
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00124533	0.0594868789164506
OTOMANDIBULAR SYNDROME	0.00124533	0.0594868789164506
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00124533	0.0594868789164506
FREEMAN-SHELDON SYNDROME	0.00124533	0.0594868789164506
DUANE-RADIAL RAY SYNDROME; DRRS	0.00124533	0.0594868789164506
KNOBLOCH SYNDROME	0.00124533	0.0594868789164506
BRANCHIOGENIC DEAFNESS SYNDROME	0.00124533	0.0594868789164506
DISTAL MONOSOMY 10P	0.00124533	0.0594868789164506
TRISOMY 4P	0.00124533	0.0594868789164506
X-LINKED RETINAL DYSPLASIA	0.00124533	0.0594868789164506
WOOLLY HAIR	0.00124533	0.0594868789164506
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00124533	0.0594868789164506
OCULOCUTANEOUS ALBINISM	0.00124533	0.0594868789164506
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.00124533	0.0594868789164506
X-LINKED RECESSIVE OCULAR ALBINISM	0.00124533	0.0594868789164506
HIDROTIC ECTODERMAL DYSPLASIA	0.00124533	0.0594868789164506
EEM SYNDROME	0.00124533	0.0594868789164506
FETAL IODINE SYNDROME	0.00124533	0.0594868789164506
PETERS ANOMALY	0.00124533	0.0594868789164506
FETAL HYDANTOIN SYNDROME	0.00124533	0.0594868789164506
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.00124533	0.0594868789164506
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.00124533	0.0594868789164506
NON-DISTAL MONOSOMY 10Q	0.00124533	0.0594868789164506
GASTROCUTANEOUS SYNDROME	0.00124533	0.0594868789164506
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00124533	0.0594868789164506
OPTIC PATHWAY GLIOMA	0.00124533	0.0594868789164506
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00124533	0.0594868789164506
BENCZE SYNDROME	0.00124533	0.0594868789164506
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00124533	0.0594868789164506
CHAR SYNDROME	0.00124533	0.0594868789164506
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00124533	0.0594868789164506
STEINERT MYOTONIC DYSTROPHY	0.00124533	0.0594868789164506
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00124533	0.0594868789164506
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.0594868789164506
RETINAL CONE DYSTROPHY 3B	0.00124533	0.0594868789164506
CONGENITAL HYDROCEPHALUS	0.00124533	0.0594868789164506
PENTASOMY X	0.00124533	0.0594868789164506
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.00124533	0.0594868789164506
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00124533	0.0594868789164506
INTELLECTUAL DISABILITY, WOLFF TYPE	0.00124533	0.0594868789164506
SPINOCEREBELLAR ATAXIA TYPE 25	0.00124533	0.0594868789164506
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.00124533	0.0594868789164506
PROGEROID SYNDROME, PETTY TYPE	0.00124533	0.0594868789164506
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.00124533	0.0594868789164506
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00124533	0.0594868789164506
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00124533	0.0594868789164506
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00124533	0.0594868789164506
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.00124533	0.0594868789164506
CONGENITAL DISORDER OF GLYCOSYLATION	0.00124533	0.0594868789164506
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00124533	0.0594868789164506
BUSCHKE-OLLENDORFF SYNDROME	0.00124533	0.0594868789164506
SENIOR-LOKEN SYNDROME 9	0.00124533	0.0594868789164506
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00124533	0.0594868789164506
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00124533	0.0594868789164506
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0009615380000000001	0.0459307128066987
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.0009615380000000001	0.0459307128066987
VISCERAL STEATOSIS, CONGENITAL	0.0009615380000000001	0.0459307128066987
SUDDEN CARDIAC FAILURE, INFANTILE	0.0009615380000000001	0.0459307128066987
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0009615380000000001	0.0459307128066987
JOUBERT SYNDROME 27	0.0009615380000000001	0.0459307128066987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0009615380000000001	0.0459307128066987
JOUBERT SYNDROME 28	0.0009615380000000001	0.0459307128066987
FOLATE MALABSORPTION, HEREDITARY	0.0009615380000000001	0.0459307128066987
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0009615380000000001	0.0459307128066987
ETHANOLAMINOSIS	0.0009615380000000001	0.0459307128066987
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.0009615380000000001	0.0459307128066987
EHLERS-DANLOS SYNDROME, TYPE VI	0.0009615380000000001	0.0459307128066987
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.0009615380000000001	0.0459307128066987
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.0009615380000000001	0.0459307128066987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.0009615380000000001	0.0459307128066987
ARIMA SYNDROME	0.0009615380000000001	0.0459307128066987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0009615380000000001	0.0459307128066987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.0009615380000000001	0.0459307128066987
JOUBERT SYNDROME 26	0.0009615380000000001	0.0459307128066987
JOUBERT SYNDROME 25	0.0009615380000000001	0.0459307128066987
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.0009615380000000001	0.0459307128066987
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.0009615380000000001	0.0459307128066987
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0009615380000000001	0.0459307128066987
ROIFMAN SYNDROME; RFMN	0.0009615380000000001	0.0459307128066987
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.0009615380000000001	0.0459307128066987
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.0009615380000000001	0.0459307128066987
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0009615380000000001	0.0459307128066987
VICI SYNDROME; VICIS	0.0009615380000000001	0.0459307128066987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.0009615380000000001	0.0459307128066987
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.0009615380000000001	0.0459307128066987
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
GLUTARIC ACIDEMIA I; GA1	0.0009615380000000001	0.0459307128066987
GLYCOGEN STORAGE DISEASE II	0.0009615380000000001	0.0459307128066987
GLYCOGEN STORAGE DISEASE IV	0.0009615380000000001	0.0459307128066987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.0009615380000000001	0.0459307128066987
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.0009615380000000001	0.0459307128066987
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.0009615380000000001	0.0459307128066987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0009615380000000001	0.0459307128066987
HOLOPROSENCEPHALY 1; HPE1	0.0009615380000000001	0.0459307128066987
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0009615380000000001	0.0459307128066987
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.0009615380000000001	0.0459307128066987
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0009615380000000001	0.0459307128066987
HEART AND BRAIN MALFORMATION SYNDROME	0.0009615380000000001	0.0459307128066987
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.0009615380000000001	0.0459307128066987
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0009615380000000001	0.0459307128066987
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0009615380000000001	0.0459307128066987
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.0009615380000000001	0.0459307128066987
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.0009615380000000001	0.0459307128066987
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0009615380000000001	0.0459307128066987
ACID PHOSPHATASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
RIGID SPINE SYNDROME	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.0009615380000000001	0.0459307128066987
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0009615380000000001	0.0459307128066987
NOONAN SYNDROME 11; NS11	0.0009615380000000001	0.0459307128066987
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.0009615380000000001	0.0459307128066987
ADAMS-OLIVER SYNDROME 1; AOS1	0.0009615380000000001	0.0459307128066987
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.0009615380000000001	0.0459307128066987
AURICULOCONDYLAR SYNDROME	0.0009615380000000001	0.0459307128066987
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0009615380000000001	0.0459307128066987
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0009615380000000001	0.0459307128066987
HYPERCALCEMIA, INFANTILE, 1	0.0009615380000000001	0.0459307128066987
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.0009615380000000001	0.0459307128066987
NEUTRAL LIPID STORAGE MYOPATHY	0.0009615380000000001	0.0459307128066987
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.0009615380000000001	0.0459307128066987
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.0009615380000000001	0.0459307128066987
HOLOPROSENCEPHALY 2; HPE2	0.0009615380000000001	0.0459307128066987
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0009615380000000001	0.0459307128066987
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.0009615380000000001	0.0459307128066987
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0009615380000000001	0.0459307128066987
COFFIN-SIRIS SYNDROME 10; CSS10	0.0009615380000000001	0.0459307128066987
MYOTONIC DYSTROPHY 1	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.0009615380000000001	0.0459307128066987
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.0009615380000000001	0.0459307128066987
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.0009615380000000001	0.0459307128066987
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.0009615380000000001	0.0459307128066987
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.0009615380000000001	0.0459307128066987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.0009615380000000001	0.0459307128066987
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0009615380000000001	0.0459307128066987
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.0009615380000000001	0.0459307128066987
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0009615380000000001	0.0459307128066987
JOUBERT SYNDROME 1	0.0009615380000000001	0.0459307128066987
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.0009615380000000001	0.0459307128066987
GRISCELLI SYNDROME, TYPE 1	0.0009615380000000001	0.0459307128066987
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0009615380000000001	0.0459307128066987
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.0009615380000000001	0.0459307128066987
TEMTAMY SYNDROME; TEMTYS	0.0009615380000000001	0.0459307128066987
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.0009615380000000001	0.0459307128066987
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0009615380000000001	0.0459307128066987
PSEUDO-TORCH SYNDROME 2	0.0009615380000000001	0.0459307128066987
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0009615380000000001	0.0459307128066987
JOUBERT SYNDROME 32; JBTS32	0.0009615380000000001	0.0459307128066987
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.0009615380000000001	0.0459307128066987
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.0009615380000000001	0.0459307128066987
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.0009615380000000001	0.0459307128066987
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.0009615380000000001	0.0459307128066987
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.0009615380000000001	0.0459307128066987
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0009615380000000001	0.0459307128066987
JOUBERT SYNDROME 35; JBTS35	0.0009615380000000001	0.0459307128066987
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.0009615380000000001	0.0459307128066987
CHIARI MALFORMATION TYPE II	0.0009615380000000001	0.0459307128066987
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0009615380000000001	0.0459307128066987
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0009615380000000001	0.0459307128066987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.0009615380000000001	0.0459307128066987
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0009615380000000001	0.0459307128066987
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.0009615380000000001	0.0459307128066987
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0009615380000000001	0.0459307128066987
MAPLE SYRUP URINE DISEASE; MSUD	0.0009615380000000001	0.0459307128066987
JOUBERT SYNDROME 8	0.0009615380000000001	0.0459307128066987
LIVER FAILURE, INFANTILE, TRANSIENT	0.0009615380000000001	0.0459307128066987
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.0009615380000000001	0.0459307128066987
GLYCOGEN STORAGE DISEASE IXC	0.0009615380000000001	0.0459307128066987
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.0009615380000000001	0.0459307128066987
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0009615380000000001	0.0459307128066987
PORPHYRIA, ACUTE HEPATIC	0.0009615380000000001	0.0459307128066987
EPISODIC ATAXIA, TYPE 6	0.0009615380000000001	0.0459307128066987
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0009615380000000001	0.0459307128066987
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.0009615380000000001	0.0459307128066987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0009615380000000001	0.0459307128066987
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0009615380000000001	0.0459307128066987
FONTAINE PROGEROID SYNDROME; FPS	0.0009615380000000001	0.0459307128066987
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0009615380000000001	0.0459307128066987
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.0009615380000000001	0.0459307128066987
TEMPLE-BARAITSER SYNDROME; TMBTS	0.0009615380000000001	0.0459307128066987
COMBINED SAPOSIN DEFICIENCY	0.0009615380000000001	0.0459307128066987
MENKES DISEASE	0.0009615380000000001	0.0459307128066987
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.0009615380000000001	0.0459307128066987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.0009615380000000001	0.0459307128066987
LISSENCEPHALY 3; LIS3	0.0009615380000000001	0.0459307128066987
JOUBERT SYNDROME 7	0.0009615380000000001	0.0459307128066987
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0009615380000000001	0.0459307128066987
MENTAL RETARDATION, X-LINKED 102	0.0009615380000000001	0.0459307128066987
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.0009615380000000001	0.0459307128066987
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0009615380000000001	0.0459307128066987
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0009615380000000001	0.0459307128066987
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.0009615380000000001	0.0459307128066987
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0009615380000000001	0.0459307128066987
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.0009615380000000001	0.0459307128066987
ACETYL-COA CARBOXYLASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0009615380000000001	0.0459307128066987
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.0009615380000000001	0.0459307128066987
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.0009615380000000001	0.0459307128066987
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0009615380000000001	0.0459307128066987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0009615380000000001	0.0459307128066987
CHROMOSOME 4Q21 DELETION SYNDROME	0.0009615380000000001	0.0459307128066987
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0009615380000000001	0.0459307128066987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.0009615380000000001	0.0459307128066987
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.0009615380000000001	0.0459307128066987
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.0009615380000000001	0.0459307128066987
MENTAL RETARDATION, X-LINKED 41	0.0009615380000000001	0.0459307128066987
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.0009615380000000001	0.0459307128066987
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0009615380000000001	0.0459307128066987
EPILEPSY, HOT WATER, 1	0.0009615380000000001	0.0459307128066987
MENTAL RETARDATION, X-LINKED 99	0.0009615380000000001	0.0459307128066987
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.0009615380000000001	0.0459307128066987
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0009615380000000001	0.0459307128066987
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0009615380000000001	0.0459307128066987
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.0009615380000000001	0.0459307128066987
LARSEN-LIKE SYNDROME	0.0009615380000000001	0.0459307128066987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.0009615380000000001	0.0459307128066987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.0009615380000000001	0.0459307128066987
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.0009615380000000001	0.0459307128066987
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.0009615380000000001	0.0459307128066987
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.0009615380000000001	0.0459307128066987
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.0009615380000000001	0.0459307128066987
NIEMANN-PICK DISEASE, TYPE C2	0.0009615380000000001	0.0459307128066987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.0009615380000000001	0.0459307128066987
HYPOTONIA-CYSTINURIA SYNDROME	0.0009615380000000001	0.0459307128066987
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0009615380000000001	0.0459307128066987
JOUBERT SYNDROME 6	0.0009615380000000001	0.0459307128066987
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.0009615380000000001	0.0459307128066987
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0009615380000000001	0.0459307128066987
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0009615380000000001	0.0459307128066987
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.0009615380000000001	0.0459307128066987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.0009615380000000001	0.0459307128066987
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0009615380000000001	0.0459307128066987
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0009615380000000001	0.0459307128066987
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.0009615380000000001	0.0459307128066987
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0009615380000000001	0.0459307128066987
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.0009615380000000001	0.0459307128066987
TIMOTHY SYNDROME; TS	0.0009615380000000001	0.0459307128066987
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0009615380000000001	0.0459307128066987
JOUBERT SYNDROME 3; JBTS3	0.0009615380000000001	0.0459307128066987
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
MEVALONIC ACIDURIA; MEVA	0.0009615380000000001	0.0459307128066987
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0009615380000000001	0.0459307128066987
JOUBERT SYNDROME 5	0.0009615380000000001	0.0459307128066987
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.0009615380000000001	0.0459307128066987
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.0009615380000000001	0.0459307128066987
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0009615380000000001	0.0459307128066987
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.0009615380000000001	0.0459307128066987
JOUBERT SYNDROME 4	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0009615380000000001	0.0459307128066987
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0009615380000000001	0.0459307128066987
GOLDBERG-SHPRINTZEN SYNDROME	0.0009615380000000001	0.0459307128066987
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.0009615380000000001	0.0459307128066987
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.0009615380000000001	0.0459307128066987
PIERSON SYNDROME	0.0009615380000000001	0.0459307128066987
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.0009615380000000001	0.0459307128066987
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0009615380000000001	0.0459307128066987
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0009615380000000001	0.0459307128066987
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.0009615380000000001	0.0459307128066987
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.0009615380000000001	0.0459307128066987
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0009615380000000001	0.0459307128066987
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.0009615380000000001	0.0459307128066987
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
XIA-GIBBS SYNDROME	0.0009615380000000001	0.0459307128066987
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.0009615380000000001	0.0459307128066987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0009615380000000001	0.0459307128066987
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0009615380000000001	0.0459307128066987
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.0009615380000000001	0.0459307128066987
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.0009615380000000001	0.0459307128066987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0009615380000000001	0.0459307128066987
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.0009615380000000001	0.0459307128066987
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.0009615380000000001	0.0459307128066987
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0009615380000000001	0.0459307128066987
ELEJALDE DISEASE	0.0009615380000000001	0.0459307128066987
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.0009615380000000001	0.0459307128066987
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.0009615380000000001	0.0459307128066987
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0009615380000000001	0.0459307128066987
NAVAJO NEUROHEPATOPATHY	0.0009615380000000001	0.0459307128066987
NIEMANN-PICK DISEASE, TYPE A	0.0009615380000000001	0.0459307128066987
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.0009615380000000001	0.0459307128066987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.0009615380000000001	0.0459307128066987
INFANTILE LIVER FAILURE SYNDROME 1	0.0009615380000000001	0.0459307128066987
OSTEOPENIA AND SPARSE HAIR	0.0009615380000000001	0.0459307128066987
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0009615380000000001	0.0459307128066987
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.0009615380000000001	0.0459307128066987
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0009615380000000001	0.0459307128066987
SYDENHAM CHOREA	0.0009615380000000001	0.0459307128066987
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.0009615380000000001	0.0459307128066987
OHDO SYNDROME	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.0009615380000000001	0.0459307128066987
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0009615380000000001	0.0459307128066987
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0009615380000000001	0.0459307128066987
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.0009615380000000001	0.0459307128066987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0009615380000000001	0.0459307128066987
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.0009615380000000001	0.0459307128066987
NEMALINE MYOPATHY 10	0.0009615380000000001	0.0459307128066987
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0009615380000000001	0.0459307128066987
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.0009615380000000001	0.0459307128066987
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
METHYLMALONIC ACIDURIA, CBLB TYPE	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0009615380000000001	0.0459307128066987
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0009615380000000001	0.0459307128066987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.0009615380000000001	0.0459307128066987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.0009615380000000001	0.0459307128066987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.0009615380000000001	0.0459307128066987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.0009615380000000001	0.0459307128066987
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.0009615380000000001	0.0459307128066987
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.0009615380000000001	0.0459307128066987
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0009615380000000001	0.0459307128066987
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0009615380000000001	0.0459307128066987
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0009615380000000001	0.0459307128066987
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.0009615380000000001	0.0459307128066987
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0009615380000000001	0.0459307128066987
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.0009615380000000001	0.0459307128066987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.0009615380000000001	0.0459307128066987
XYLOSIDASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
ZUNICH NEUROECTODERMAL SYNDROME	0.0009615380000000001	0.0459307128066987
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0009615380000000001	0.0459307128066987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0009615380000000001	0.0459307128066987
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.0009615380000000001	0.0459307128066987
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.0009615380000000001	0.0459307128066987
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.0009615380000000001	0.0459307128066987
ROIFMAN SYNDROME	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.0009615380000000001	0.0459307128066987
JOUBERT SYNDROME 15	0.0009615380000000001	0.0459307128066987
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.0009615380000000001	0.0459307128066987
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.0009615380000000001	0.0459307128066987
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.0009615380000000001	0.0459307128066987
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.0009615380000000001	0.0459307128066987
STT3A-CDG	0.0009615380000000001	0.0459307128066987
STT3B-CDG	0.0009615380000000001	0.0459307128066987
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0009615380000000001	0.0459307128066987
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.0009615380000000001	0.0459307128066987
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.0009615380000000001	0.0459307128066987
TAY-SACHS DISEASE; TSD	0.0009615380000000001	0.0459307128066987
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0009615380000000001	0.0459307128066987
LISSENCEPHALY 5; LIS5	0.0009615380000000001	0.0459307128066987
GLYCOGEN STORAGE DISEASE IXB	0.0009615380000000001	0.0459307128066987
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.0009615380000000001	0.0459307128066987
PYRUVATE CARBOXYLASE DEFICIENCY	0.0009615380000000001	0.0459307128066987
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.0009615380000000001	0.0459307128066987
PEROXISOME BIOGENESIS DISORDER 3B	0.0009615380000000001	0.0459307128066987
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.0009615380000000001	0.0459307128066987
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.0009615380000000001	0.0459307128066987
SUSAC SYNDROME	0.0009615380000000001	0.0459307128066987
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0009615380000000001	0.0459307128066987
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0009615380000000001	0.0459307128066987
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0009615380000000001	0.0459307128066987
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0009615380000000001	0.0459307128066987
PEROXISOME BIOGENESIS DISORDER 11B	0.0009615380000000001	0.0459307128066987
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.0009615380000000001	0.0459307128066987
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.0009615380000000001	0.0459307128066987
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0009615380000000001	0.0459307128066987
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0009615380000000001	0.0459307128066987
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.0009615380000000001	0.0459307128066987
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.0009615380000000001	0.0459307128066987
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0009615380000000001	0.0459307128066987
SULFOCYSTEINURIA	0.0009615380000000001	0.0459307128066987
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.0009615380000000001	0.0459307128066987
